  |
  |
Posters
| TOPIC 01.1 |
| Topic 01.1. |
| Blood Safety - TTD - HIV |
| P-001 IMPLEMENTATION OF HIV P24 ANTIGEN AND ANTIBODY COMBINED SCREENING ASSAYS IN BLOOD TRANSFUSION INSTITUTE NOVI SAD |
| S. Bogdanovic, N. Bujandric, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia and Montenegro) |
| P-002 USING THE HARMONIC MEAN TO ESTIMATE BLOOD DONORS RECENTLY INFECTED BY HIV AND TO CALCULATE THE RISK THEY POSE TO THE SOUTH AFRICAN BLOOD SUPPLY |
| G.C. Buckle, G.L. Webb (N.A., Pennington, South Africa) |
| P-003 HTLV I/II INFECTION IN BLOOD DONORS: SEROPREVALENCE AND PERFORMANCE OF DIFFERENT KITS |
| A.O. Chiera, G. Larranaga, C. Bonacina, N. Etchenique (Hemotherapy Institute of Buenos Aires Pr, La Plata. Provincia De Buenos Aires, Argentina) |
| P-004 PATTERNS OF BLOOD PRODUCT TRANSFUSION AT A TERTIARY GYNAECOLOGY UNIT |
| Ndlovu J., Dreyer G (University of Pretoria, Pretoria, South Africa) |
| P-005 SURVEILLANCE OF TRANSFUSION TRANSMITTE INFECTION IN FIRST TIME BLOOD DONORS |
| V. Durro, A. Abazaj, S. Spahiu, S. Seferi (NBTSA, Tirana, Albania) |
| P-006 BLOOD DONORING, PROGRESS IN THE TESTING ON HIV VIRUS |
| C. Gavrancic, B. Gavrancic, T. Jakica (Blood Transfusion Institute, Novi Sad, Yugoslavia) |
| P-007 THE PREVALENCE OF HUMAN HERPESVIRUS 8 (HHV-8) AMONG TEHRAN BLOOD DONORS, HAEMODIALYSIS PATIENTS, AND HIV POSITIVE INDIVIDUALS |
| A. Gharehbaghian, A. Zaghal, M. Farhadi Langerudi, S. Sadri (The Research Center of IBTO, Tehran, Iran) |
| P-008 COST-EFFECTIVENESS OF HIV SCREENING OF BLOOD DONATIONS IN GHANA |
| M. van Hulst, K.W.C. Sagoe, J.E. Vermande, W.P.A. Van der Tuuk Adriani, E.K. Torpey, J. Ansah, J.A. Mingle, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital, Groningen, Netherlands) |
| P-009 TRENDS IN INCIDENCE OF MAJOR TRANSFUSION TRANSMISSIBLE VIRAL INFECTION IN FARS BLOOD DONORS FROM 2002 TILL END OF 2006 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-010 A SURVEY OF EPIDEMIOLOGICAL STATUS AND PREVALENCE RATE OF HIV CASES IN BLOOD DONORS DURING 2005 IN SHIRAZ BLOOD TRANSFUSION ORGANIZATION |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-011 RISK BEHAVIOR AMONG BLOOD DONORS WHO GIVE BLOOD IN ORDER TO BE TESTED FOR HIV IN SHIRAZ BLOOD TRANSFUSION IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-012 REDUCING THE RISK OF BLOOD BORNE TRANSMISSION HBS, HCV AND HIV THROUGH BLOOD TRANSFUSION BY DONOR SELF-DEFERRAL |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-013 THE TRANSFORMATION OF THE BOTSWANA NATIONAL BLOOD TRANSFUSION SERVICE |
| M.K.A. Kayembe, C. Pule, C.I. Tema, J. van Hasselt, S.M. Gaolekwe, B. Gibbs (National Health Laboratory, Gaborone, Botswana) |
| P-014 PREVALENCE OF BLOOD BORNE DISEASE MARKERS AND RESIDUAL RISK IN BLOOD DONORS AT CROATIAN INSTITUTE OF TRANSFUSION MEDICINE 1995-2005 |
| L.M. Lovric, I. Mihaljevic, K. Strahija Tomic, B.M. Balija, J.I. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia) |
| P-015 A REVIEW OF BLOOD DONOR RISK MODEL IN ZIMBABWE |
| T. Mapako, A. Mvere (National Blood Service Zimbabwe, Harare, Zimbabwe) |
| P-016 AN ANALYSIS OF HIV RISK FACTORS FROM POST-DONATION COUNSELLING RECORDS |
| T. Mapako, S. Shamu, A. Mvere, J. Parirewa (National Blood Service Zimbabwe, Harare, Zimbabwe) |
| P-017 HIV-1 INCIDENCE IN BLOOD DONORS IN FRANCE BETWEEN 1992 AND 2004: USE OF AN IMMUNOASSAY TO IDENTIFY RECENT INFECTIONS |
| J.P. Pillonel, F. Barin, S. Laperche, P. Bernillon, S. le Vu, B. Liandier, G. Andreu, J.C. Desenclos (Institut de Veille Sanitaire, Saint-Maurice, France) |
| P-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS DURING THE IMMUNOLOGICAL WINDOW PERIOD BY THE IMPLEMENTATION OF NUCLEIC ACID AMPLIFICATION TECHNOLOGY |
| P.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M. Lemos, M.C.C. Poli, R. Colella, M.M.C. Magri, N.J.F. Cavalcanti, E.C. Sabino, N.A. Salles, D.A.F. Chamone (Banco de Sangue de Sao Paulo, São Paulo, Brazil) |
| P-019 A STATISTICAL DONOR STATUS MODEL THAT MINIMISES THE RISK OF TRANSFUSION-TRANSMITTED HIV IN SOUTH AFRICA |
| J.P. Swanevelder, A. Heyns, R. Reddy, M.P. Busch (South African National Blood Service (SANBS), Roodepoort (Johannesburg), South Africa) |
| P-020 COPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS B VIRUS AMONG VOLUNTEER BLOOD DONORS |
| B. Tiwari, P. Ghimire (Central Blood Transfusion Service, Kathmandu, Nepal) |
| P-021 DOES A HIGH RESULT FOR A QUALITY CONTROL SAMPLE INDICATE A HIGHER FALSE REACTOR RATE IN THE ABBOTT PRISM ASSAYS USED FOR BLOOD DONOR SCREENING? |
| S.K. Walker, B. Francis, K. Smeh, S. Ismay, E.M. Dax, M. Karakaltsas (National Serology Reference Laboratory, Fitzroy, Australia) |
| P-022 TRENDS IN INCIDENCE AND PREVALENCE OF MAJOR TRANSFUSIONTRANSMISSIBLE VIRAL INFECTIONS IN UKRAINIAN BLOOD DONORS |
| M. Zadorin (Clinical research Institute, Kiev, Ukraine) |
| P-023 C-REACTIVE PROTEIN IN HIV POSITIVE SUBJECTS |
| F. Tarabadi, M. Mostakhdemi, M. Shaeigan, G. Babaei, M. Aghaeepour (Iranian Blood Transfusion Organization R, Tehran, Iran) |
| P-024 SOME HEMATOLOGICAL PARAMETERS IN HIV-AIDS PATIENTS IN ILE-IFE, NIGERIA |
| A.O. Adeloye, M.A. Durosinmi (Obafemi Awolowo University, Ile-ife, Nigeria) |
| TOPIC 01.2 |
| Topic 01.2. |
| Blood Safety - TTD - Hepatitis |
| P-025 UTILITY OF SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS ANTIGEN AND ANTIBODIES IN HEMODIALYSIS PATIENTS. |
| J.C. Alados Arboledas, L. Calbo, S. de Tena, M.D. Lopez, J.L. de Francisco, C. de Miguel (Hospital Del Sas De Jerez, Jerez De La Frontera (Cadiz, Spain) |
| P-026 INCIDENCE OF HBSAG, ANTI-HCV, ANTI-HIV ANTIBODIES IN BLOOD DONORS IN OHRID MUNICIPALITY-REPUBLIC OF MACEDONIA |
| A.M. Aleksioska (Medical Center, Ohrid, Macedonia) |
| P-029 EPIDEMIOLOGICAL INVESTIGATION OF TRANSFUSION TRANSMISSIBLE INFECTIONS IN BULGARIA |
| S. Bakalova, P. Kirova, A. Slivov (National Center of Hematology and Transfusion, Sofia, Bulgaria) |
| P-030 THE ELEVATED ALANINE AMINOTRANSFERASE AND HEPATITIS IN BLOOD DONORS |
| E. Berberi, N. Borici, I. Seferi (National Blood Transfusion Centre, Tirana, Albania) |
| P-031 HEPATITIS B IN BLOOD DONORS: ANALYSIS OF TESTING RESULTS IN THE PERIOD 2000-2005 IN BLOOD TRANSFUSION INSTITUTE NOVI SAD |
| B.N. Bujandric, B.S. Bogdanovic, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia and Montenegro) |
| P-032 BENEFITS OF HCV ANTIGEN/ANTIBODY TESTING; A COMPARISON OF THE NEW ABBOTT MUREX HCV AG/AB COMBINATION ASSAY WITH ANTIBODY ONLY TESTING AND A COMPETITOR HCV COMBINATION ASSAY |
| J. Burch, B. Rodgers, J. James, N. Napier, E. Furze, H. Trencher, S. Blincko, D. Trotter, L. McBryne (Abbott Murex, Dartford, Kent, United Kingdom) |
| P-033 HEPATITIS B VIRUS GENOTYPES, CORE PROMOTER AND PRE-CORE MUTATIONS IN SCOTTISH BLOOD DONORS |
| F. Davidson, C. Lycett, E. Erwin, J. Petrik, B. Dow (Scottish National Blood Transfusion Serv, Edinburgh, United Kingdom) |
| P-034 DEVELOPMENT OF A NEW HEPATITIS B SURFACE ANTIGEN ASSAY WITH IMPROVED SENSITIVITY TO WILD TYPE AND VARIANT HBSAG FOR USE ON THE ORTHO CLINICAL DIAGNOSTICS VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM |
| A. Diment, M. van Cleve, S. Son, H. Todd, C. Ching, B. Herring, J. Zheng, P. Kilmartin (Ortho Clinical Diagnostics, High Wycombe, United Kingdom) |
| P-035 NAT HBV: TRANSFUSION SAFETY AND INFECTIVE RESIDUAL RISK |
| M. D'Onofrio, L. Paesano, E. Perna, S. Formisano (AOU "Federico II", Napoli, Italy) |
| P-036 SERO-PREVALENCE OF ANTI- HBC AND ANTI-HBS IN ECONOMIC IMMIGRANTS BLOOD DONORS IN A BLOOD TRANSFUSION CENTER |
| V. Fakitsa, K. Kourenti, M. Papakonstantinou, J. Chaniotis, A. Flangini, G. Lyrakos, P. Karida, B. Restermont, S. Stefanakou, E. Mpotsaki, E. Theologou, K. Sofraniadou (District General Hospital of Nikea, Athens, Greece) |
| P-037 EVALUATION OF THE INTRODUCTION OF OTHER MARKERS OF HEPATITIS B IN ROUTINE TESTING |
| K. Farmaki, C. Papa, I.T. Tzoumari, M.S. Sotiraki, A.C. Chrysanthou, M. Savvanos (General Hospital of Corinth, Corinth, Greece) |
| P-038 A PROTEOMIC APPROACH IN HUMAN PLASMA TO INVESTIGATE POTENTIAL BIOMARKERS FOR RESOLUTION OF ACUTE HEPATITIS C VIRUS INFECTION |
| C. Fournier-Wirth, S. Molina, D. Misse, F. Veas, P. Maurel, J. Coste, C. Fournier-Wirth (Etablissement Français du Sang, Montpellier, France) |
| P-039 POLYMORPHISM OF THE HLA-DQ5 PROMOTER REGION INFLUENCES HUMORAL IMMUNE RESPONSE IN HBSAG VACCINATION AND SISTEMIC LUPUS ERITHEMATOSUS |
| V. Galvani, V. Dolzan, B. Vidan-Jeras (General Hospital Izola, Izola, Slovenia) |
| P-040 PREVALENCE OF HBSAG, HCV, HIV AMONG POTENTIAL VOLUNTARY NON-REMUNERATED BLOOD DONORS: TWELVE YEARS OF OBSERVATION (1994-2005) |
| G. Garozzo, L. Morando, E. Parrino, G. Bussetti, P. Bonomo (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy) |
| P-041 HBV-DNA AND HBCAB IGG IN BLOOD DONORS’ POPULATION |
| G.P. Ghiazza, E. Cesale Ros, G. Cornagliotto, G. Demarin, G. Demarchi, V. Gariglio, R. Marinoni, A. Martinelli, M. Ricotti, M. Trive, F. Eliantonio, A. Garofalo, G. Ghisetti, M. Lupo, F. Palazzo, M. Palazzo, B. Tea, L. Albin (A.S.O. OIRM-S.Anna, Torino, Italy) |
| P-042 PREVALENCE OF TRANSFUSION-TRANSMISSIBLE VIRAL INFECTION IN FIRST-TIME BLOOD DONORS IN UNITED ARAB EMIRATES |
| H. Gohar (Sharjah Blood Transfusion Center, Sharjah, United Arab Emirates) |
| P-043 REACTIVITY OF GENOTYPICALLY DISTINCT HEPATITIS B VIRUS SURFACE B VIRUS ANTIGENS (HBSAG) BY AN AUTOMATED CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY |
| N.S.L. Gonçales, M.C. Favarelli, P.A. Tonetto, R.G.F. Domínguez, J.B.A. Neto, F.L. Goncales (University of Campinas-UNICAMP, Campinas, Brazil) |
| P-044 EVALUATION THE PERFORMANCE OF QUANTITATIVE HEPATITIS B SURFACE ANTIGEN (HBSAG) BY AN AUTOMATED CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY, IN A BRAZILIAN BLOOD BANK. |
| N.S.L. Gonçales, M.C. Favarelli, J.B.A. Neto, R.G.F. Domínguez, G.Q. Prado, R. Guedes (University of Campinas-UNICAMP, Campinas, Brazil) |
| P-045 DEVELOPMENT OF HUMAN ANTI-CMV IGG ASSAY FOR THE ARCHITECT ANALYZER |
| J. Herzogenrath, I. Curdt, H. Christ, S. Bernhardt, R. Stricker, R. Stricker, M. Hausmann (Abbott GmbH & Co. KG, Wiesbaden, Germany) |
| P-046 COMBINATION HEPATITIS C VIRUS ANTIGEN AND ANTIBODY IMMUNOASSAY AS A NEW TOOL FOR EARLY DIAGNOSIS OF INFECTION |
| G.C. Icardi, F. Ansaldi, C. Sticchi, C. Riccio, P. Lai, B. Bruzzone (University of Genoa, Genoa, Italy) |
| P-047 THE FIRST NATIONAL REPORT OF TT( TRANSFUSION TRANSMITTED) VIRUS PREVALENCE IN DIFFERENT RACIAL GROUPS ADMITTED TO AHWAZ TRANSFUSION SERVICE (IRAN) BY POLYMERASE CHAIN REACTION(PCR) |
| M.A. Jalali Far, T. Zanieh, S.A. Emam, A.A. Pourfathollah (IBTO Research Center, Ahwaz, Iran) |
| P-048 RELATION OF HEPATITIS C VIRUS (HCV) PREVALENCE, ABO AND RH BLOOD GROUPS AND OTHER RISK INDICATORS AMONG BLOOD DONORS IN PORT HARCOURT, NIGERIA |
| A. Jeremiah, B. Koate (Rivers State University of Sci & Tech, Port Harcourt, Nigeria) |
| P-049 EVALUATION OF THE ENHANCED ARCHITECT® ANTI-HCV ASSAY FOR DONOR SCREENING |
| G. Jonas, C. Beckert, C. Pelzer, M. Hausmann, H.-P. Kapprell (Abbott GmbH & Co. KG, Wiesbaden, Germany) |
| P-050 A CASE CONTROL OF EPIDEMIOLOGICAL STATUS OF HEPATITIS B POSITIVE CASES AMONG SHIRAZIAN BLOOD DONORS IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-051 A SURVEY OF EPIDEMIOLOGICAL STATUS OF HEPATITIS C INFECTION AMONG SHIRAZIAN BLOOD DONORS IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-052 RISK BEHAVIOUR AND MOTIVATION OF HEPATITIS C CASES IN BLOOD DONORS DURING 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-053 EVALUATION OF THREE AUTOMATED ANALYZERS FOR VIRAL SCREENING TESTS IN BLOOD DONORS |
| M.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, D.J. Oh, Q. Park, N.S. Cho, Y.J. Cha, B.M. Shin (Korean Red Cross, Seoul, South-Korea) |
| P-054 REACTIVATION OF HEPATITIS B VIRUS (HBV) IN A MULTITRANSFUSED PATIENT - CONFIRMATION BY LOOK-BACK STUDY USING STORED SPECIMENS |
| S Kino, Y. Tomoda, R. Endo, K. Shibusa, K. Ikuta, K. Sato, Y. Kogo, K. Morishita, S. Sato, T. Kato, H. Ikeda (Asahikawa Medical College Hospital, Asahikawa, Japan) |
| P-055 CONFIRMATION FOR DISCOVERED HCV-AB TO VOLUNTEER DONORS IN THE DEPARTMENT FOR TRANSFUSION IN TETOVO DURING 2005 BY USING PCR TECHNIQUE |
| E. Kocovska, S. Kostovska, T.T. Timova (Tetovo Hospital, Tetovo, Macedonia) |
| P-056 PREVALENCE OF ANTI-HBC ANTIBODIES IN BLOOD DONORS IN THE SOUTH REGION OF POLAND |
| J. Kusmierczyk, J. Zatorska, J. Ras, A.S. Swierk, A. Glista, Z.B. Banach, A.G. Gasiorkiewicz, A.K. Kolbusz (Regional Blood Centre, Cracow, Poland) |
| P-057 OCCURRENCE OF HBSAG MUTANTS IN TWO KOREAN BLOOD DONORS |
| S.Y. Kwon, K.W. Youn, O.J. Kwon, S.W. Ryu, E.J. Kim, U.S. Joung, M.W. Hwang, D.H. Seo, N.S. Cho (Korean Red Cross, Seoul, South-Korea) |
| P-058 HEPATITIS B VIRUS GENOTYPES AND SURFACE ANTIGEN VARIANTS IN FRENCH BLOOD DONORS |
| S. Laperche, A. Sevant-Delmas, F. Bouchardeau, A. Girault, M. Mercier, F. Wind, M.H. Elghouzzi (INTS, Paris, France) |
| P-059 HEPATITIS C VIRAL INFECTION AMONG BLOOD DONORS - ROUTE OF TRANSMISION |
| I. Libek, D. Mijovic Nikolic (Clinical Hospital Zemun, Belgrade, Serbia and Montenegro) |
| P-060 SEROPREVALENCE OF VIRAL HEPATITIS A IN BLOOD DONORS IN MARIBOR |
| B.M.V. Majcen Vivod, V.U.S. Urlep Salinovic, L. Lokar, B.B. Bizjak, I.M. Maracic (Maribor Teaching Hospital, Maribor, Slovenia) |
| P-061 HEPATITIS B AND MOLECULAR SCREENING ASSAYS: EVIDENCE FOR DIFFERENT OUTCOMES OF THIS INFECTION |
| M. Miceli, P. Iudicone, G. Isacchi, A. Agresti, M. Palange, A. Di Lorenzo, E. Mannella (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy) |
| P-062 LOW RATE OF OCCULT HEPATITIS B VIRUS INFECTION AMONG ANTI-HBC POSITIVE BLOOD DONORS IN YOUNG VOLUNTEER DONORS OF KOREA |
| H.K. Min, C. Ihm, Y.G. Kim (Medical & Quality Management Office, Dae, Taejeon, South-Korea) |
| P-063 INCREASED RISK OF HEPATITIS IN TAIWANESE MALE CONSCRIPTEES WITH TATTOOS |
| D.E.R. Ming-der (Yung-Kang Veterans Hospital, Yuan-kang City, Tainan, Taiwan) |
| P-064 EVOLUTION OF HCV GENOTYPES IN LISBON REGIONAL BLOOD CENTER |
| M.I. Neves, J. Pereira, F. Ferreira, G. Sousa (Instituto Português do Sangue/CRSL, Lisboa, Portugal) |
| P-065 THE PREVALENCE OF HEPATITIS MARKERS AMONG THE PATIENTS WITH ALL |
| T. Nurka, R. Çina, G. Kuli, S. Lako, V. Kardhashi (National Blood Transfusion Service, Tirana, Albania) |
| P-066 PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG) SEROPOSITIVITY IN SICKLE CELL ANAEMIA PATIENTS IN BENIN CITY |
| E.C. Okocha, O.A. Ejele (Nnamdi Azikiwe University, Nnewi, Nigeria) |
| P-067 SEROLOGICAL MARKERS FOR HBV INFECTION IN PORTUGUESE BLOOD DONORS |
| M. Queiros, C. Carvalho, S. Neto, J. Leal, P Mota, C. Moreira, C. Castro (IPS Centro Regional do Porto, Porto, Portugal) |
| P-068 EVALUATION OF THE COBAS TAQSCREEN MPX TEST FOR THE SIMULTANEOUS DETECTION OF HCV, HBV, HIV-1 GROUP M, HIV-1 GROUP O AND HIV-2. EXPERIENCE OF THE PORTO REGIONAL BLOOD CENTRE |
| L. Queiros, A. Tender, A. Aguiar, J. Azevedo (Centro Regional de Sangue do Porto, Porto,Portugal) |
| P-069 THE IMPORTANCE OF NEOPTERIN TESTING FOR DIAGNOSTICS |
| A. Ragimov, N. Dashkova, N. Nikishova (National Research Center of Surgery, Moscow, Russian Federation) |
| P-070 ANTI-HBC TESTING OF BLOOD DONORS IN INDIA - VALUE AND FOLLOW-UP STRATEGIES TO IMPROVE BLOOD SAFETY WITH MINIMUM LOSSES |
| H. Ranganathan, J. Diment, K. Kulathu, N. Iyer (Global Hospital, Hyderabad, India) |
| P-071 HCV INFECTION IN MULTI-TRANSFUSED AND PUTATIVE IMMUNO-COMPROMISED PATIENTS IN ARGENTINA |
| M.C.R. Remesar, C. Gamba, S. Oknaian, M. Batalla, A.E. Del Pozo (Hospital de Pediatria Garrahan, Buenos Aires, Argentina) |
| P-072 EVALUATION OF A NEW HCV COMBINATION ASSAY IN THE TAIWANESE BLOOD DONOR POPULATION |
| C. Rodgers, K.T. Lin, Y.W. Wu, Y.J. Lee, J.W. Chen, K.C. Lin (Abbott Laboratories, Dartford,United Kingdom) |
| P-073 EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASED ON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENING BLOOD DONATIONS IN ARGENTINA |
| E. Rodriguez, A. Guichón, M.E. Acevedo, L. Tomasone, R.J. Fernández (Fundación Hemocentro Buenos Aires, Buenos Aires, Argentina) |
| P-074 MOLECULAR EPIDEMIOLOGY OF HCV IN PORTUGAL |
| S.S. Sargento, A.M. Almeida, C. Ferreira, E. Silva, P. Neto, C. Colaborators (Hospitais da Universidade de Coimbra, Coimbra, Portugal) |
| P-075 SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUS IN SPANISH BLOOD DONORS: EVIDENCE OF OCCULT HEPATITIS B |
| S. Sauleda, R.M. Maymo, M. Piron, D. Candotti, J.P. Allain, J.M. Hernandez, L.l. Puig, N. Casamitjana (Banc de Sang i Teixits, Barcelona, Spain) |
| P-076 EPIDEMIOLOGY OF HIV, HCV AND HBV INFECTIONS IN ABOUT 1.4 MILLION VOLUNTARY, NON-REMUNERATED BLOOD DONATIONS OF THE GERMAN RED CROSS BLOOD DONOR SERVICE BADEN-WUERTTEMBERGHESSEN IN THE YEAR 2005. |
| E. Schellenberg, S. Findhammer, K. Frank, K. Gubbe, A. Karl, G. Geusendam, A. Vosberg, T. Dengler, U. Mayr-Wohlfahrt, M. Loehr, E. Gruenelt, M. Schmidt, W. Sireis, E. Seifried (Red Cross Blood Donor Service Ba-Wue-He, Frankfurt am Main, Germany) |
| P-077 ANTI-HBC SCREENING OF BLOOD DONORS - A COMPARISON OF SEVEN ANTI-HBC SCREENING ASSAYS |
| M.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl, M. Loehr, E. Gruenelt, W. Sireis, W.K. Roth, E. Seifried, G. Geusendam (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-078 IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONOR SCREENING IN GERMANY |
| M.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl, M. Loehr, E. Gruenelt, W. Sireis, E. Seifried, G. Geusendam (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-079 PREVALENCE OF ANTI-HBC ANTIBODIES IN SWISS BLOOD DONORS, A 4 MONTH SURVEY AT THE BLOOD TRANSFUSION CENTER BASEL |
| C. Stebler, L. Infanti, B. Eiche, M. Santoro, C. Doepfner, T. Rüefli, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-080 TRANSFUSION OF BLOOD FROM TWO DANISH BLOOD DONORS INFECTED WITH HEPATITIS B VIRUS ESCAPE MUTANTS – DIFFERENT OUTCOME IN 10 RECIPIENTS |
| H. Ullum, L. Harritshøj, U. Wend, P. Platz, H. Ring-Larsen, E. Dickmeiss, W.G. Wolfram (Rigshospitalet, Copenhagen, Denmark) |
| P-081 HCV GENOTYPE DISTRIBUTION AMONG NORTHEAST-THAI BLOOD DONORS |
| Y. Urwijitaroon, C. Sengthong, S. Barusrux (Fac.Associated Medical Sciences, Khon Kaen, Thailand) |
| P-082 HBV DNA DETECTION IN HBSAG NEGATIVE/ANTI-CORE POSITIVE ITALIAN FIRST TIME BLOOD DONORS |
| C. Velati, L. Romanò, L. Fomiatti, G. Cambiè, A. Zanetti (Dipartimento di Medicina Trasfusionale, Sondrio, Italy) |
| P-083 TRANSFUSION-TRANSMITTED DISEASES AND THEIR FREQUENCY CHANGE BY THE YEARS IN BLOOD DONORS OF A HOSPITAL BLOOD BANK IN GREECE |
| K. Ziciadis, F. Karabini, E. Xanthi, A. Tzolou, E. Chrisostomou, E. Zervou (University Hospital of Ioannina, Ioannina, Greece) |
| P-084 THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGH BLOOD TRANSFUSION IN UNITED ARAB EMIRATES |
| A.H.A. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates) |
| P-085 EVIDENCE ON ANTI-HBc REACTIVITY AMONG GREEK BLOOD DONORS AND CORRELATION BETWEEN ANTI-HBc TITRE AND THE PRESENCE OF HBV DNA |
| A. Varaklioti, I. Kalfa, A. Kapsalis, A. Kouramba, P. Kotsi, A. Karafoulidou (2nd Blood Transfusion Center, Athens, Greece) |
| TOPIC 01.3 |
| Topic 01.3 |
| Blood Safety - TTD - TSEs |
| P-086 HIGH RATE OF VCJD TRANSMISSION IN MICE BY INTRAVENOUS INOCULATION OF WHOLE BLOOD |
| L. Cervenakova, O. Yakovleva, C. McKenzie (J.H.Holland Laboratory, ARC, Rockville, United States of America) |
| P-087 PERFORMANCE CHARACTERISTICS OF PALL’S ENHANCED LEUKOTRAP AFFINITY PRION REDUCTION FILTER |
| O. Coker, F. Andrade, S. Pesci, T. Budziak, F. Madraswalla, J. Peterson, B. Selman, G. DelGiacco (Pall Corporation, Port Washington, United States of America) |
| P-088 CREUTZFELDT-JAKOB DISEASE LOOK-BACK STUDY: AN UPDATE |
| K.A. Dorsey, S. Zou, E.P. Notari, C.T. Fang, R.Y. Dodd, L.B. Schonberger (American Red Cross, Rockville, United States of America) |
| P-089 ABILITY OF THE MACOPHARMA PRION CAPTURE (P-CAPTTM) FILTER TO REMOVE BRAIN PRPRES IN LEUKOREDUCED HUMAN RBC |
| L.G. Gregori, B. Lambert, R. Rohwer (VA Medical Center, Baltimore, United States of America) |
| P-090 IN VITRO EVALUATION OF RED CELL CONCENTRATES AFTER FILTRATION OVER THE NEW COMPOSAFE PR SYSTEM (SYSTEM FOR PRION REDUCTION FROM LEUKOCYTE DEPLETED RCC) |
| D. de Korte, R. Vlaar, C.W.N. Gouwerok, M. Kleine, S. Borghi, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-091 DETECTION OF INFECTIOUS PRION IN BLOOD BY PROTEIN MISFOLDING CYCLIC AMPLIFICATION TECHNOLOGY (PMCA) |
| F. Leon, C. Segarra, J. Coste (Etablissement Français du Sang, Montpellier, France) |
| P-092 REMOVAL OF THE ENDOGENOUS TSE INFECTIVITY PRESENT IN BLOOD USING PRDT TSE AFFINITY LIGANDS AND INTEGRATION OF THE LIGANDS INTO THE MACOPHARMA P-CAPT(TM) FILTER |
| G. Rohwer, L. Gregori, P. Gurgel, J. Lathrop, P. Edwardson, B. Lambert, R.G. Carbonell, S.J.B. Burton, D.J.H. Hammond (VA Maryland Health Care System, Baltimore, United States of America) |
| P-093 WHAT DIFFERENCE IN PRION PROTEIN EXPRESSION AND PROCESSING IN HUMAN BLOOD CELLS BETWEEN METHIONINE HOMOZYGOUS AND VALINE DONORS AT CODON 129 OF THE PRNP GENE |
| C. Segarra, S. Lehmann, J. Coste (Etablissement Français du Sang, Montpellier, France) |
| TOPIC 01.4 |
| Topic 01.4. |
| Blood Safety - TTD - West Nile Virus |
| P-094 WEST NILE VIRUS (WNV) AND DENGUE VIRUS (DV) ARE LOW RISK FOR TRANSFUSION IN GHANA |
| J.P. Allain, C. Li, K. Danso, E. Addo-Yobo, S. Owusu-Ofori (University of Cambridge, Cambridge, United Kingdom) |
| P-095 MONITORING OF GENETIC VARIABILITY OF WEST NILE VIRUS IN BLOOD DONOR SPECIMENS USING A MICROARRAY-BASED ASSAY |
| M. Rios, A. Grinev, S. Daniel, M. Laassri, V. Chizhikov, K. Chumakov, I.K. Hewlett (CBER/FDA, Bethesda, United States of America) |
| TOPIC 01.5 |
| Topic 01.5. |
| Blood Safety - TTD - Emerging Pathogens |
| P-100 IMMUNOGLOBULIN G ANTIBODIES AGAINST ENVIRONMENTAL MOULDS IN A NORWEGIAN HEALTHY POPULATION SHOWS A BIMODAL DISTRIBUTION FOR ASPERGILLUS VERSICOLOR |
| G. Hetland, B. Rydjord, V. Svenningsen, H.G. Wiker (Ulleval University Hospital, Oslo, Norway) |
| P-101 THE NEEDS OF LOOK BACK ON SCREENING OF HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1 AND 11 (HTLV I / II) AMONG BLOOD DONORS IN SAUDI ARABIA |
| S. ibrahim Hindawi, G.A. Damanhouri, I.S. Kawashti, I. Felemban, M. Alshawa, M. Khanbashi (KAUH, Jeddah, Saudi Arabia) |
| P-102 TRANSFUSION-TRANSMITTED HUMAN PARVOVIRUS B19 INFECTION IN A THALASSAEMIA PATIENTS |
| M. Mahmoodian Shooshtari, M. Nabi Foroghi, Z. Sharifi (Research Center of IBTO, Tehran, Iran) |
| P-103 IN VITRO EVALUATION OF CELL-MEDIATED IMMUNITY TO EPSTEIN BARR VIRUS |
| M. Mahmoodian Shooshtari, M. Bani Talebi Dehkordi, Z. Sharifi (Research Center of IBTO, Tehran, Iran) |
| P-104 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLASMA AND PLATELETS USING HELINX TECHNOLOGY, AS UTILIZED IN THE INTERCEPT BLOOD SYSTEM |
| L. Corash, L. Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham, K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, United States of America) |
| TOPIC 01.6 |
| Topic 01.6. |
| Blood Safety - TTD - Nucleic Acid Amplification Technology (NAT) |
| P-105 THE CONTRIBUTION OF NUCLEID ACID TESTING (NAT) IN BLOOD TRANSFUSION SAFETY. DETECTION OF FOUR NAT HBV DNA POSITIVE, HBS AG NEGATIVE IN SINGLE BLOOD DONATIONS |
| C. Politi, V. Dimitra, L. Kavallierou, V. Triantaltillou, (G.Gennimatas Hospital, Athens, Greece) |
| P-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HBV/HCV NAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT IN KUMASI, GHANA |
| J.P. Allain, S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie (University of Cambridge, Cambridge, United Kingdom) |
| P-107 PREVALENCE OF HCV AND HGV INFECTION AMONG THALASSEMICS, HEMOPHILICS, AND HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITIS |
| S. Amini Kafi-abad, A. Talebian, S. Samiee, F. Ranjbar Kermani, M.M. Moghtadaie, F. Ferdowsian, N.P. Pasandideh, Z. Ataie, M. Kavari, A. Gharehbaghian (Research Center of Iranian Blood Transfusion, Tehran, Iran) |
| P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NAT SYSTEMS CHIRON PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201 |
| A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel, G. Andreu (EFS Centre Atlantique, Tours, France) |
| P-109 WINDOW PERIOD OF HIV INFECTION IN A REPEAT BLOOD DONOR |
| L. Barea, R. Gonzalez, J.l. Bueno, L. Muñoz, A. Garcia, E. Castro (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNA POSITIVE/ HBSAG NEGATIVE BLOOD DONORS |
| E. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematology and Blood Transfusion, Warsaw, Poland) |
| P-111 HIGH THROUGH-PUT, INDIVIDUAL DONOR TESTING (IDT) USING THE PROCLEIX TIGRIS SYSTEM: A 5-MONTH EXPERIENCE |
| R. Cable (Western Province Blood Transfusion Servi, Cape Town, South Africa) |
| P-112 INTERPRETATION OF HBV NAT RESULTS IN HEALTHY SUBJECTS |
| G. Cambie, A. Degiuli, S. Conca, E. Parabiaghi, L. Vignati, M.L. Nardella, M. D'Agostino, F. D'Agostino (Azienda Ospedaliera di Lodi, Lodi, Italy) |
| P-113 ACUTE PHASE AND OCCULT HBV INFECTIONS WITH MULTIPLE MUTATIONS IN THE SURFACE ANTIGEN “A” DETERMINANT DETECTED BY HBV/HCV/HIV-1 TMA SCREENING OF SPANISH BLOOD DONORS |
| E. Castro, P. Torres, R. González, A. Ontañón, L. González Ponte, M. Sedeño, J.M. Echevarría, M. Koppelman, H. Zaaijer, J.M. Hernández, N. Lelie (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-114 ANALYTICAL PERFORMANCE OF PROCLEIX DUPLEX AND TRIPLEX TMA ASSAYS IN AN HISTORICAL PROFICIENCY PROGRAMME |
| A. van Drimmelen, P.N. Lelie, D. Jardine (AcroMetrix Europe, Alkmaar, Netherlands) |
| P-115 REAL- TIME PCR ASSAY BY LIGHT CYCLER FOR THE DETECTION OF PLASMODIUM SPECIES |
| S. Dupont, A. Berry, J.M. Fondere, C. Segarra, C. Maugard, T. Levayer (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-116 AN HCV SEROCONVERSION DETECTED USING A NAT TEST PROCEDURE DURING SCREENIG OF BLOOD AND BLOOD COMPONENTS IN A DONOR POPULATION IN ITALIAN CAMPANIA REGION |
| C. de Felice, C. de Felice, F. Morelli, A. Miscioscia, D. Ametrano, C. Fasulo, S. Guardascione, M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy) |
| P-117 INDIVIDUAL HEPATITIS B VIRUS NUCLEIC ACID TESTING (HBV-NAT) ON 61.825 BLOOD DONATIONS IN MADRID, SPAIN |
| R. Gonzalez, J.M. Echevarría, A. Avellon, L. Barea, J.L. Bueno, E. Castro (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-118 EVALUATION OF SINGLE NAT IN A NATIONAL BLOOD SERVICE |
| A. Gottreich, B. Cohen, L. Shvartz, V. Arad, O. Frenkel, V.B. Yahalom, E. Shinar (Magen David Adom, Tel-hasomer, Israel) |
| P-119 PERFORMANCE CHARACTERISTICS OF A NEW MULTIPLEX NAT SCREENING TEST FOR HBV, HCV AND HIV: THE COBAS TAQSCREEN MPX TEST ON THE COBAS S 201 SYSTEM |
| S. Herman, Y. Ohhashi, E. Kyger, H. Halait, M. Wiedmann, M. Zauke, L. Pietrelli (Roche Molecular Systems, Inc., Pleasanton, United States of America) |
| P-120 EXPERIENCE OF A LARGE GERMAN RED CROSS BLOOD DONOR SERVICE WITH NAT-TESTING: RESULTS OF SCREENING MORE THAN 9 MILLION BLOOD DONATIONS FOR HIV-1, HCV AND HBV |
| M.K. Hourfar, W.K. Roth, A. Themann, K. Gubbe, U. Mayr-Wohlfart, E. Seifried, M. Schmidt (German Red Cross, Institute Frankfurt, Frankfurt, Germany) |
| P-121 SIMULTANEOUS SCREENING FOR HCV, HIV-1 AND HBV IN BLOOD DONATIONS WITH THE FULLY AUTOMATED SYSTEM |
| P. Iudicone, M. Miceli, A. Agresti, M. Palange, A. Di Lorenzo, S. Berardini, C. Amedeo, A. Tudisco, R. Colaceci, E. Mannella (A.O. S.Camillo-Forlanini, Rome, Italy) |
| P-122 QUALITY CONTROL PROGRAMME FOR NUCLEIC ACID SCREENING IN BLOOD SERVICE LABORATORIES |
| K. Jardine, B.R.J. Dent, T. Pham, W. Dimech, E.M. Dax (National Serology Reference Laboratory, Fitzroy, Australia) |
| P-123 EVALUATION OF THE COBAS TAQSCREEN MULTIPLEX TEST AND S201 AUTOMATED NAT PLATFORM IN THE SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE. |
| L. Jarvis, A. Cleland, T. Dunsford, K. Mulligan, J. Petrik (SNBTS, Edinburgh, United Kingdom) |
| P-124 HBV AND HCV INFECTED BLOOD DONATIONS INTERDICTED BY INDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT) IN LITHUANIA |
| V. Kalibatas, J. Irzikeviciene, N. Lelie (National Blood Centre, Vilnius, Lithuania) |
| P-125 ANALYTICAL AND CLINICAL PERFORMANCE OF THE PROCLEIX ULTRIO HIV-1/HCV/HBV ASSAY IN LOW VIRAL LOAD SAMPLES |
| A. Katsoulidou, Z. Moschidis, V. Sypsa, M. Chini, G. Papatheodoridis, N. Tassopoulos, K. Mimidis, A. Karafoulidou, A. Hatzakis (Athens University Medical School, Athens, Greece) |
| P-126 THE IMPORTANCE OF IMPLEMENTING THE HBV DNA SCREENING USING NAT TESTING FOR TRANSFUSIONAL VALIDATION IN A HIGH HBV RISK AREA |
| M. Manca, A. Spano, R. Occhineri, F. Fadda, P. Manchia, F. Lumbau, P. Murgia, G. Tala, G. Sanna, G. Cossu (AUSL 1 - Sassari, Sassari, Italy) |
| P-127 HCV, HIV-1, HBV MOLECULAR SCREENING FOR BLOOD DONATION: FROM SEMI-AUTOMATE SYSTEMS TO THE FULLY AUTOMATED INSTRUMENT PLATFORM |
| E. Mannella, P. Iudicone, M. Palange, A. Agresti, R. Colaceci, A. Tudisco, C. Amedeo, S. Berardini, M. Miceli (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy) |
| P-128 COMPARISON OF THE CHIRON PROCLEIX® TIGRIS® AND ROCHE COBAS S 201 NUCLEIC ACID TESTING (NAT) SYSTEMS FOR SIMULTANEOUS DETECTION OF HIV/HCV RNA AND HBV DNA |
| A.R. Margaritis, S. Brown, C.R. Seed, P. Kiely, B. D'Agostino, C.K. Lin, A.J. Keller (Australian Red Cross Blood Service, Perth, Australia) |
| P-129 BENEFITS OF THE TEST CHIRON PROCLEIX ULTRIO ASSAY HCV/HIV/HBB IN THE IMPROVEMENT OF BLOOD SAFETY |
| F. Morelli, C. de Felice, M.M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy) |
| P-130 AUTOMATED HANDLING OF LARGE POOLS FOR MULTIPLEX NAT SCREENING OF HCV, HIV-1 (GROUPS M & O), HIV-2, AND HBV ON THE COBAS S 201 SYSTEM |
| J. Nunes, H. Rothe, C. Parkhouse, I. Trefil, J. Weinberger, G. Velasco-Corpuz, J. Sopher (Roche Molecular Systems, Pleasanton, United States of America) |
| P-131 HCV, HIV, HBV GENOME DETECTION IN BLOOD DONORS WITH THE USE OF A NEW MOLECULAR ASSAY |
| E. Perna, M. D'Onofrio, L. Paesano, G. Ciardiello, E. D'Agostino, S. Formisano (AOU Federico II, Naples, Italy) |
| P-132 HBV DNA TESTING IN BLOOD DONORS REACTIVE FOR ANTI HBC ANTIBODY - A PILOT STUDY FROM SOUTH INDIA |
| H. Ranganathan, N. Iyer, D. Saranath, K. Kulathu (Global Hospital, Hyderabad, India) |
| P-133 PREVALENCE OF CMV-DNA IN IRANIAN HEALTHY BLOOD DONORS |
| F. Ranjbar Kermani, S. Amini, A. Talebian, S. Samiei, F. Ferdowsian, M. Sobhani (Iranian Blood Transfusion Research Center, Tehran, Iran) |
| P-134 EARLY EXPERIENCE WITH INDIVIDUAL DONATION HBV/HCV/HIV-1 NUCLEIC ACID AMPLIFICATION TESTING (ID-NAT) IN THE SOUTH AFRICAN NATIONAL BL0OD SERVICE |
| W. Sykes, M. Vermeulen, A. Neill, E. Kuun, N. Lelie, J. Mitchell, L. Pillay, R. Reddy (South African National Blood Service, Pinetown, South Africa) |
| P-135 NAT SCREENING FOR HIV/HCV (PROCLEIX, CHIRON) IN SINGLE DONATION IN COIMBRA, PORTUGAL (2000-2006) |
| J.N. Teixeira, F. Henggeler, R. Diniz, B. Caldeira, N. Mateus, H. Gonçalves (Portuguese Blood Institute, Coimbra, Portugal) |
| P-136 EVALUATION OF ACCEPTED BLOOD DONORS WITH A MULTIPLEX NUCLEIC ACID TEST (NAT)AT CHIANG MAI UNIVERSITY HOSPITAL, THAILAND |
| L.T. Thaikruea, N.N. Niwes, S.T. Thongsawat, L.N. Litrakoon, L.F. Fonksatidkil, P.S. Sompan, A.H. Heaton, D.N. Nichols, K.N. Nelson (Department of Community Medicine, Chiang Mai 50200, Thailand) |
| P-137 NAT SCREENING FOR HCV, HIV AND HBV ON BLOOD DONATIONS IN ITALY |
| C. Velati, L. Fomiatti, L. Romanò, L. Baruffi, A. Zanetti (Dipartimento di Medicina Trasfusionale, Sondrio, Italy) |
| P-138 ANALYTICAL PERFORMANCE CHARACTERISTICS OF THE PROCLEIX ULTRIO HIV-1/HCV/HBV ASSAY ON TIGRIS IN A LARGE SCALE EVALUATION OF INDIVIDUAL DONATION NAT IN SOUTH AFRICA |
| M. Vermeulen, W. Sykes, L. Gaggia, N. Lelie, R. Reddy, E. Kuun, A. Neil (South African National Blood Service (SANBS), Johannesburg, South Africa) |
| P-139 DETECTION OF BRUCELLA AMONG VOLUNTARY BLOOD DONORS IN TURKEY BY USING NEW REAL TIME PCR METHOD |
| T. Yavuz, D. Kaya (Duzce University Medical School, Duzce, Turkey) |
| P-140 DRUG RESISTANCE INHIBITION IN KEUKEMIC CELLS BY ANTISENSE OLIGONUCLEOTIDES |
| F. Nadali, A.A. Pourfatollah, K. Alimoghaddam (School of Medicine, Isfahan, Iran) |
| TOPIC 01.7 |
| Topic 01.7. |
| Blood Safety - TTD - Bacterial Contamination |
| P-141 ROUTINE BACTERIAL MONITORING OF PLATELETS AT THE WELSH BLOOD SERVICE |
| R. Ahya, G. Rowe, M. Hayward, S. Pearce, R. Jones (Welsh Blood Service, South Glamorgan, United Kingdom) |
| P-142 DETECTION OF MICROBIAL CONTAMINATION OF POOLED WHOLE BLOOD-DERIVED PLATELET-RICH PLASMA PLATELETS IN THE GREATEST BLOOD BANK ROUTINE OF LATIN AMERICA |
| G.A.O.B. Barna, R.K.F. Guillaume, C.R. Kamakura, S.R. Matana, M.V. Moço, P.C. Sierra, S.M. Winkaler, P.E. Dorlhiac-Llacer, D.A.F. Chamone (Pro-Sangue Sao Paulo Blood Center, Sao Paulo, Brazil) |
| P-143 BACTERIA RAPID DETECTION IN NON LEUCOCYTE REDUCED WHOLE BLOOD PLATELETS |
| I. Besson Faure, I. Besson Faure, A. Raimondo, A.E. Houlle Declomesnil (Hemosystem, Marseille, France) |
| P-144 AUTOMATION OF THE SCANSYSTEM™ PROCESS |
| I. Besson Faure, R. Chollet, A.E. Houlle Declomesnil (Hemosystem, Marseille, France) |
| P-145 PREVENTION OF TRANSFUSION-TRAMSMITTED BACTERIAL INFECTIONS |
| E.K. Klausa, B.M. Muzala - Bogdan, J.K. Korsak (Regional Centre
of Transfusion Medicine, Wroclaw, Poland) |
| P-146 COMPARISON OF TWO SYSTEMS (BACT/ALERT VS SCANSYSTEM) FOR ROUTINE BACTERIAL DETECTION IN T-SOL BUFFY COAT PLATELET CONCENTRATES |
| M. Lambermont, R. de Meuter, D. Sondag (Service du Sang, Belgian Red Cross, Brussels, Belgium) |
| P-147 VALUE OF ANAEROBIC CULTURE IN BACTERIAL SURVEILLANCE PROGRAMME FOR PLATELET CONCENTRATES |
| C. Lee, C.K. Lee, P.L. Ho, W.C. Tsoi, C.K. Lin (HK Red Cross Blood Transfusion Service, Hong Kong, China) |
| P-148 DETECTION OF BACTERIAL CONTAMINATION IN RED CELL UNITS USING THE PALL ENHANCED BACTERIAL DETECTION SYSTEM |
| C.P. McDonald, K. Goodhand, K. Wilkins, J. Colvin (National Blood Service, London, United Kingdom) |
| P-149 ARE THE BACT/ALERT AND PALL ENHANCED BACTERIAL DETECTION SYSTEMS SUITABLE FOR SCREENING PLATELET ADDITIVE SOLUTION (PAS) PLATELET CONCENTRATES? |
| C.P. McDonald, J. Sapsford, J. Colvin, C. Biggs, K. Goodhand (National Blood Service, London, United Kingdom) |
| P-150 EVALUATION AND ROUTINE PERFORMANCE OF A "BEST PRACTICE" DONOR ARM DISINFECTION PROCEDURE: CHLORAPREP® |
| C.P. McDonald, C. Biggs, B. Lees, N. Beckman, J. Kellington, G. Evans (National Blood Service, London, United Kingdom) |
| P-151 BACTERIAL CONTAMINATION OF BLOOD COMPONENTS |
| S.M. Milosavljevic, A.M. Andjelic, N.N. Nedeljkovic, V.P. Poprzen, D.V. Vidanovic (National Blood Transfusion Institute, Belgrade, Serbia and Montenegro) |
| P-152 PLATELET BACTERIA SCREENING - HOW TO APPLY THE DIFFERENT APPROACHES? |
| Th. Montag-Lessing (Paul Ehrlich Institute, Langen, Germany) |
| P-153 REDUCTION OF BACTERIAL LOAD DURING PREPARATION OF POOLED PLATELET CONCENTRATES FROM BUFFY COATS EXPLAINS A SIMILAR CONTAMINATION RATE AS IN APHERESIS PLATELETS |
| H. Müller, A. Bayer, H. Mohr (DRK-Blutspendedienst NSTOB, Springe, Germany) |
| P-154 GROWTH PROPERTIES OF DIFFERENT BACTERIA STRAINS IN PLATELET CONCENTRATES AND CONSEQUENCES FOR THE APPLICATION OF SCREENING METHODS |
| S.B. Nicol, M. Schmidt, J. Brachert, Th. Montag (Paul Ehrlich Institut, Langen, Germany) |
| P-155 DETECTION OF BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES: A REAL TIME DNA POLYMERASE CHAIN REACTION TEST IS FEASIBLE BEFORE TRANSFUSION |
| P. Pagliaro, C. Glingani (Ospedale Carlo Poma, Mantova, Italy) |
| P-156 DEVELOPMENT OF A REAL-TIME POLYMERASE CHAIN REACTION FOR THE DETECTION OF GRAM-POSITIVE BACTERIA IN PLATELET CONCENTRATES |
| M. Piron, N. Casamitjana, M. Bes, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain) |
| P-157 EVALUATION OF THE CORRECT USE OF VIRKON DISINFECTANT IN REDUCING BACTERIAL CONTAMINATION OF PLATELETS COMPONENTS PREPARED IN TEHRAN BLOOD CENTER WITHIN SECOND HALF OF 2005 |
| M Sadeh (Islamic Azaad University, Tehran, Iran) |
| P-158 NOVEL APPLICATION WITH QUENCHING DYE IMPROVES OPTIMIZED SCANSYSTEMTM FOR RAPID BACTERIAL DETECTION |
| M.S. Schmidt, A. Themann, S.-B Nicol, T. Montag, W.K. Roth, E. Seifried, M.K. Hourfar (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-159 DEATH AFTER TRANSFUSION OF PLATELET CONCENTRATE CONTAMINATED WITH KLEBSIELLA PNEUMONIAE |
| M.S. Schmidt, S.-B Nicol, M.K. Hourfar, W. Sireis, W. Weichert, E. Seifried, T. Montag (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| TOPIC 01.8 |
| Topic 01.8. |
| Blood Safety - TTD - Parasites and Protozoa |
| P-160 IMPLEMENTATION OF CHAGAS DISEASE SCREENING IN FRENCH BLOOD DONORS |
| A. Assal, C. Cornillot, N. Baudoncourt, O. Garraud, G. Andreu (EFS Centre Atlantique, Tours, France) |
| P-161 CORRELATION BETWEEN THE SPECIFIC SERUM IMMUNOGLUBULINES ( IGE,IGG) WITH EOSINOPHILIA IN CYSTIC HYDATIDOSIS PATIENTS |
| Z. Ghayour (School of Medicine, Isfahan, Iran) |
| P-162 PREVALENCE OF TRYPANOSOMA CRUZI INFECTION AFTER SCREENING OF BLOOD DONORS AT RISK IN NORTHEAST SPAIN |
| M. Piron, R.M. Maymo, J.M. Hernandez, M. Verges, M. Portus, R. Fisas, N. Casamitjana, J. Munoz, J. Gascon, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain) |
| P-163 EFFICACY OF THE LEUKOREDUCTION TO REDUCE THE RISK OF LEISHMANIA INFANTUM TRANSFUSION TRANSMISSION. STUDY IN BLOOD DONORS FROM THE MAJORCA ISLAND (BALEARIC ISLANDS, SPAIN) |
| C. Riera, P. Lopez-Chejade, R. Fisa, T. Serra, M. Sedeno, T.
Jimenez, E. Girona, M. Mascaro, J. Muncunill, M. Udina, A. Forteza, M. Gallego, J. Carrio, M. Portus (Universitat de Barcelona/Facultad de Far, Barcelona, Spain) |
| P-164 SERO - EPIDEMIOLOGICAL STUDY OF CHAGAS’ DISEASE AND SYPHILIS IN THE CENTENNIAL PROVINCIAL HOSPITAL ROSARIO ARGENTINA |
| P. Sciarratta, M.A. Operto, J. Valverde (Fac. Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina) |
| P-165 EVALUATION OF THE ARCHITECT SYPHILIS TP ASSAY IN A SWISS BLOOD BANK- A PROSPECTIVE COMPARISON WITH THE SERODIA TPPA ASSAY |
| C. Stebler, L. Infanti, M. Santoro, T. Rüefli, C. Doepfner, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-166 MEASUREMENT OF P. VIVAX PARASITEMIA. |
| I.B. Suh, S.W. Ryu, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea) |
| TOPIC 02.1 |
| Topic 02.1. |
| Red Cells - Immunohaematology |
| P-168 DIFFICULTIES IN THE DETECTION OF KIDD ANTIBODIES |
| S. Adam, V. Kretschmer (Institut of Transfusion Medicine, Marburg, Germany) |
| P-169 AN ACUTE HAEMOLYTIC TRANSFUSION REACTION (AHTR) DUE TO AN UNDETECTABLE ANTI-JKA |
| S. Adam, G. Bringmann, M. Bieringer, H.J. Heyers, V. Kretschmer (Institut of Transfusion Medicine, Marburg, Germany) |
| P-170 FLOW CYTOMETRY AND PANEL REACTIVE ANTIBODY METHODS FOR DETECTING ANTI-HLA CLASS-I ANTIBODIES |
| M. Aghaeipour (Iranian Blood Transfusion Research Cente, Tehran, Iran) |
| P-171 DETERMINATION OF A DISSOCIATION PARAMETER IN RED BLOOD CELLS AGGLUTINATED BY MONOCLONAL ANTIBODY ANTI-A USING A LASER BACKSCATTERING TECHNIQUE |
| L.V. Altube, P. Foresto, B. Riquelme, A. Marenzana, J. Valverde (UNR, Rosario, Argentina) |
| P-172 IL-8 & TNF-A LEVELS IN DUFFY NEGATIVE BLOOD DONORS |
| O.A. Asher, C. Pariente, H. Kanety, S. Gelman, E. Shinar, V. Yahalom (Blood Services Center, Magen David Adom, Ramat Gan, Israel) |
| P-173 FIRST FINDING OF GY(A-) PHENOTYPE IN THE CZECH REPUBLIC SINCE ITS DISCOVERY IN 1967. POSSIBLE RELATIONSHIP TO ORIGINAL PROBANDS FOUND IN THE USA IN 1967-1968 |
| H. Banzetova, D. Bystricka, O. Cerna, M. Pisacka, J. Poole, J. Svobodna, P. Trubac (Hospital of Ceske Budejovice, Ceske Budejovice, Czech Republic) |
| P-174 ABO BLOOD GROUP GENOTYPING IN CROATIAN BLOOD DONORS |
| J. Bingulac-Popovic, V. Drazic, J. Culej, I. Babic, Z. Hundric-Haspl, C. Maglov, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-175 ABO BLOOD GROUPS AND RISK OF THROMBOSIS |
| J. Bingulac-Popovic, V. Drazic, I. Babic, J. Culej, M. Tomicic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-176 THE COMPUTER COSSMATCH: THE VALIDATION AND 1ST. IMPLEMENTATION IN CZECH REPUBLIC |
| M. Bohonek, D. Horcickova, M. Blazkova, T. Lejdar, P. Svenda (Central Military Hospital, Prague, Czech Republic) |
| P-177 UNEXPECTED RESULTS IN BLOOD GROUP SEROLOGY: THE CHALLENGE OF IMMUNOHAEMATOLOGICAL PUZZLING |
| A.G. van den Bos, B.D. Steetzel, C. Mouton, S. Kapteijns-van Kordelaar, V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands) |
| P-178 ASSESSMENT OF IMMUNOLOGICAL PROPERTIES OF MIRASOL PATHOGEN REDUCTION TREATED RED BLOOD CELLS |
| K.A. Buytaert-Hoefen, H. Reddy, S. Doane, R. Goodrich (Navigant Biotechnologies, Lakewood, Colorado, United States of America) |
| P-179 EXPRESSION OF ABH ANTIGENS IN PATIENTS WITH PRECANCEROUS AND CANCEROUS ORAL LESIONS |
| C. Campi, S. García Borrás, L. Racca, A. Racca, C. Cotorruelo, C. Biondi (Universidad Nacional de Rosario, Rosario, Argentina) |
| P-180 HIGH-THROUGHPUT DNA ANALYSIS FOR RED BLOOD CELL ANTIGENS FACILITATES THE TRANSFUSION SUPPORT WITH ANTIGEN-MATCHED BLOOD IN POLYTRANSFUSED PATIENTS |
| L.C. Castilho, J. Pellegrino Jr, M. Mota, G. Hashmi, S. Shariff, M. Seul, F. Costa (Unicamp, Campinas, Brazil) |
| P-181 DNA ANALYSIS IN A MICROARRAY AS A SUBSTITUTE FOR DOMBROCK TYPING: A NOVEL ALLELE IN BRAZILIANS |
| L.C. Castilho, W. Baleotti Jr, K. Ribeiro, D.C. Credidio, G. Hashmi, M.E. Reid (Unicamp, Campinas, Brazil) |
| P-182 RHD GENOTYPING OF BLOOD DONORS MAY PREVENT ALLOIMMUNIZATION BY D ANTIGEN |
| L.C. Castilho, T. Paixao, C. Barros, D.C. Credidio, K. Ribeiro, F. Costa (Unicamp, Campinas, Brazil) |
| P-183 A NOVEL DO ALLELE COMBINATION NAMELY DOB-WL |
| L.C. Castilho, W. Baleotti Jr, M.E. Reid, M. Rios, J. Pellegrino Jr, A. Fabron Jr, F. Costa (Unicamp, Campinas, Brazil) |
| P-184 EVALUATION OF THE GALILEO AUTOMATED BLOOD BANK SYSTEM FOR WEAK D DETECTION ON BLOOD DONORS |
| M. Chabert, M.J. Rodrigues, C. Cordeiro, P. Fernandes, V. Paquete, M. Rodrigues, J. Pereira, P. Mendonca (Instituto Português do Sangue, Lisboa, Portugal) |
| P-185 THE VALUE OF ELUTION TEST USING GEL MICROCOLUMN AGGLUTINATION METHOD FOR ACID ELUATES |
| P. Chalkia, E. Kostopoulou, A. Tsoukala, V. Avgoloupi, P. Didoudi, S. Intzepeli, V. Bakaloudi, E. Ntinopoulou, H. Hassapopoulou, E. Hassapopoulou (Ahepa Hospital, Thessaloniki, Greece) |
| P-186 MOLECULAR GENETIC ANALYSIS AND FREQUENCY SURVEY OF H DEFICIENT PHENOTYPE IN FUJIAN POPULATION |
| Q. Chi, Y.J. Guo, W. Tang, Y. Chen, C.Q. Wang, G.L. Chen (Fujian Blood Center, Fuzhou, China) |
| P-187 PATERNAL RHD ZYGOSITY: SEROLOGY VERSUS GENETIC ANALYSIS |
| M. Christiansen, W. Kjellberg, O.B. Petersen, N. Grunnet (Aarhus University Hospital, Aarhus N, Denmark) |
| P-188 ACHIEVING REDUCED CYCLE TIMES FOR PRETRANSFUSION TESTING WITH TEST ORDER ENTRY MODIFICATIONS ON AUTOMATION |
| C. Colavecchia, A. Coovadia, S. South (Sunnybrook & Womens College HS Centre, Toronto, Canada) |
| P-189 MOLECULAR BACKGROUNDS FOR THE DCE (R0) HAPLOTYPE |
| C. Cotorruelo, G. Munini, S. García Borrás, L. Racca, R. Di Mónaco, C. Biondi, A. Racca (Universidad Nacional de Rosario, Rosario, Argentina) |
| P-190 ANALYSIS OF THE DEFORMABILITY OF ADHERED CELLS BY MEANS OF DIGITAL IMAGE PROCESSING |
| V. Danieli, A. D'Arrigo, D. Riquelme (Fac. Cs. Bioq. y Farm. - U.N.R., Rosario, Argentina) |
| P-191 FLEXIBILITY, SAFETY AND HIGH TROUGHPUT IN SAMPLING PROCESSUS OF BLOOD DONOR OR PATIENT SAMPLES FOR COMPLETE BLOOD GROUP SEROLOGY - EVALUATION OF A NEW AUTOMATE : HEMOS EVOLUTION (BIORAD) |
| M. Delamaire, S. Gaucheron, S. Flageul, G. Semana (Etablissement Français du Sang, Rennes, France) |
| P-192 HEREDITARY HEMOCHROMATOSIS: THE HAPTOGLOBIN 2-2 TYPE DISPLAYS A SIGNIFICANT BUT MODERATE INFLUENCE ON PHENOTYPIC EXPRESSION OF THE PREDOMINANT C282Y HOMOZYGOUS GENOTYPE |
| G. le Gac, C. Ka, V. Scotet, I. Gourlaouen, L. Bryckaert, C. Férec (EFS-Bretagne, INSERM U613, Brest, France) |
| P-193 K NULL PHENOTYPE CAUSED BY PREMATURE STOP CODON IN EXON 14 OF KEL GENE: A CASE REPORT. |
| A. Doescher, F. Wagner, E.K. Petershofen (German Red Cross Blood Transf.Service, Oldenburg, Germany) |
| P-194 MOLECULAR GENETIC RHCE CHARACTERIZATION OF 100 CASES WITH PROBLEMS IN AUTOMATED RH DETERMINATION. |
| A. Doescher, E.K. Petershofen, F. Wagner (German Red Cross Blood Transf.Service, Oldenburg, Germany) |
| P-195 PERFORMANCE EVALUATION STUDY OF A NOVEL LATERAL FLOW ASSAY FOR SIMULTANEOUS TYPING OF ABO, D, RHESUS SUBGROUPS AND K (“MDMULTICARD”) |
| C.G. Geisen, P. Schwind, E. Seifried (DRK Blood Donor Service, Frankfurt, Germany) |
| P-196 DIRECT ANTIGLOBULIN TEST (DAT) WITH A WALK AWAY INSTRUMENT AUTOVUE |
| L.W. Gustafsson (Karolinska, Stockholm, Sweden) |
| P-197 GYPB SILENCING IN AFRICAN AMERICANS BUT NOT IN CAUCASIANS |
| G. Hashmi, T. Shariff, Y. Zhang, K. Hue-Roye, D. Charles-Pierre, C. Lomas-Francis, M. Reid (Bioarrays Solutions, Warren, United States of America) |
| P-198 SEROLOGIC DIFFERENTIATION BETWEEN PARTIAL D AND WEAK D AND CORRELATION WITH RHESUS PHENOTYPES CCEE |
| E. Hassapopoulou, E. Kostopoulou, V. Bakaloudi, E. Ntinopoulou, P. Chalkia, P. Didoudi, V. Avgoloupi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-199 DBRBC- A NEW COLLABORATIVE RED BLOOD CELL BIOINFORMATICS RESOURCE |
| M. Helmberg, M. Feolo, D. Hoffman, R. Dunivin, O. Blumenfeld (Medical University Graz, Graz, Austria) |
| P-200 A NEW GENERATION OF ANTIBODY SCREENING TEST USING E.M. TECHNOLOGY ON A FULLY AUTOMATED SYSTEM AND A MANUAL WORKSTATION |
| F. Herbert, A. Boulet, D. Buns, A. Delanoe, P. Desmet, V. Godefroy, J.M. Pelosin, S. Petit, S. Sergent, O. Boulet, L. Fauconnier, S. Thorigny (Diagast, Loos, France) |
| P-201 ABO DISCREPANCIES AFTER INTENSIVE CHEMOTHERAPY FOR MALIGNANT DISEASES |
| T.I. Izumi, Y. Okada, K. Kashiwazaki, S. Tsunoda, H. Kobayashi, M. Akutsu, Y. Kano (Tochigi Cancer Center, Utsunomiya, Japan) |
| P-202 PERFORMANCE COMPARISON OF MEDION-MDMULTICARD, ID-DIAMED AND SCANGEL-BIORAD RHD/ABO SEROTYPING USING A MULTI-VARIANT, CAUCASIAN-SPECIFIC, GENOTYPED DONOR PANEL |
| C. Gassner, E. Rainer, E. Pircher, L. Markut, G. Kormoczi, C. Jungbauer, D. Wessin, R. Klinghofer, H. Schennach, P. Schwind, D. Schonitzer (Central Institute for Blood Transfusion, Innsbruck, Austria) |
| P-203 EVALUATION OF THE DIAGAST READY-TO-USE OLYMP RANGE FOR THE NEW ANALYSER OLYMPUS PK 7300 |
| L. Keyser, K. Keyser, C. Cordier, V. Godefroy, J.M. Pelosin, C. Gues, S. Simon, S. Thorigny (Diagast, Loos, France) |
| P-204 LINKAGE DISEQUILIBRIUM OF RHD 1227A AND IVS7+293T LEADING TO ABERRANT RNA SPLICING IN DEL INDIVIDUALS |
| H.L. Eng, T.M. Lin, Y.F. Yang, Y.C. Wang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin (Chang Gung Memorial Hosp and University, Kaohsiung County, Taiwan) |
| P-205 THE FREQUENCY AND CLINICAL SIGNIFICANCE OF DELAYED SEROLOGICAL TRANSFUSION REACTIONS IN KOREAN POPULATION |
| C. Kim, T. Park, E. Lee, H. Son (Pusan National University Hospital, Busan, South-Korea) |
| P-206 THE ANTI-D PROGRAMME - THE SOUTH AFRICAN EXPERIENCE |
| P. Fogg, E. Smart, C. Olsen, V. Somerset, V. Poovalingam (South African National Blood Service ECR, Durban, South Africa) |
| P-207 DEVELOPMENT OF A MONOCLONAL ANTI-GLOBULIN REAGENT |
| H. Fraser, A. Mackie, D.A. Colligan, R.G. Drake, E. Shakir, J. Robb, A.G. Robb (Scottish National Blood Transfusion Serv, Glasgow, United Kingdom) |
| P-208 THE IMPORTANCE OF USING A COMBINATION OF D-TYPING METHODS AND REAGENTS IN PATIENTS |
| E. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, V. Bakaloudi, P. Chalkia, V. Avgoloupi, P. Didoudi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-209 SIGNIFICANT DIFFERENCES IN THE SENSITIVITY OF DIFFERENT GEL CENTRIFUGATION TECHNIQUES |
| V. Kretschmer, M. Bornmann, K. Schmidt, R. Karger (Institute Transfus. Med. Haemostaseol., Marburg, Germany) |
| P-210 COMPARATIVE ANALYSIS OF THE ABO AND RH CDE PHENOTYPE FREQUENCIES AMONG VARIOUS ETHNIC GROUPS IN PORT HARCOURT, NIGERIA |
| A. Jeremiah, I. Buseri (Rivers State University of Sci & Tech, Port Harcourt, Nigeria) |
| P-211 PARTIAL D (DNB) IN A PREGNANT WOMAN WITH RHD POSITIVE SEROLOGY AND DEVELOPMENT OF ANTI-D: CASE REPORT |
| V. Drazic, J. Mikulandra-Mratinovic, J. Bingulac-Popovic, S. Dajak, I. Babic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-212 A COMPARISON OF CONVENTIONAL TUBE TECHNIQUE AND GEL TECHNIQUE IN EVALUATION OF DIRECT ANTIGLOBULIN TEST |
| D. Khetan, R. Chaudhary, S. Das (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-213 BLOOD GROUPING AUTOMATION IN A BLOOD TRANSFUSION CENTER |
| V. Fakitsa, M. Papakonstantinou, A. Flangini, K. Maltezis, I. Flessiopoulou, G. Lyrakos, S. Giannoulea, H. Desilla, C.H. Antoniou, P. Alexiou, T. Micha, E. Sotiropoulou, K. Sofroniadou (District General Hospital of Nikea, Athens, Greece) |
| P-214 ISOLATED MOTHER/CHILD MISMATCH IN THE RH SYSTEM |
| E.M. Dauber, M. Klintschar, D. Mayr, W.R. Mayr (Medical University of Vienna, Vienna, Austria) |
| P-215 DIRECT COOMBS (DAT) IN NEWBORN CHILDREN WITH HEAMOLYTIC JAUNDICE |
| E. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, P. Chalkia, S. Intzepeli, V. Avgoloupi, P. Didoudi, V. Bakaloudi, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-216 ANTI-Mg FOUND IN ABO TEST REAGENT OF HUMAN ORIGIN - CASE REPORT |
| R. Djordjevic, S. Draskovic, M. Sindjic, S. Tadic, M. Jovicic, Z. Smiljkovic, N. Tijanic, O. Ciric (National Blood Transfusion Institute, Belgrade, Serbia and Montenegro) |
| P-217 DRB1 ALLELES IN ARGENTINIAN PATIENTS WITH CHAGAS DISEASE |
| S. García Borrás, O. Pellizon, C. Cotorruelo, C. Biondi, J. Beloscar, O. Bottasso, C. Diez, A. Racca (Facultad de Ciencias Bioquímicas, Rosario, Argentina) |
| P-218 CLASSIFICATION OF PARTIAL D VARIANTS BY SEROLOGICAL AND MOLECULAR METHODS |
| S.S. Kulkarni, K. Vasantha, S.C. Gupte, D. Mohanty, K. Ghosh (Institute of Immunohaematology, Mumbai, India) |
| P-219 APLICATION OF FLOW CYTOMETRY IN DETERMINATION OF SUB-POPULATION OF RED BLOOD CELL |
| N. Lebensohn, L. Di Tullio, J. Valverde, P. Foresto (Fac. Cs. Bioquímias y Farmacéuticas - UNR, Rosario, Argentina) |
| P-220 AN UNUSUAL CASE OF AN ANTIBODY TO A HIGH FREQUENCY ANTIGEN IN A PATIENT WITH A POSITIVE DAT AND FREE AUTOANTIBODY |
| E. Lee, M. Redman, R. Malde (National Blood Service, London, United Kingdom) |
| P-221 STANDARDIZATION OF FETAL DNA EXTRACTION FOR NON INVASIVE PRENATAL RHD TYPING |
| J. Legler, L. Liu, A. Ait Soussan, C.E. van der Schoot (University Clinics Goettingen, Goettingen, Germany) |
| P-222 IMPAIRED INTERACTION IN RHD/RHAG-ANKYRIN COMPLEX ACCOUNTS FOR RHD DEFICIENCY IN DEL PHENOTYPE |
| T.M. Lin, H.L. Eng, Y.F. Yang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin, Y.C. Wang (National Cheng Kung University, Tainan, Taiwan) |
| P-223 COMPARISON OF SCANGEL, DIAMED, IN-HOUSE SPAT AND TUBE LISS ANTIGLOBULIN TEST FOR ANTIBODY DETECTION |
| L.A. Mohabir, C. Womersley (Welsh Blood Service, Pontyclun, United Kingdom) |
| P-224 FREQUENCY OF BLOOD GROUPS ABO AND RHESUS D IN THE GUINEAN POPULATION |
| A. Loua, M.R. Lamah, M. Camara (Centre National de Transfusion Sanguine, Conakry, Guinea) |
| P-225 CHARACTERIZATION OF A NOVEL B(A) ALLELE WITH BBBA TYPE AT THE ABO BLOOD GROUP |
| L. Lu, Q. Yu, Y.Q. Su, Z.H. Deng (ShenZhen Institute Of TransfusionMedicin, Shenzhen, China) |
| P-226 COMPARATIVE STUDY OF TUBE AND GEL TECHNIQUES FOR COMPATIBILITY TESTING AND ANTIBODY IDENTIFICATION |
| R.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India) |
| P-227 RHD GENE MOLECULAR VARIANTS IN THE WESTERN PART OF FRANCE : IDENTIFICATION OF 13 NEW ALLELES |
| C. le Marechal, C. Guerry, C. Benech, L. Burlot, F. Cordellier, M. Delamaire, C. Ferec (French Blood Center, Brest, France) |
| P-228 GENOTYPING OF DUFFY, KIDD, MNS BLOOD GROUPS : THE EFS PYRENEES MEDITERRANEE EXPERIENCE |
| C. Maugard, R. Aznar, N. Chikh, C. Segarra, O. Bouix, J. Coste (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-229 ANTI-JK3 ALLOANTIBODIES IN THE PATIENT WITH JK NULL PHENOTYPE AND JKA/JKA GENOTYPE |
| E. Brojer, B. Michalewska, A. Kucmierz, M. Pelc-Klopotowska, A. Orzinska, H. Lopienska (Institute of Haematology and Blood Transfusion, Warsaw, Poland) |
| P-230 EVALUATION OF THE DIAGAST ERYTHROCYTES MAGNETIZED TECHNOLOGY |
| L.A. Mohabir, C. Womersley, Y. Barbreau, A.S. Degryse, J.M. Pelosin (Welsh Blood Service, Pontyclun, United Kingdom) |
| P-231 UNUSUAL ANTIBODY SPECIFICITY IN AN AFRICAN AMERICAN PATIENT WITH U-VARIANT RED BLOOD CELLS |
| C. Lomas-Francis, K. Hue-Roye, A. Fuchisawa, S.Y. Choo, C. m.d. Whitsett (New York Blood Center, New York, United States of America) |
| P-232 EVALUATION OF A NEW TECHNOLOGY FOR BLOOD GROUPING AND PHENOTYPING |
| M.A. Mota, M.G. Aravechia, V.L. Wakim, A.M. Sakashita, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-233 POST-TRANSFUSION HYPERHEMOLYSIS AFTER HEMOLYTIC TRANSFUSION REACTION IN A PATIENT WITH SEVERE ANEMIA: CASE REPORT |
| M.A. Mota, A.M. Sakashita, N. Hamerschlak, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-234 APPLICATION OF FY GENOTYPING TO DETERMINE BLOOD GROUP-SPECIFIC CHIMERISM AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION |
| M.A. Mota, A.A. Ciferri, R.A.A. Pereira, A.M. Sakashita, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-235 IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF HY AND JOA NEGATIVE BLOOD DONORS IN SOUTHERN USA |
| M. Moulds, W. Long, Q. Chen, M. Stone, D. Tulley, E. Lowery, A. Steinmetz, J. Moulds (LifeShare Blood Centers, Shreveport, United States of America) |
| P-236 ANTIBODY PREVALENCE IN A HETEROGENEOUS POPULATION OF PREGNANT WOMEN AND NEONATES |
| S. Mudahi-Orenstein, N. Lev, Y. Dakosta, O. Zelig, N. Manny (Hadassah Hebrew University Medical Center, Jerusalem, Israel) |
| P-237 DETECTION OF WEAK D TYPE 1, 2 AND 3 WITHIN WEAK D/C+ AND WEAK D/E+ RECIPIENTS IN DAILY PRACTICE : SEROLOGY, MOLECULAR BIOLOGY OR BOTH ? |
| F. Noizat-Pirenne, M. Verdier, A. Lejealle, A. Mercadier, A. Fialaire-Legendre, C. Tournamille, P. Bonin, P. Bierling, H. Ansart-Pirenne (Etablissement Français du Sang, Créteil, France) |
| P-238 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303 RBC FOR PATHOGEN INACTIVATION SUBSTANTIALLY REDUCES THE POTENTIAL FOR CROSS-REACTIVITY |
| A. North, G. Garratty, M.A. Schott, P. Arndt, G. Castro, A. Erickson, P. Mintz, L. Corash (Cerus Corporation, Concord, Ca, United States of America) |
| P-239 THREE NEW FUT1 ALLELES ENCODE DEFECTIVE FUCOSYLTRANSFERASES IDENTIFIED FROM PARA-BOMBAY PHENOTYPE INDIVIDUALS |
| K. Ogasawara, H. Tsuneyama, M. Uchikawa, S. Itou, K. Tadokoro, M. Satake, K. Nakajima (Red Cross Central Blood Institute, Tokyo, Japan) |
| P-240 A CASE OF SEVERE RH D ALLOIMMUNIZATION TREATED BY INTENSIVE PLASMA EXCHANGE AND HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN |
| P.M. Palfi, L. Matthiesen, J.O. Hilden, A. Selbing, G. Berlin (University Hospital, Linköping, Sweden) |
| P-241 MCLEOD PHENOTYPE - PHENOTYPE AND GENOTYPE IN A CASE OF MCLEOD SYNDROME WITH SEVERE NEUROLOGICAL SYMPTOMES |
| M. Písacka, L. Tilley, M. Kralova, J. Klempir, J. Roth (Instituteof Hematology and Blood Transfusion, Prague, Czech Republic) |
| P-242 MEDIATORS OF THE SELECTIVE CLEARANCE OF SENESCENT ERYTHROCYTES |
| A. Racca, C. Biondi, M.A. Ensinck, S. García Borrás, L. Racca, C. Cotorruelo (Facultad de Bioquímica, Rosario, Argentina) |
| P-243 RHMOD PHENOTYPE CAUSED BY DOUBLE HETEROZYGOSITY FOR TWO NEW ALLELES OF THE RHAG GENE |
| A. Scharberg, H. Tsuneyama, K. Ogasawara, M. Uchikawa, H.H. Keller, K. Panter, J. Senne, S. Penz, E. Richter, P. Bugert (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany) |
| P-244 OUR EXPIRIENCES IN TYPING AND SCREENING RED CELL ALO-ANTIBODIES IN SERA OF PATIENTS WHO ARE TESTED BY THE COLUMN AGGLUTINATION TECHNOLOGY ANTI-HUMAN GLOBULIN TEST |
| B. Stankovic, M. Trkuljic (Institute of Transfusiology, Belgrade, Yugoslavia) |
| P-245 B-CELL MEMORY AGAINST RHD ANTIGEN IN HYPERIMMUNIZED DONORS IS MAINLY PRESENT IN A CD27 NEGATIVE IGM POSITIVE B-CELL SUBSET |
| C.E. van der Schoot, C.E. van der Schoot, L.J. Gruneberg, O.H.M. Verhagen, G. Vidarsson, S.E. Dohmen (Sanquin Research, Amsterdam, Netherlands) |
| P-246 O BLOOD GROUP, WHERE ART THOU? |
| A. Seltsam, C. Figueiredo, C. Das Gupta, O. Bock, R. Blasczyk (Hannover Medical School, Hannover, Germany) |
| P-247 THE INCIDENCE OF DCE RH PHENOTYPE IN NAKASERO BLOOD BANK DONORS |
| P. Senyonga (Uganda Blood Transfusion Service, Kampala, Uganda) |
| P-248 RBC ALLOANTIBODIES FREQUENCY IN PREGNANT WOMEN |
| L. Suput-Tomas, M. Paunovic, B. Jankovic-Orescanin, G. Buric (Clinical-Hospital Center "Zvezdara", Belgrade, Serbia and Montenegro) |
| P-249 PROJECT IN DEVELOPING PANEL CELLS FOR ANTIBODY SCREENING AND IDENTIFICATION IN INDONESIA |
| R.S.E.G. Sjavitri Evi Gantini, T.H. Titik Herniwati, R.L. Crookes, M.R. Muhammad Rizal (CBTS Indonesian Red Cross, Jakarta, Indonesia) |
| P-250 A REVIEW OF THE CLINICAL SIGNIFICANCE OF ANTI-RH19 AND ANTI-RH34 ANTIBODIES DETECTED IN SOUTH AFRICAN PATIENTS |
| E.A. Smart, P. Fogg, S. Nadesan, I. Joseph (South African National Blood Service, EC, Durban, South Africa) |
| P-251 USING NON-TRADITIONAL QUALITY TOOLS TO EVALUATE AUTOMATION FOR PRETRANSFUSION TESTING |
| F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| P-252 THE FIRST TWO CASE REPORTS OF ANTI-JAHK (RH53) IN PREGNANT WOMEN |
| A. Scharberg, K. Panter, J. Senne, S. Penz, E. Richter, G. Bojarsky, M. Leuteritz (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany) |
| P-253 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN IN THE MNS BLOOD GROUP SYSTEM, TD |
| M. Uchikawa, H. Tsuneyama, K. Ogasawara, Y Suzuki, R. Yabe, T Enomoto, M Satake, K Nakajima (Tokyo Blood Center, Tokyo, Japan) |
| P-254 THE EVALUATION OF GENOTYPES OF LEWIS BLOOD GROUP IN KOREAN USING DIRECT SEQUENCING AND RFLP. |
| I.B. Suh, S.W. Ryu, J.S. Kim, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea) |
| P-255 IDENTIFICATION OF A NOVEL A1V-O1V HYBRID ALLELE WITH G829A MUTATION IN A CHIMERIC INDIVIDUAL OF AELBEL PHENOTYPE |
| C.F. Sun, D.P. Chen, W.T. Wang, J.P. Liu (Chang Gung Memorial Hospital, Tao-yuan, Taiwan) |
| P-256 EVALUATION OF MICROPLATE SYSTEM FOR ABO AND RH(D) BLOOD GROUPING |
| J.S. Shukla, R. Chaudhary, D. Khetan, A. Sonker (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-257 INVESTIGATIONS ON THE ROLE OF ANTIBODY FRAMEWORK SEQUENCES, AS DETERMINED BY VH GERMLINE GENE USAGE, ON ANTI-D ACTIVITY |
| S.J. Thorpe, C. Ball, B. Fox, R. Thorpe, K.M. Thompson, A.F. Bristow (NIBSC, Potters Bar, United Kingdom) |
| P-258 THE NUMBER OF REPEATS IN THE CBF/NF-Y ENHANCER VNTR REGION DOES NOT INFLUENCE THE LEVEL OF ABO TRANSCRIPTS IN BLOOD AND ERYTHROPOIETIC CULTURE |
| I. Thuresson, H. Dykes, T. Olofsson, L. Olsson, M. Chester (Department of Laboratory Medicine,, Lund, Sweden) |
| P-259 IMPORTANCE OF IMMUNEPROPHYLAXIS FOR HEMOLYTIC DISEASE OF THE NEWBORN |
| O.W. Torres, F. Oliveto, M. Direne (Maternidad Sardá, Buenos Aires, Argentina) |
| P-260 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN IN THE KELL BLOOD GROUPP SYSTEM, KYO |
| M. Uchikawa, T. Onodera, K. Ogasawara, H. Tsuneyama, C. Toyoda, R. Yabe, T Enomoto, M Satake, K Nakajima (Tokyo Blood Center, Tokyo, Japan) |
| P-261 MOLECULAR GENETIC ANALYSIS OF FUT1 AND FUT2 GENE IN PARA-BOMBAY CHINESE: A NOVEL FUT1 ALLELE IS IDENTIFIED |
| Y.Q. Su, T.L. Wei, Q. Yu, G.G. Wu, Y.L. Liang, S.Z. Ging (ShenZhen Institute Of Transfusion Medicine, Shen Zhen, China) |
| P-262 ALLOIMMUNISATION IN D NEGATIVE WOMEN FOLLOWING ROUTINE ANTENATAL ANTI-D IMMUNOGLOBULIN PROPHYLAXIS (RAADP) IN THE NORTH EAST OF SCOTLAND: A FIVE-YEAR RETROSPECTIVE STUDY |
| J. Urbaniak, A. Greiss, C. Promwong, R. Witterick, J. Burnett (University of Aberdeen, Aberdeen, United Kingdom) |
| P-263 ASSESSEMENT OF IRREGULAR RED CELL ALLOANTIBODIES IN VOLUNTARY BLOOD DONORS |
| E. Velkova, T. Makarovska-Bojadzieva, A. Hristova-Dimceva, I. Nikoloska, J. Angelovski, K. Dimitrovski, V. Stefanovska (Institute of Transfusion Medicine, Skopje, Macedonia) |
| P-264 STUDY ABOUT THE FUT2 GENE STRUCTURE OF XINJIANG UIGHUR AND HAN NATIONALITY |
| W. Wei, S. Su (Transfusion Medicine, Shenzhen, China) |
| P-265 NOVEL JKNULL ALLELES IN INDIVIDUALS OF DIFFERENT ETHNIC ORIGINS |
| S. Wester, T. Johnson, T. Copeland, R. Storry, L. Olsson (Blood Centre, Lund, Sweden) |
| P-266 TYPING DISCREPANCIES REVEAL TWO NEW KELNULL MUTATIONS IN THE INTRONS FLANKING EXON 8 |
| S. Wester, C. Ligthart, M.T. Steffensen, M. de Haas, R. Storry, M.L. Olsson (Blood Centre, Lund, Sweden) |
| P-267 ADSORPTION OF ANTIBODIES USING DIFFERENT ADSORPTION TECHNIQUES |
| J. de Wildt-Eggen, A. Scholten, J. Ebelties, M.J. Dijkstra-Tiekstra, E. Adema (Sanquin Blood Bank North East, Groningen, Netherlands) |
| P-268 BLOOD CHIMERISM LIMITED TO ONE OF THE TWINS |
| E.M. Dauber, C. Wolf, A. Leo, W.R. Mayr (Medical University of Vienna, Vienna, Austria) |
| P-269 DUFFY ANTIGEN EXPRESSION ON RETICULOCYTES DOES NOT ALTER FOLLOWING BLOOD LOSS IN AN AUTOLOGOUS DONATION MODEL |
| M. Wood, C. Brown, P. Hutchinson, V. Markovska, I.J. Woolley (Australian Red Cross Blood Service, Melbourne, Australia) |
| P-270 FY EXPRESSION IS INCREASED IN SOUTHEAST ASIAN OVALOCYTOSIS |
| J. Woolley, P. Hutchinson, J. Kazura, J. Reeder, A. Cortes (Monash Medical Centre, Clayton, Australia) |
| P-271 THE ELUCIDATION OF MOLECULAT GENETIC BASIS FOR TEN NOVEL ABO BLOOD GROUP ALLELES IDENTIFIED IN CHINESE POPULATION |
| G.G. Wu, Q. Yu, Z.H. Deng, Y.L. Lian, Y.Q. Su (Shen-Zhen Institute of Transfusion Medic, Shen-zhen, China) |
| P-272 A FAMILY INVESTIGATION OF A WEAK D TYPE 15 DONOR |
| W. Xiong, B.Ch. Yang, C.P. Shao (Shenzhen Blood Center, Shenzhen, China) |
| P-273 GENERATION OF RHD-CE(2~9)-D ALLELE BY GENE CONVERSION IN CIS |
| W. Xiong, C.P. Shao, B.Ch. Yang (Shenzhen Blood Center, Shenzhen, China) |
| P-274 IGNT (GCNT2) MUTATION ANALYSIS OF ADULT I PHENOTYPE IN ISRAEL: DETECTION OF A NOVEL MUTATION |
| V.B. Yahalom, E. Pras, R. Goldman-Levi, A. Abu, O. Asher, D. Zadok, C. Levene, I. Avni, E. Shinar (Magen David Adom - NBS, Ramat Gan, Israel) |
| P-275 HLA ANTIGENS IN IRANIAN MAJOR BETA-THALASSEMIC PATIENTS |
| F. Yari, M. Sobhani, F. Sabaghi, M. Zaman vaziri (Iranian Blood Transfusion organization, Tehran, Iran) |
| P-276 MOLECULAR POLYMORPHISM OF O ALLELES IN CHINESE HAN POPULATION |
| Q. Yu, Z.H. Deng, Y.L. Liang, G.G. Wu, Y.Q. Su, D.M. Wang (ShenZhen Institute Of TransfusionMedicin, Shenzhen, China) |
| P-277 THE MOLECULAR BACKGROUND AND POLYMORPHISM OF DEL IN CHINESE |
| Z. Zhu, Q. Li (Shanghai Blood Center, Shanghai, China) |
| P-278 MOLECULAR AND FAMILY ANALYSES REVEALED TWO NOVEL ALLELES IN A SURVEY OF A CHINESE TRUE D– POPULATION |
| Z. Zhu, L. Ye, Z. Guo, Q. Li (Shanghai Blood Center, Shanghai, China) |
| P-279 IMPORTANCE OF NONINVASIVE FETAL GENE EXAMINATION IN ALLOIMMUNIZED MOTHERS |
| B. Zupanska, A. Orzinska, M. Nowaczek-Migas, K. Guz, A. Gibala, J. Rumas-Bec, E. Brojer (Institute of Haematol.& Blood Transfusion, Warsaw, Poland) |
| P-280 APPROACH TO A PATIENT WITH RED CELL AUTO AND ALLOANTIBODIES-CASE REPORT |
| T.M. Makarovska-Bojadzieva (National Institute of Blood Transfusion, Skopje, Macedonia) |
| P-281 THE USE OF GLYCATED HAEMOGLOBIN (HBA1C) FOR MONITORING DIABETIC CONTROL IN NNEWI, SOUTH-EAST NIGERIA |
| E.C. Okocha, A.L. Asomogha, R.N. Asomogha (Nnamdi Azikiwe University, Nnewi, Nigeria) |
| P-282 TRANSFUSION OF NORMAL BLOOD TO PATIENTS WITH RARE ADULT I PHENOTYPE |
| M Lin, Y.S. Chan, C.L. Wang, E.J. Hsueh (Mackay Memorial Hospital, Taipei, Taiwan) |
| P-283 BLOOD GROUP GENOTYPES IN IRANIAN THALASSEMIC PATIENTS & SOME BLOOD DONORS |
| M. Shaiegan, A. Azarkeivan, S. Samiei, Z. Ataee, M. Kavari, H. Lotfi, P. Lotfi (IBTO Research Center, Tehran, Iran) |
| TOPIC 02.2 |
| Topic 02.2. |
| Red Cells - Immune Haemolytic Anaemias |
| P-284 ADVERSE HAEMOLYTIC TRANSFUSION EVENTS: CONSIDER THE ROLE OF DRUGS |
| A.G. van den Bos, J. Gerrits-Kuiper, M.H.P.O. Moors, V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands) |
| P-285 APPLICATION OF FLOW CYTOMETRY IN DETECTION OF RED CELL BOUND IGG IN AIHA: COMPARISON WITH CONVENTIONAL TUBE TECHNIQUE AND GEL TEST |
| R. Chaudhary, S. Das, R. Gupta (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-286 ABO-HEMOLYTIC DISEASE OF THE NEWBORN (HDN): TWO YEARS OF EXPERIENCE |
| M. Garcia Rosasco, G. Bassani, J. Valverde (National University of Rosario, Rosario, Argentina) |
| P-287 CLINICAL RELEVANCE OF NON-RHESUS-D-IEA TITER AND MONOCYTE-DRIVEN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TEST RESULT FOR THE PREDICTION OF SEVERE HAEMOLYTIC DISEASE OF THE NEWBORN. |
| M. de Haas, K. Bilgin, T. Vrijkotte, J.M. Koelewijn, M.A.M. Overbeeke, C.E. Van der Schoot, G.J. Bonsel (Sanquin, Amsterdam, Netherlands) |
| P-288 NON-INVASIVE FETAL RHD GENOTYPING AND FETAL SEXING IN MATERNAL BLOOD |
| M. de Haas, B.E.M. Bossers, A. Ait Soussan, P.C. Ligthart, L.D.M. Schuitemaker, G.C.M.L. Page-Christiaens, C.E. Van der Schoot (Sanquin, Amsterdam, Netherlands) |
| P-289 IMMUNE HEMOLYSIS AFTER LIVER TRANSPLANTATION |
| Z. Hundric-Haspl, N. Jurakovic-Loncar, M. Tomicic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia) |
| P-290 CLINICAL OUTCOMES OF ABO INCOMPATIBLE RED BLOOD CELL (RBC) TRANSFUSIONS |
| N.D. Kalmin, K. Janatpour, H.M. Jensen, P.V. Holland (South Texas Blood & Tissue Center, San Antonio, United States of America) |
| P-291 EVALUATION OF THE SENSITIVITY OF THE DIRECT ANTIGLOBULIN TEST (DAT) BY THE ROUTINE SEROLOGICAL TUBE TEST (DAT-T) AND BY THE MICROCOLUMN GEL TEST (DAT-G) FOR WARM-TYPE AUTO-IMMUNE HAEMOLYTIC ANAEMIA (AIHA) DIAGNOSTICS |
| E.K. Klausa, S.B. Bochenek, A.M. Misiaszek (Regional Centre of Transfusion Medicine, Wroclaw, Poland) |
| P-292 PREDICTIVE VALUE AND SENSITIVITY OF FIRST TRIMESTER SCREENING FOR IRREGULAR ERYTHROCYTE ANTIBODIES TO DETECT NON-RHESUS-D-IEA-MEDIATED HAEMOLYTIC DISEASE OF THE NEWBORN IN THE NETHERLANDS |
| J.M. Koelewijn, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel, M. de Haas (Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands) |
| P-293 RISK FACTORS FOR RHESUS-D-IMMUNIZATION DESPITE POSTAND ANTENATAL ANTI-D-PROPHYLAXIS |
| J.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel (Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands) |
| P-294 AETIOLOGICAL FACTORS RELATED TO A POSITIVE DIRECT ANTIGLOBULIN TEST (DAT) IN HIV INFECTED PATIENTS |
| M. Lai, G. D'Onofrio, E. Visconti, E. Tamburrini, R. Cauda, G. Leone (Catholic University Immunohematology Lab, Roma, Italy) |
| P-295 LOWER HEMOGLOBIN LEVELS IN DAT POSITIVE HIV POSITIVE PATIENTS, ITS RELATIONSHIP WITH THE AGGLUTINATON STRENGHTS AND DIFFERENCES IN THE CLINICAL STAGES |
| M. Lai, E. Visconti, G. D'Onofrio, E. Tamburrini, R. Cauda, G. Leone (Catholic University Immunohematology Lab, Roma, Italy) |
| P-298 A FAMILY OF HEMOLYTIC DISEASE OF THE NEWBORN FOR TWO GENERATIONS POTENTIALLY DUE TO ANTI-KG |
| J. Takahashi, S. Kubo, H. Takahashi, M. Hirashima, T. Ezaki, K. Kimura, M. Tsuzi, T. Nakade, M. Horie, Y. Tomorari, H. Matsukura, F. Hirayama, K. Tsubaki, H. Minowa, Y. Tani, H. Shibata (Japanese Red Cross Osaka Blood Center, Osaka, Japan) |
| P-299 GRAFT VERSUS HOST ANTI-RH(D) FOLLOWING RH-INCOMPATIBLE ORTOTOPTIC LIVER TRANSPLANTATION (OLT): A CASE REPORT |
| D. Venturelli, M. Masetti, L. Bensi, M.G. Baldini, G. Gerunda, M. de Palma (Azienda Policlinico, Modena, Italy) |
| P-300 ANTI-M IMMUNIZATION: A POSSIBLY UNDERDIAGNOSED CAUSE OF FETAL HEMOLYTIC ANEMIA AND INTRAUTERINE DEATH |
| A. Wikman, A. Edner, G. Gryfelt, B. Jonnson, J.I. Henter (Karolinska University Hospital, Stockholm, Sweden) |
| P-301 THE ASSOCIATION OF FCGAMMA RECEPTOR IIA (CD32) POLYMOPHISM AND IGG SUBCLASS CONCENTRATION IN MATERNAL SERUM IN ABO HEAMOLYTIC DISEASE OF NEWBORN |
| Y. Zhang, M. Liu, S. Liu (Blood Reseach Lab, Xi'an, China) |
| TOPIC 02.3 |
| Topic 02.3. |
| Red Cells - Antigen Modification |
| P-302 ANIMAL TRIALS OF MPEG MODIFIED RED BLOOD CELLS |
| Y. Qiu (Beijing Red Cross Blood Center, Beijing, China) |
| P-303 EFFECTS OF SYNTHETIC POLYCATIONS ON ERYTHROCYTE MEMBRANE ANALYZED BY OPTICAL METHODS |
| D. Riquelme, P. Grandfils, B. Fontana, M. Alessi, R. Valverde, G. Foresto, F. Relancio, F. Stoltz, A. Dumas (Fac. de Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina) |
| P-304 ABNORMAL GLYCOSILATION OF ABH ANTIGENS IN HUMAN SPERM AND ITS RELATIOSHIP WITH DNA DAMAGE ASSESED BY (TDT- MEDIATEDDUTP- NICK END LABELING) TUNEL ASSAY IN INFERTILE MEN |
| A.S. Brufman, Ch. Chaingam, E.A. Solis, E.G. Orellano (National University of Rosario, Rosario, Argentina) |
| P-305 THE CA19-9 ANTIGEN AND THE LEWIS STATUS OF PATIENTS WITH RENAL PELVIS DILATATION |
| G Koritsiadis (Athens University, Laiko Gnrl Hospital, Athens, Greece) |
| TOPIC 02.4 |
| Topic 02.4. |
| Red Cells - Transfusion |
| P-306 A FORTUITOUS BENEFIT OF RED BLOOD CELL EXCHANGE IN TREATMENT OF A CHILD WITH ACUTE CHEST SYNDROME |
| C.F.M. Danielson, M. Heiney, W. Jackson, M. Skipworth, A. Miguel, L.J. McCarthy (Wishard Memorial Hospital, Indianapolis, United States of America) |
| P-307 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303 RBC FOR PATHOGEN INACTIVATION IN THREE DIFFERENT ADDITIVE SOLUTIONS MAINTAINS RBC FUNCTION |
| A. Erickson, M.A. Schott, V.A. Lee, G.M. Castro, T. Peterson, A. North (Cerus Corporation, Concord, United States of America) |
| P-308 HYPERHEMOLYSIS SYNDROME |
| V. Fakitsa, M. Papakonstantino, A. Flangini, F. Drini, G. Lyrakos, K. Maltezis, P. Stasinopoulou, L. Haliou, E. Erotokritou, K. Sofroniadou, M. Drosou (District General Hospital of Nikea, Athens, Greece) |
| P-309 RETROSPECTIVE ANALYSIS OF TRANSFUSION RATE IN HIP FRACTURE SURGERY |
| V. Fakitsa, K. Maltezis, M. Papakonstantinou, J. Maniakis, T. Micha, E. Sotiropoulou, A. Flangini, F. Drini, N. Prevezas (District General Hospital of Nikea, Athens, Greece) |
| P-310 ERYTHROCYTAIRE CHARGE SURFACE PROPERTIES DURING STORAGE |
| P. Foresto, N. Lebensohn, M. D'Arrigo, J. Valverde (Fac. Cs. Bioquímias y Farmacéuticas - UNR, Rosario, Argentina) |
| P-311 THE ESTABLISHMENT OF RED CELL BLOOD TYPE DATA BANK FOR MN, P, KIDD, DUFFY AND LEWIS ANTIGEN SYSTEMS |
| M. Liu, S. Ye, J. Qi (Blood Center of Shaanxi Province China, Xi`an, China) |
| P-312 EVALUATION OF PRODUCT QUALITY AND DONOR SAFETY FOLLOWING DOUBLE UNIT RED CELL APHERESIS USING THE ALYX COMPONENT COLLECTION SYSTEM |
| A. Sen, K. Chatterjee (Armed Forces Transfusion Centre, New Delhi, India) |
| P-313 EDUCATION OF NURSES IN TRANSFUSION THERAPY |
| D. Sovic (University Hospital, Zagreb, Croatia), J. Dodig (University Hospital "Sestre Milosdrnice", Zagreb, Croatia) |
| P-314 THE IMPLEMENTATION OF RESTRICTIVE STRATEGY FOR PRBCS TRANSFUSION IN TREATMENT OF CARDIAC SURGERY PATIENTS |
| E. Ambarkova Vilarova, M.Z. Mitrev, M. Blagoevska, C.A. Crvenpanova (Special Hospital for Cardiosurgery, Skopje, Macedonia) |
| P-315 IMPROVING BLOOD TRANSFUSION PRACTICE IN A DISTRICT GENERAL MATERNITY UNIT |
| R. Mudenha, R. Lindsay, V. Rodie, A. Todd, A.J. Thomson (Royal Alexandra Hospital, Glasgow, United Kingdom) |
| P-316 HAEMOVIGILANCE: DETECTION OF ADVERSE REACTIONS ASSOCIATED WITH BLOOD TRANSFUSION |
| Z. Cermakova (Faculty Hospital, Ostrava, Czech Republic) |
| P-317 A FATAL CLINICAL DILEMMA MIMICKING AN INTRAVASCULAR HAEMOLYTIC TRANSFUSION REACTION |
| R. Sinha (Singh), D. Roxby (Flinders Medical Centre, Adelaide, Australia) |
| P-318 TRANSFUSED BLOOD COMPONENTS VERSUS THE RESERVED FOR SURGICAL PATIENTS |
| S. Ortakovska, M. Balamovski, T. Timova, M. Blagoevska, R. Grubovic (General Hospital, Gevgelija, Gevgelija, Macedonia) |
| P-319 BLOOD TRANSFUSION PRACTICE-PUBLIC VERSUS PRIVATE HOSPITALS |
| T.M. Makarovska-Bojadzieva, M. Blagoevska, J. Samonikov-Tosevska, R. Grubovik (National Institute of Blood Transfusion, Skopje, Macedonia) |
| P-321 ONTARIO NURSE TRANSFUSION COORDINATORS (ONTRAC): A PROVINCIAL BLOOD CONSERVATION PROGRAM |
| J. Freedman, K. Luke, M. Escobar, M.B. Garvey, J.A. Chiavetta (St Michael's Hospital, Toronto, Ontario, Canada) |
| P-322 RED CELL TRANSFUSION IN POLAND - A NATIONAL SURVEY |
| A. Rosiek, A. Dzieciatkowska, M. Letowska (Institute of Hematology, Warsaw, Poland) |
| P-323 COMPARISON OF OPERATOR PROCESSES FOR PRETRANSFUSION TESTING ON THE ORTHO AUTOVUE INNOVA, GALILEO, AND CLASSIC ID-GEL STATION USING FAILURE MODES AND EFFECTS ANALYSIS |
| F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| P-324 HAEMOGLOBINOPATHIES IN BLOOD DONORS FROM YOGYAKARTA, INDONESIA; MOLECULAR MUTATION AND THEIR IMPLICATION TO BLOOD TRANSFUSION PRACTICE |
| M. Sofro, F. Lanni (YARSI University, Jakarta, Indonesia) |
| P-325 RED BLOOD CELLS TRANSFUSION AT THE OBSTETRIC AND GYNECOLOGIC DEPARTMENT OF THE CLINICAL HOSPITAL CENTER ZVEZDARA IN BELGRADE |
| J.O.B. Jankovic Orescanin (Clinical Hospital Center Zvezdara, Belgrade, Serbia and Montenegro) |
| P-326 THE MAJOR INTEGRAL PROTEINS OF RBCS LIPID RAFTS DURING STORAGE |
| A. Kriebardis, M. Antonelou, K. Stamoulis, E. Economou-Petersen, L. Margaridis, I. Papassideri (University of Athens, Athens, Greece) |
| P-327 IRREGULAR ANTIBODIES TO RED BLOOD CELLS IN PATIENTS ON CHRONIC HAEMODIALYSIS |
| G.P. Poposki, V.T. Tomanoski, S.M. Mena (Institute of Nephrology, Struga, Macedonia) |
| P-328 EMPOWERMENT OF LABORATORY STAFF TO IMPLEMENT LOCAL GUIDELINES IS HIGHLY EFFECTIVE IN PREVENTING INAPPROPRIATE TRANSFUSIONS AND ENABLES BLOOD CONSERVATION |
| J. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom) |
| P-329 NEW ADDITIVE SOLUTION FOR IMPROVED STORAGE OF RED BLOOD CELLS (RBC) |
| M. Löf, C.F. Högman (University Hospital, Uppsala, Sweden) |
| P-330 EXTENDED RED CELL ANTIGEN TYPING OF BLOOD DONORS USING THE PK7200 |
| S. Valensky (Western Province Blood Transfusion Servi, Cape Town, South Africa) |
| P-331 COMPARISON OF IN VITRO BLOOD COMPONENT QUALITY USING TWO DIFFERENT DESIGN BUTANE-1,4-DIOL COOLING SYSTEMS |
| P.F. van der Meer, M. Eijzenga, W. Karssing, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-332 INVESTIGATION OF MIXING OF WHOLE BLOOD UNDER VARIOUS FLOW RATES USING THE HEMOLIGHT PLUS COLLECTION MIXER |
| P.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-333 ARE UK GUIDELINES FOR PROVISION OF BLOOD FOR PATIENTS WITH SICKLE CELL DISEASE FOLLOWED? |
| J.L. White, C.E. Milkins, D. Benkhaled, M. Rowley (UK NEQAS (BTLP), Watford, United Kingdom) |
| P-334 THE USE OF BLOOD AND BLOOD COMPONENTS IN THE ORTHOPEDIC DEPARTMENT DURING YEAR 2005 |
| E. Kocovska, M. Kocovski (Tetovo Hospital, Tetovo, Macedonia) |
| P-335 STORAGE OF WHOLE BLOOD INFLUENCES THE RESPONSE OF RED CELLS TO AN ALKALINE STORAGE MEDIUM |
| D. de Korte, H.G.H. Korsten, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-336 STORED RED CELL CONCENTRATES OF HEMOCHROMATOSIS PATIENTS: ARE THEY DIFFERENT? |
| M. Luten, B. Roerdinkholder-Stoelwinder, E. Rombout-Sestrienkova, H.J. Bos, W.J. de Grip, G.J.C.G.M Bosman, V.M.J. Novotny (Sanquin Blood Bank South East Region, Nijmegen, Netherlands) |
| P-337 EVALUATION OF THE IN VITRO QUALITY OF FROZEN AND THAWED RED CELLS PROCESSED WITH THE HAEMONETICS® ACP®215 |
| J.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-338 EFFECT OF THE PH ON THE ATP CONTENT AND GLYCOLITIC ACTIVITY OF THAWED RED CELLS |
| J.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-339 CORRELATION BETWEEN REQUESTS OF BLOOD AND ITS PRODUCTS AND BLOOD TRANSFUSION IN A UNIVERSITY HOSPITAL IN GREECE |
| K. Zervou, K. Ziciadis, E. Xanthi, A. Tzolou, E. Chrisostomou, F. Karabini (University Hospital of Ioannina, Ioannina, Greece) |
| P-340 RED BLOOD CELL TRANSFUSION POSITIVELY IMPACTS SURVIVAL IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION |
| S.G. Ganguly, P. Bradley, S. Patel, L. Divine, S. Skikne, C. Bodensteiner (University of Kansas Medical Center, Kansas City, United States of America) |
| P-341 A CASE OF A PATIENT WITH MCLEOD PHENOTYPE AND CGD WHO DID NOT PRODUCE ANTI-KX REGARDLESS OF PACKED RED CELLS TRANSFUSIONS FROM RANDOM DONORS DURING NONMYELOABLATIVE CORD BLOOD TRANSPLANTATION |
| Y. Tani, J. Takahashi, F. Hirayama, N. Hatakeyama, M. Yamamoto, Y. Kuroiwa, N. Mizue, M. Yoda, Y. Sakiyama, N. Suzuki, H. Shibata (Japanese Red Cross Osaka Blood Center, Osaka, Japan) |
| P-342 MULTI-ETHNIC DONOR GENOTYPING ON THE COMMON SINGLE NUCLEOTIDE POLYMORPHISMS ENCODING RED BLOOD CELL ANTIGENS DOES NOT RELIABLY PREDICT RED BLOOD CELL PHENOTYPES |
| P. A. Maaskant - van Wijk, M. Feskens, J.D. van Wintershoven, L. Douglas-Berger, M. Bogaerts, D.J. van Rhenen (Sanquin Bloodbank Southwest Region, Rotterdam, Netherlands) |
| P-343 INCIDENCE OF ALLOIMMUNIZATION IN BLACKS FROM AFRICA VS. USA |
| M. Moulds, G. Noumsi, A. Tounkara, Y. Guindo, J.M. Moulds (LifeShare Blood Centers, Shreveport, La, United States of America) |
| P-344 RE-ESTABLISHING OF STORED RBC’S CHARACTERISTICS STUDIED BY FLOW CYTOMETRY |
| L. Di Tullio Budassi, F. Relancio, B. Riquelme, P. Foresto, J. Valverde (Fac. Cs. Bioq. y Farm - UNR, Rosario, Argentina) |
| P-345 RED BLOOD CELL PHENOTYPE DETERMINATION OF 2,345 NEW YORK BLOOD DONORS BY DNA ANALYSIS IN A BEADCHIP FORMAT |
| G. Hashmi, T. Shariff, J. Cristobal, Y. Zhang, C. Chau, M. Seul, P. Vissavajjhala, K. Hue-Roye, D. Charles-Pierre, C. Lomas-Francis, C. Baldwin, M. Reid (Bioarrays Solutions, Warren, United States of America) |
| P-346 ALLOIMMUNIZATION AGAINST RBC (RED BLOOD CELL) TRANSFUSIONS IN PATIENTS OF THE REGIONAL BLOOD BANK OF LONDRINA – PARANÁ - BRAZIL |
| M. Saito, M.R.S. Turra, A.N.J. Koti, K.M. Arai, L.G.F.T. Turkowski, C.C. Faune (Hemocentro Regional Londrina, Londrina, Brazil) |
| P-347 AUTOMATED DOUBLE VS. STANDARD RBC COLLECTION: CHARACTERICS OF PRODUCTS AND ITS CLINICAL EFFICACY |
| P. Accorsi, M. Dell'Isola, P. Striani, F. Esattore, S. Falorio, M. Profico, G. Di Bernardo, A. Iacone, P. Accorsi (Pescara Civil Hospital, Pescara, Italy) |
| P-348 HAEMOSTATIC DISORDERS IN PATIENTS WITH EPH-GESTOSIS |
| T.T. Timova, L. Maninska, S. Ortakovska, E. Kocovska, R. Madzunkov, S. Kostovska (General hospital-Strumica, Strumica, Macedonia) |
| TOPIC 03.1 |
| Topic 03.1. |
| Haemostasis - Recent Therapeutic Advances |
| P-349 PLATELET GEL IN POST-SURGICAL INFECTED WOUNDS HEALING IN HEART SURGERY |
| S. Misso, B. Feola, L. Paesano, M. D'Onofrio, G. Fratellanza, E. D'Agostino, E.M. Bruno, M. Nigro, A. Minerva (Unit Operative Haemapheresis, Caserta, Italy) |
| P-350 NEUROSURGERY IN A HEMOPHILIC CHILD WITH CENTRAL NERVOUS SYSTEM HEMORRHAGE |
| O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich, A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina) |
| P-351 RECOMBINANT FVII TREATMENT IN A HEMOPHILIA A PATIENT WITH HIGH TITER INHIBITOR AND CENTRAL NERVOUS SYSTEM HEMORRHAGE |
| O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich, A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina) |
| P-352 THROMBOPHILIC MARKERS FREQUENCY IN THE PATIENTS WITH DEEP VENOUS THROMBOSIS |
| B. Kostovska, M. Stegnar, V. Neceva, C. Dimova, J. Pejceva, M. Blazevska, L. Jamovski (Institute of blood Transfusion, Skopje, Macedonia) |
| Topic 03.2 |
| Topic 03.2. |
| Haemostasis - Related to Blood Transfusion |
| P-353 CRYOPRECIPITATE-REMOVED PLASMA 'CRYO-REMOVED PLASMA' AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B |
| P. Lepatan, M. Chua, F. Hernandez, M. Montoya, J. Ong, E. Rodriguez (Hemophilia Center of Cebu, Cebu, Philippines) |
| P-354 BERNARD SOULIER SYNDROM IN IRAN |
| F. Razjou (Iranian Blood Transfusion Research Centre, Tehran, Iran) |
| P-355 HAEMORHEOLOGICAL ALTERATIONS IN NIGERIAN TRANSFUSED PATIENTS |
| I. Ajayi (University of Benin, Benin City, Nigeria) |
| P-356 CORRECTION OF HEMOSTASIS SYSTEM IN PATIENTS WITH TYPHOID BLEEDINGS |
| B. Bahovadinov, A. Vahidov (Republican Sientific Centre of Blood, Dushanbe, Tajikistan) |
| P-357 THE USE OF RECOMBINANT FVIIA (RFVIIA) IN PATIENTS WITH UNCONTROLLABLE SURGICAL OR POST SURGICAL BLEEDING |
| P. Kotsi, M. Gavalaki, I. Anastasopoulou, O. Katsarou, G. Kanellopoulou, A. Karafoulidou (Laikon General Hospital, Athens, Greece) |
| P-358 ASSESSMENT OF FRESH FROZEN PLASMA USAGE AT THE CLINICAL HOSPITAL CENTER RIJEKA |
| N. Vukelic-Damijani, S. Balen, L. Caser (Clinical Hospital Center, Rijeka, Croatia) |
| P-359 FREQUENCY OF TRANSMISIVE VIRUS MARKERS AT HEMOPHILIANS IN CORELLATION WITH HEPATIC FUNCTION |
| S.K. Kostovska, V. Filipche, V.N. Neceva, P.J. Pejceva, I.S. Ilievska, D.V. Dejanova, D.N. Dimovska (Institute of Blood Transfusion, Skopje, Macedonia) |
| TOPIC 03.3 |
| Topic 03.3. |
| Haemostasis - Thrombotic Thrombocytopaenic Purpura (TTP) |
| P-360 SOLVENT/DETERGENT TREATED PLASMA, OCTAPLAS AND UNIVERSALLY APPLICABLE PLASMA, IN TTP AND HUS: QUANTIFICATION OF ADAMTS13 AND FACTOR H LEVELS |
| A. Heger, C. Kannicht, J. Römisch, T.E. Svae (Octapharma Pharmazeutika ProduktionsgmbH, Vienna, Austria) |
| P-361 RELAPSING THROMBOTIC THROMBOCYTOPENIA PURPURA FOLLOWING CORONARY ARTERY VEIN GRAFT SURGERY |
| R. Sinha (Singh), D. Roxby, C. Kollias (Flinders Medical Centre, Adelaide, Australia) |
| P-362 REMISSION OF SEVERE THROMBOTIC THROMBOCYTOPENIC PURPURA REFRACTORY TO INTENSE PLASMA EXCHANGE WITH SMALL DOSES OF RITUXIMAB THERAPY |
| I. Karadogan, A. Ugur-Bilgin, K. Temizkan, L. Undar (Akdeniz University School of Medicine, Antalya, Turkey) |
| P-363 THERAPEUTIC PLASMA EXCHANGE IN THROMBOTIC MICROVASCULAR SYNDROMS |
| D. Barz (Institute of Transfusionmedicine, Jena, Germany) |
| P-364 EMPLOYMENT OF HUMAN ALBUMIN SOLUTION AND FRESH FROZEN PLASMA AS FLUID REPLACEMENT IN PATIENTS TREATED WITH PLASMAEXCHANGE FOR TTP |
| L. Salvaneschi, C.G. Perotti, P. Bergamaschi, G.L. Viarengo, C. Del Fante (IRCCS Policlinico "San Matteo", Pavia, Italy) |
| Topic 04.1 |
| Topic 04.1. |
| Pathogen Reduction/Inactivation - Red Cells |
| P-365 HEMOCOMPATIBILITY OF P-CAPT? PRION REDUCTION FILTERS |
| T. Lathrop, M. Poncheri, L. Gheorghiu, D. Hammond (American Red Cross, Rockville, United States of America) |
| Topic 04.2 |
| Topic 04.2. |
| Pathogen Reduction/Inactivation - Platelets |
| P-366 PLATELET CONCENTRATES PRODUCED BY THE ORBISAC BC SYSTEM AND TREATED WITH THE INTERCEPT BLOOD SYSTEM: EVALUATION OF THE IN VITRO PLATELET QUALITY |
| S. Misso, M. Nigro, G. Fratellanza, G. Aurioso, E. D'Agostino, R. Sepulveres, E.M. Bruno, S. Formisano (Unit Operative Haemapheresis, Caserta, Italy) |
| P-367 PHOTOCHEMICAL TREATMENT WITH AMOTOSALEN AND UVA LIGHT INACTIVATED HIGH TITERS OF AN EMERGING SOUTH FRANCE VIRAL STRAIN OF WEST NILE VIRUS |
| C. Vignoli, P. Gallian, A.M. Dombey, L. Lin, V. Mayaudon, Ph. de Micco (Etablissement Français du Sang, Marseille, France) |
| P-368 THE EFFICACY OF PHOTOCHEMICAL TREATMENT WITH AMOTOSALEN AND UVA (INTERCEPTTM) FOR THE INACTIVATION OF TRYPANOSOME CRUZI (T.CRUZI) IN BUFFY COAT DERIVED PLATELET COMPONENTS |
| E. Castro, N. Girones, J.L. Bueno, J. Carrion, M. Fresno (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-369 THERAPEUTIC EFFICACY AND SAFETY OF TRANSFUSION OF PATHOGEN-INACTIVATED PLATELETS TO PEDIATRIC PATIENTS |
| L. Van Haute, Y. Benoit, V. Bordon, B. De Moerloose, E. Vandecruys, S. Van Lancker, M. Van Vooren, B. Vandekerckhove (Red Cross Flanders, Gent, Belgium) |
| P-370 PATHOGEN INACTIVATION OF TRYPANOSOMA CRUZI IN PLATELET CONCENTRATES WITH RIBOFLAVIN AND UV LIGHT |
| L.J. Cardo, J. Salata, J. Mendez, H. Reddy, R. Goodrich (Walter Reed Army Institute of Research, Silver Spring, United States of America) |
| P-371 AGITATION DURING TREATMENT IMPROVES THE INACTIVATION OF PATHOGENS IN PLATELET CONCENTRATES BY UVB IRRADIATION |
| H. Mohr, A. Bayer, F. Tolksdorf, W.H. Walker, T.H. Mueller (Blood Center of the German Red Cross, Springe, Germany) |
| P-372 TRANSFUSION OF PATHOGEN INACTIVATED PLATELET CONCENTRATES IN CHILDREN |
| V.W. Witt, G. Stiegler, P. Höcker, C. Peters, H. Gadner (St. Anna Kinderspital, Vienna, Austria) |
| P-374 STORAGE OF APHERESIS AND POOLED BUFFY-COAT PLATELET CONCENTRATES TREATED WITH PATHOGEN INACTIVATION USING THE INTERCEPT BLOOD SYSTEM |
| P. Schlenke, V. Franck, L. Lin, H. Kirchner (University Lübeck School of Medicine, Lübeck, Germany) |
| P-375 EVALUATION OF THE INTERCEPT BLOOD SYSTEM FOR AMICUS APHERESIS PLATELET CONCENTRATES: MEETING TARGET PRODUCT CHARACTERISTICS |
| M. Lambermont, R. de Meuter, G. Bastin (Service du Sang, Belgian Red Cross, Brussels, Belgium) |
| P-376 PHOTOCHEMICAL PATHOGEN INACTIVATION OF HIGH-DOSE APHERESIS PLATELET CONCENTRATES USING THE INTERCEPT BLOOD SYSTEM |
| J.C. Osselaer, C. Debry, M. Goffaux, M. van Hooydonk, V. Mayaudon, L. Lin, L. Corash (Mont-Godinne University Hospital, Yvoir, Belgium) |
| P-377 INACTIVATION OF HIGH LEVELS OF BACTERIA USING THE INTERCEPT BLOOD SYSTEM UNDER ROUTINE BLOOD BANK PROCEDURES |
| A. Ontanon, I. Romon, C. Hurtado, J. Hsu, L. Lin, V. Hermosa (Banco de Sangre de Cantabria, Santander, Spain) |
| P-378 IMPACT OF PHOTOCHEMICAL TREATMENT (INTERCEPT) ON PLATELET USE IN ROUTINE PRACTICE |
| J.C. Osselaer, C. Doyen, C. Chatelain, C. Debry, M. Goffaux, N. Messe, M. van Hooydonk, A. Sonnet, A. Bosly, J.S. Lin, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium) |
| P-379 A PROSPECTIVE OBSERVATIONAL COHORT SAFETY STUDY OF 5,106 PLATELET TRANSFUSIONS PREPARED WITH PHOTOCHEMICAL TREATMENT (INTERCEPT) |
| J.C. Osselaer, N. Messe, T. Hervig, J.L. Bueno, E. Castro, A. Espinosa, A. Iacone, K. Junge, M. Jacquet, J. Flament, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium) |
| P-380 ROUTINE PRODUCTION OF INTERCEPT-TREATED APHERESIS PLATELET CONCENTRATES FOR PEDIATRIC PATIENTS |
| M. Stiegler, V Witt, P Mörtl, G Leitner, P Höcker (Medical University of Vienna, Vienna, Austria) |
| Topic 04.3 |
| Topic 04.3. |
| Pathogen Reduction/Inactivation - Plasma |
| P-381 QUALITY OF METHYLENE BLUE PLASMA OVER THE LAST FIVE YEARS |
| A. Castrillo, A. Eiras, J. Cid, A. Castro, M. Adelantado, M. Abalo, C. Areal, J. Flores, J. Cabrera (Centro de Transfusion de Galicia, Santiago De Compostela, Spain) |
| P-382 COMPARATIVE STUDY OF TREATED AND UNTREATED FRESH FROZEN PLASMA AS SOURCE OF FIBRINOGEN CONCENTRATES OBTAINED FROM METHYLENE BLUE TREATED PLASMA FROM MACO PHARMA MACO-TRONIC SYSTEM |
| E. Lachert, J. Kubis, J. Antoniewicz-Papis, A. Goller, M. Letowska, G. Kulla (Institute of Hematology, Warsaw, Poland) |
| P-383 MINI-POOL SOLVENT/DETERGENT VIRAL INACTIVATION OF PLASMA AND CRYOPRECIPITATE IN A DISPOSABLE BAG SYSTEM BY BLOOD CENTERS |
| T. Burnouf, H.A. Goubran, M. Radosevich, M.A. Sayed, G. Gorgy, M. El-Ekiaby (Human Plasma Product Services, Lille, France) |
| P-384 MIRASOL PATHOGEN REDUCTION TREATED FRESH FROZEN PLASMA MAINTAINS PROTEIN QUALTITY |
| K.A. Buytaert-Hoefen, D. Gampp, R. Edrich, R. Goodrich (Navigant Biotechnologies, Lakewood, United States of America) |
| P-385 COAGULATION FUNCTION IN FRESH FROZEN PLASMA PREPARED WITH TWO PHOTOCHEMICAL TREATMENT METHODS |
| J.C. Osselaer, C. Debry, M. Goffaux, E. Dubuc, B. Chatelain, M. Rheinschmidt, L. Lin (Mont-Godinne University Hospital, Yvoir, Belgium) |
| P-386 THERAFLEX MB-PLASMA PROCEDURE: PLASMA QUALITY AFTER 15 MONTH STORAGE AND REDUCTION OF METHYLENE BLUE AND PHOTOPRODUCTS |
| S. Reichenberg, W.H. Walker, A. Hoburg, N. Müller (Maco Pharma International GmbH, Langen, Germany) |
| P-387 COAGULATION FACTOR ACTIVITY IN 180 ML AND 325 ML UNITS OF PHOTOCHEMICALLY TREATED PLASMA (INTERCEPT™ PLASMA) AFTER STORAGE FOR 12 MONTHS AT -18ºC |
| L. Pinkoski, T. Peterson, J. Bayat, H. Evans, Y. Singh, L. Corash (Cerus Corporation, Concord, United States of America) |
| P-388 FRESH FROZEN PLASMA FOR MANAGEMENT OF HEMOSTASIS DURING MINOR AND MAJOR SURGICAL PROCEDURES ASSOCIATED WITH COAGULOPATHY |
| L. Corash, N. Bass, L. Petz, R. Steadman, M. Streif, J. McCullough, P.D. Mintz (Cerus Corporation, Concord, United States of America) |
| P-389 STABILITY OF COAGULATION FACTORS IN PLASMA PREPARED WITH PHOTOCHEMICAL TREATMENT (INTERCEPT) STORED FOR ONE YEAR |
| J.P. Cazenave, H. Isola, M.L. Wiesel, D. Kientz, M. Laforêt, V. Mayaudon, L. Pinkoski, Y. Singh, L. Corash (Etablissement Français du Sang - Alsace, Strasbourg, France) |
| TOPIC 05.1 |
| Topic 05.1. |
| Donor Management - Developing Donor Programs |
| P-390 A CASE - CONTROLLED STUDY OF CONTRIBUTING FACTOR FOR VASOVEGAL REACTION IN BLOOD DONORS |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-391 EDUCATIONAL PROGRAMS FOR HEALTH WORKERS, PATIENTS AND RELATIVES, WITH SPECIAL TOPIC IN ONCOHEMATOLOGY DISEASES AND TRASNFUSION MEDICINE SUPPORT, INCLUDING MANAGEMENT OF THE DONATION PROCESS |
| C.D. Dufour, N. Carballido, F. Dufour, S. Bogosevich, J. Fischer, M.F. Morgante, A. Drago, M. Aleman, A. Di Cosimo, M.A. Candia, Z.P. Labrana, J. Maurizio, M.C. del Rodriguez, B. Coda, V. Garcia, A. Perotti, B. Riquelme, M. Martinez, S. Cersosimo, M.F. Bujia, F. Barros, N. Choudjury, L. Bouzas, E. Dufour (Argencord, Un Cordon para la Vida, Buenos Aires, Argentina) |
| P-392 ENGAGING PRIVATE SECTOR IN BLOOD DONOR MOBILIZATION |
| N. Wangendo (Bloodlink foundation, Nairobi, Kenya) |
| P-393 FREQUENCY OF BLOOD DONATIONS BY PEOPLE WITH HEREDITARY G-6-PD DEFICIENCY |
| I. Bayramalibeily, A. Ragimov, N. Gaibov (Moscow Medicin Academy, Moscow, Russian Federation) |
| P-394 EFFECT OF IMPLEMENTING THE BLOOD DONOR NATIONAL SELECTION CRITERIA ON BLOOD UNITS DISCARD RATE, EGYPT EXPERIENCE |
| F. Moftah (NBTS, MOH, Giza, Egypt) |
| P-395 HEREDITARY HEMOCHROMATOSIS. TREATMENT AND BLOOD DONORS |
| V. Fakitsa, M. Papakonstantinou, A. Flangini, V. Syriou, G. Lyrakos, K. Maltezis, K. Toumanidi, K. Sofroniadou (District General Hospital of Nikea, Athens, Greece) |
| P-396 COMPARISION EVALUATION OF HEMOGLOBIN (HB) MEASURMENT BY COLOR SCALE AND AUTOMATED CELL BLOOD COUNTER IN FEMALE BLOOD DONORS |
| M.R. Deyhim (Iranian Blood Transfusion Research Centre, Tehran, Iran) |
| P-397 DONORS WITH HYPERFERRITINEMIA |
| G. Garozzo, P. Bonomo, L. Morando (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy) |
| P-398 ELECTROPHORETIC CONTROL OF SERUM PROTEIN IN VACCINATED PLASMA DONORS IN THE PLASMAPHERESIS PROGRAM |
| O. Savic, I. Jaglicic, M. Saracevic, N. Vavic, M. Sindjic, S. Pelevic (National Blood Transfusion Institute, Belgrade, Serbia and Montenegro) |
| P-399 DONOR CARE FOR DEFERRED DONORS IN A DEVELOPING COUNTRY |
| J.P. Allain, S. Owusu-Ofori, O. Opare-Sem, F. Sarkodie, R. Rahman (University of Cambridge, Cambridge, United Kingdom) |
| P-400 INSIDENCE OF VIRAL MARKERS AND SYPHILIS ANTIBODIES IN BLOOD DONORS OF HIGH SCOOLS IN KUMANOVO |
| L. Slavkovska (Medical Center, Kumanovo, Macedonia) |
| P-401 EVALUATION OF THE DOUBLE RED BLOOD CELLS COLLECTION USING ALYX IN KOREAN BLOOD DONORS |
| M.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, O.J. Jeong, N.S. Cho, I.K. Paik, H.O. Kim, J.S. Seo (Korean Red Cross, Seoul, South-Korea) |
| P-402 BLOOD-DONOR SHIP IN PROVINCIAL ADMINISTRATION |
| B. Belic, A. Stajic, E. Sumec (Assembly of Vojvodina, Novi Sad, Serbia and Montenegro) |
| P-403 THERAPEUTIC RED CELL DEPLETION WITH THE CYMBAL™ AUTOMATED BLOOD COLLECTION SYSTEM |
| P. Poullin (University Hospital La Conception, Marseille, France) |
| P-404 BLOOD DONOR CLUBS AS AN AVENUE FOR SUFFICIENT SAFE BLOOD |
| P.K. Mukuria, M. Wheeler, J. Mwangi (Hope World Wide, Nairobi, Kenya) |
| P-405 PROJECT MANAGEMENT AS A RECOMMENDABLE APPROACH TO IMPROVE DONOR MANAGEMENT IN RESTRICTED ECONOMY COUNTRIES (PRELIMINARY RESULTS) |
| C.Th. Smit Sibinga, A.P.M. Los, W.P.A. van der Tuuk Adriani (Academic Institute IDTM, Groningen, Netherlands) |
| P-406 RECALLING BLOOD DONORS: A STUDY EVALUATING THE WILLINGNESS OF IRANIAN BLOOD DONORS TO DONATE AGAIN AND TO BE RECALLED |
| M. Maghsudlu, M. Maghsudlu, S. Nasizadeh, M.M. Seyfi (Research Center-Iran bloodtransfusionorg, Tehran, Iran) |
| P-407 DONOR SELECTION CRiTERIA AS A MEANS OF SAFE BLOOD TRANSFUSION PRACTICES IN WESTERN UGANDA |
| L. Tumwesigye, G. Kansiime (Uganda Service, Fort Portal, Uganda) |
| P-408 SECURING ADEQUATE AND SAFE BLOOD SUPPLY FOR MULTITRANSFUSED PATIENTS WITH THALASSAEMIA : A COMPUTERIZED PROGRAMME |
| C. Politi, C. Politis, S. Fragatou, A. Antypas, C. Armyros, K. Ventiadi, V. Malamou, P. Katsea, C. Richardson (Hospital "G.Gennimatas", Athens, Greece) |
| P-409 A PILOT PROJECT IN YOUTH BLOOD DONOR RECRUITMENT |
| M. Dambuza, I. Tema, S. Gaolekwe, B. Gibbs, M. Kayembe, J. van Hasselt (Safe Blood for Africa Foundation, Johannesburg, South Africa) |
| P-410 NEW DONOR SYSTEM FOR THE PATIENT WITH THALESSEMIA: BLOOD MOTHER AND BLOOD FATHER |
| D. Canatan, G. Alanoglu, H. Dirican, N. Balta, N.O. Oguz, K.C. Karadogan, R. Cosan (Suleyman Demirel University, Isparta, Turkey) |
| P-411 IMPACT OF ALLOGENEIC 2-UNIT RBC APHERESIS ON IRON STORES OF BRAZILIAN BLOOD DONORS |
| A.M.J Mendrone Junior, C.A. Arrais, S.A.M. Gualandro, S.C. Chen, E.M. Murphy, E.C.S. Sabino, D.A.F. Chamone (Fundação Pro-Sangue/Hemocentro de SP, São Paulo, Brazil) |
| P-412 EVALUATION OF THE DOUBLE RED BLOOD CELLS COLLECTION USING ALYX IN KOREAN BLOOD DONORS |
| M.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, O.J. Jeong, N.S. Cho, I.K. Paik (Korean Red Cross, Seoul, South-Korea) |
| Topic 05.2 |
| Topic 05.2. |
| Donor Management - Recruiting and Managing Donors |
| P-413 DONOR SATISFACTION - KEY POINT OF DONOR MANAGEMENT STRATEGY |
| R. Jovanovic, V. Kulidzan, V. Ubavin (Blood Transfusion Institute, Novi Sad, Serbia and Montenegro) |
| P-414 DOUBLE RED BLOOD CELL COLLECTION WITH ALYX: AN ITALIAN MULTICENTER EXPERIENCE ON DONOR ACCEPTANCE AND SAFETY |
| P. Accorsi, G. Nardi, O. de Masi, D. Spadini, F. Gianmattei, S. Falorio, F. Esattore, A. Iacone (Pescara Civil Hospital, Pescara, Italy) |
| P-415 FACTORS IN THE LOW RECRUITMENT OF VOLUNTARY BLOOD DONORS AMONG ELIGIBLE NIGERIANS |
| J.O. Adewuyi, H.O. Olawumi (University of Ilorin, Ilorin, Nigeria) |
| P-416 CHANGING BLOOD DONORS PROFILE IN RIO DE JANEIRO, BRAZIL: 1988-2004 |
| L.A. Amorim, M.E. Lopes, L.M. Amorim, M. Cardoso, C. Lobo, L. Silva, K.M.M. Motta (Hemorio, Rio De Janeiro, Brazil) |
| P-417 WHOLE BLOOD DONOR DEFERRAL RATE AND REASONS FOR THE TURKISH POPULATION |
| O. Arslan, Y. Ozer (Ankara University, Ankara, Turkey) |
| P-418 EFFECTS OF DONOR VARIABLES ON PLATELET YIELD IN DOUBLEUNIT PLT CONCENTRATES COMPARED TO TRIPLE-UNIT PLT CONCENTRATES |
| B. Baumann-Baretti, G.B. Jaster, K.P. Krause (Haema, Leipzig, Germany) |
| P-419 VARIABILITY IN BLOOD DONOR SCREENING BY PHISICIANS AND CORRELATION WITH SEROLOGICAL MARKERS IN HEMOMINAS FOUNDATION, BRAZIL |
| A.B.F. Carneiro-Proietti, F.C.M. Loureiro, A.N. Martins (Hemominas Foundation, Belo Horizonte, Brazil) |
| P-420 KNOWLEDGE ABOUT BLOOD DONATION AND HIV INFECTIONS AMONG FIRST TIME AND REPEAT VOLUNTARY NON-REMUNARATED BLOOD DONORS (VNRBD) |
| N. Choudhury, J. Shah (Prathama Blood Center, Ahmedabad, India) |
| P-421 COMPARATIVE EVALUATION OF HEMOGLOBIN (HB) MEASUREMENT BY COLOR SCALE AND AUTOMATED CELL BLOOD COUNTER IN FEMALE BLOOD DONORS |
| M. Deyhim (Iranian Blood Transfusion Research Centre, Tehran, Iran) |
| P-422 A TWO YEARS EXPERIENCE OF IMPLEMENTING DOUBLE RED CELL COLLECTION WITH THE ALYX COMPONENT COLLECTION SYSTEM |
| G.A. Fabian (Institute for Transfusion Medicine Suhl, Suhl, Germany) |
| P-423 CERTIFICATION OF A PARTNERSHIP BETWEEN A BLOOD TRANSFUSION ESTABLISHMENT (BTE) AND VOLUNTARY BLOOD DONOR ASSOCIATIONS: A FIVE-YEAR EXPERIENCE |
| G. Follea, C. Adjou, C. Cornet, L.H.B. Henry-Baudot (EFS, Nantes, France) |
| P-424 PREVALENCE, SPECIFICITY AND TITRE OF ALLO-ANTIBODIES IN VOLONTARY BLOOD DONATIONS AND IN THE CORRESPONDING BLOOD PRODUCTS |
| B.M. Frey, E. Matheis, A. Böhlen-Bodmer, B. Grossrieder (Regional Blood Transfusion Service, Zürich, Switzerland) |
| P-425 EVALUATION OF THE REACTIONS IN 77799 BLOOD DONATIONS |
| G. Garozzo, L. Morando, C. Furnaro, M. Accardo, B. Campo, S. Parrino, G. Savasta, L. Vitale, M. Cascone, P. Bonomo (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy) |
| P-426 DONOR MOTIVATION AND RECRUITMENT PROCESS (SPECIAL REFERENCE TO NEPAL RED CROSS, BLOOD TRANSFUSION SERVICE PROGRAM) |
| K. Ghimire (Nepal Red Cross Society, Kathmandu, Nepal) |
| P-427 SURVEY OF BLOOD DONATIONS IN REPUBLIC OF MACEDONIA FROM 1997 TILL 2005 |
| R. Grubovik, M. Blagoevska, M. Grubovik, V. Stefanovska, S. Kostovska, T. Makarovska, E. Velkova (National Institute for Transfusion Medic, Skopje, Macedonia) |
| P-428 POLICE SERVICE AND BLOOD DONATION IN REPUBLIC OF MACEDONIA |
| R. Grubovik, M. Blagoevska, M. Grubovik, S. Kostovska, V. Stefanovska, E. Velkova, T. Makarovska, J. Samonikov, S. Stojkoska (National Institute for Transfusion Medic, Skopje, Macedonia) |
| P-429 A UNIQUE APPROACH TO DONOR RECRUITMENT WHEREBY A PRIMARY SCHOOL ADOPTS A FIXED SITE DONOR CENTRE FOR A MONTH |
| M Harris, I.W. Simpson, M. Griesel (South African National Blood Service (SANBS), Port Elizabeth, South Africa) |
| P-430 TODAY AND TOMORROW (tm) CONCEPT IN DONOR RECRUITING |
| M Harris, I.W. Simpson, M. Griesel (South African National Blood Service (SANBS), Port Elizabeth, South Africa) |
| P-431 AUTOMATED COLLECTIONS, MAXIMIZING EVERY DONATION |
| R. Hein, S. Ballew, J. Gardner (United Blood Services, Las Vegas, United States of America) |
| P-433 VISTA INFORMATION SYSTEM: HOW DOES THE INCREASED OPERATIONAL EFFICIENCY RESULT IN A FINANCIAL BENEFIT FOR BLOOD CENTERS? |
| F. Hofman, M. Debost, S. Rummler, M.A. Perez Vaquero (Gambro BCT, Zaventem, Belgium) |
| P-434 THE IMPACTS OF RED BLOOD CELL SIZE ON THE HARVEST OF PLATELETS BY APHERESIS |
| H.Y.S Hung, W. Chiou-Hua, L. Wen-Chuan, L. Su-Jen, L. Kuo-Sin (Taipei Blood Center,T.B.S.F, Taipei, Taiwan) |
| P-435 A STUDY OF KNOWLEDGE, ATTITUDE AND PRACTICE OF WOMEN ABOUT BLOOD DONATION |
| H. Javadzadeh Shahshahani (Research Center of Iranian BTO, Yazd, Iran) |
| P-436 KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) STUDY ABOUT BLOOD DONATION IN THE URBAN POPULATION OF YAZD, IRAN, 2004 |
| H. Javadzadeh Shahshahani, M. Attar, M. Yavari (Research Center of Iranian BTO, Yazd, Iran) |
| P-437 STRATEGIES FOR INCREASING SAFER BLOOD SUPPLIES IN KENYA |
| E.M. Kitangala, J.A. Nyamongo, J. Mwangi (National Blood Transfusion Service Kenya, Nairobi, Kenya) |
| P-438 NEW METHODS FOR DETERMINING HEMOGLOBIN/HEMATOCRIT FOR DONOR ELIGIBILITY |
| M. Kline, V. George, P. Sabol (American Red Cross, Rockville, United States of America) |
| P-439 A STUDY OF THE SOUTH AFRICAN PUBLIC’S KNOWLEDGE, ATTITUDE AND PERCEPTIONS WITH REGARD TO BLOOD TRANSFUSION |
| P.M. Knox, R. Swanevelder, G. Nothard, I. Van Schalkwyk (South African National Blood Service, East London, South Africa) |
| P-440 IS THERE AN INCREASE IN DONOR DEFERRALS? |
| P.M. Knox, M Mack (South African National Blood Service, East London, South Africa) |
| P-441 PRODUCTION OF DOUBLE UNITS OF PRBC USING THE ALYX COMPONENT COLLECTION SYSTEM IS A SAFE AND TIME SPARING PROCEDURE |
| C. Leitner, J. List, G. Stiegler, M. Horvath, A. Wagner, P. Hoecker (Clinic for Blood Group Serology and Tran, Vienna, Austria) |
| P-442 CURRENT STATUS OF PREPARATIVE GRANULOCYTE APHERESIS: DONOR SELECTION, INDICATIONS AND TECHNIQUES |
| C. Leitner, G. Stiegler, J. List, N. Worel, P. Hoecker (Clinic for Blood Group Serology and Tran, Vienna, Austria) |
| P-443 LOOKING AT FACTORS GOVERNING FAILURE RATE IN PHLEBOTOMOY |
| S.L. Loh, C.L. Toh, N. Mohd Amir, M. Koh, D. Teo (Health Sciences Authority, Singapore, Singapore) |
| P-444 COMPARISON OF HAEMOGLOBIN CONCENTRATION IN BLOOD DONORS BEFORE AND AFTER DONATION, AND DETERMINATION OF THEIR IRON STORES |
| K.M. Magnussen, N.F.A. Fogh-Andersen (Herlev University Hospital, Copenhagen C, Bagsvaerd, Denmark) |
| P-445 IRON STORES IN BLOOD DONORS LOW IN HAEMOGLOBIN CONCENTRATION AND COMPARISON OF TWO METHODS FOR MEASURING THE HAEMOGLOBINCONCENTRATION |
| K.M. Magnussen, N.B. Bork, L.A. Asmussen (Herlev University Hospital, Copenhagen C, Bagsvaerd, Denmark) |
| P-446 RAPID RESULTS INITIATIVE APPROACH FOR DONOR RECRUITMENT IN SRI LANKA |
| H.A.C.S Manchanayake, Z.S. Bharucha (National Blood Transfusion Service, Colombo 05, Sri Lanka) |
| P-447 FACTORS THAT MOTIVATE AND HINDER BLOOD DONATION IN GREECE |
| O. Marantidou, L. Loukopoulou, E. Zervou, G. Martinis, A. Egglezou, K. Fountouli, E. Xassapopoulou, S. Noussis, P. Dimoxenou, M. Parara, M. Gavalaki, D. Mixopoulos, A. Maniatis (Asklipion Hospital, Athens, Greece) |
| P-448 A COMPARISON OF DONOR RETURNS BEHAVIOR OF FIRST TIME DONORS WHO WERE RECRUITED/NOT RECRUITED AFTER FIRST DONATION IN ISFAHAN BLOOD TRANSFUSION CENTER |
| Z. Massaeli, M.R. Jaberi, M.M. Hariri (Iranian Blood Transfusion Organisation, Isfahan, Iran) |
| P-449 SHOULD WE CONTINUE TO COLLECT DONORS WITH SICKLE BLOOD CELL TRAIT |
| C. Maugard, O. Nasr, C. Bichouard, P. Aguilar-Martinez, J. Coste (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-450 SHOULD WE CONTINUE TO COLLECT DONORS WITH SICKLE BLOOD CELL TRAIT |
| C. Maugard, O.N. Nasr, C.B. Bichouard, P.A.M. Aguilar Martinez, J. Coste (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-451 DEFERRALS, AND TERMINATION OF DONATION AMONG YOUNG BLOOD DONORS |
| A.H. Misje, V. Bosnes, H.H.E. Heier (Ullevål University Hospital, Oslo, Norway) |
| P-452 BLOOD DONORS: COMPARING WALK IN AND CALL RESPONSIVE DONORS IN A NATIONAL AND PRIVATE HOSPITAL IN NAIROBI |
| O. Mwanda, H. Abdallah, H. Rana (University of Nairobi, Nairobi, Kenya) |
| P-453 EFFECTS OF WARMING METHODS ON TEMPERATURE, CARDIAC AND IMMUNE FUNCTION IN PLATELET DONORS |
| C.W. Park, H.J. Kim (Kangnam St. Mary's Hospital, Seoul, South-Korea) |
| P-454 AVOIDING 'MARKETING MYOPIA' IN VOLUNTARY BLOOD DONATION (WHAT IS WRONG WITH THE PROMOTION OF VOLUNTARY BLOOD DONATION?) |
| B. Petrovic (University of Belgrade, Beograd, Serbia and Montenegro) |
| P-455 SUITABILITY OF DONORS FOR ERYTHRO - THROMBOCYTAPHERESIS ON TRIMA ACCEL |
| R. Procházková, L.H. Hubácková, L.R. Rehorová (Regional Hospital Liberec, Liberec, Czech Republic) |
| P-456 ADVERSE REACTIONS IN BLOOD DONORS |
| H. Ranganathan (Global Hospital, Hyderabad, India) |
| P-457 THE STUDY OF THE HONESTLY OF BLOOD DONORS IN RESPECTING TO QUESTIONS WITH A SPECIAL FOCUS ON HIV |
| F. Razjou (Iranian Blood Transfusion Research Centre, Tehran, Iran) |
| P-458 BETA TESTING OF A NEW ELECTRONIC SELF-ADMINISTERED DONOR QUESTIONNAIRE SYSTEM |
| M. Weidenhausen, M. Winter, B. Selle, C. Schmitt (Haemonetics GmbH, Munchen, Germany) |
| P-459 CAN THE MINIMUM DONATION INTERVAL BE REDUCED WITHOUT INCREASING THE THRESHOLD HEMOGLOBIN REQUIREMENT?... A FEASIBILITY STUDY USING SERUM FERRITIN AS AN INDICATOR OF IRON STORES |
| J.N. Shah, D. Theyventheran, H.H. Tan, M. Koh (Health Sciences Authority, Singapore, Singapore) |
| P-460 FREQUENCY OF ADVERSE EVENTS DURING PLATELETPHRESIS DONATIONS AND ITS IMPACT ON DONOR RETENTION |
| R. Sharma, K. Karan saluja, B. Beenu thukral, N. Neelam Marwaha (Postgraduate Institute of Medical Educatation, Chandigarh, India) |
| P-461 NON-SPECIFIC APPOINTMENTS WITH A PURPOSE – A NEW APPROACH TO TELE-RECRUITING |
| I.W. Simpson, M Griesel, M Harris, J Smith (South African National Blood Service (SANBS), Port Elizabeth, South Africa) |
| P-462 FERRITIN LEVELS IN DOUBLE RED CELL DONATIONS COMPARED TO WHOLE BLOOD DONATION, A 2 YEAR OBSERVATION |
| C. Stebler, L. Infanti, B. Eiche, M. Santoro, H. Lüscher, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-463 GRANULOCYTE APHERESIS DONORS: THE IMPACT OF HYDROXYETHYL STARCH ON BLOOD COAGULATION |
| M. Stiegler, V. Kolovratova, G. Leitner, P. Höcker (Medical University of Vienna, Vienna, Austria) |
| P-464 REPORT OF A STUDY OF THE VISTATM INFORMATION SYSTEM (GAMBROBCT) CONNECTED TO TRIMA R ACCEL (GAMBROBCT)TM CELL SEPARATORS FOR THE NATIONAL BLOOD SERVICE (NBS). “THE SOUTHAMPTON EXPERIENCE” |
| A. Thompson (National Blood Service, Southampton, United Kingdom) |
| P-465 AVAILABILITY OF VOLUNTEER DONOR BLOOD IN YOGYAKARTA CITY INDONESIA |
| T. Triyono, B. Mulyono (Sardjito Hospital, Yogyakarta, Indonesia) |
| P-466 REASONS FOR THE DEFERRAL OF VOLUNTARY BLOOD DONORS IN FIVE TRANSFUSIOLOGY DEPARTMENTS OF NORTHEASTERN SLOVENIA |
| V. Urlep Salinovic, I. Maracic, P. Leber, J. Pajk, E. Kava‰, D. Ulezic Paucic, M. Seruga, L. Strmcnik (Maribor Teaching Hospital, Maribor, Slovenia) |
| P-467 GEOGRAPHICAL MODELING OF DONOR ACTIVITY IN RELATION TO TRANSFUSION INFRASTRUCTURE BY DEFINED DONOR CENTRE CATCHMENT AREA, TO ENABLE EFFECTIVE DEPLOYMENT OF RESOURCES AND MAXIMIZE SAFE DONATIONS |
| R.A. Wagner, R. Swanevelder (Strategis, Centurion, South Africa) |
| P-468 ELIGIBILITY CRITERIA FOR DOUBLE RED CELL APHERESIS UNITS : QUESTIONNAIRE ANALYSIS |
| F. Schooneman, J.J.H. Huart, S.V. van Laer (EFS Nord de France, Lille, France) |
| P-469 IMPLEMENTATION AND DEVELOPPEMENT OF MULTICOMPONENT APHERESIS IN THE PARIS REGION |
| G. Woimant, C. Fretz, D. Puydupin, D. Benomar, D. Lemau, P. Anceau, E. Pelissier, J.L. Beaumont, P. Bierling (EFS Ile de France, Paris, France) |
| P-470 RESTRICTING PREDONATION HEMOGLOBIN TESTING TO DONORS AT RISK FOR LOW HEMOGLOBIN VALUES – SURVEY OF 81319 WHOLE BLOOD DONATIONS |
| M. Ziemann, C. Brockmann, D. Steppat, G. Washington, H. Kirchner, P. Schlenke}} (UKSH, Campus Lübeck, Luebeck, Germany) |
| TOPIC 06.1 |
| Topic 06.1. |
| Plasma Derivatives and Fractionation - Clinical Indications for Plasma Derivatives |
| P-471 AUDIT ON THE USE OF FRESH FROZEN PLASMA IN ADULTS IN A GENERAL TEACHING HOSPITAL IN KUWAIT |
| H.M. Al-Abdulrazzak, H. Al-Wazzan, S. Al-Muhareb, R. Marouf (Kuwait central blood bank, Hawalli, Kuwait) |
| P-472 DEVELOPMENT OF A HIGH THROUGHPUT SEMI-AUTOMATED MOLECULAR BEACON ASSAY FOR PARVOVIRUS B19 |
| S. Jones, J. Chappa, N. Kalmin, K. Leighton, L. Myers (South Texas Blood & Tissue Center, San Antonio, United States of America) |
| P-473 A PROSPECTIVE AUDIT OF TRANSFUSION REQUESTS IN A TERTIARY CARE HOSPITAL FOR THE USE OF FRESH FROZEN PLASMA (F.F.P.) |
| R.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India) |
| P-474 DETERMINATION OF PROPORTION OF ABO BLOOD GROUPS IN MANUFACTURE OF BIOPLASMA FDP®: A UNIVERSAL PLASMA? |
| C. Rochat, P.M. Larkin (National Bioproducts Institute, Pinetown, South Africa) |
| TOPIC 07.1 |
| Topic 07.1. |
| Clinical Transfusion Practice - Leucocyte Depletion |
| P-475 RESIDUAL LEUCOCYTE PHENOTYPING IN LEUCODEPLETED RED BLOOD CELL CONCENTRATES |
| M.F.A. Alves, P. Laranjeira, N. Guerra, A. Paiva, L. Pais, P. Neto (HUC, Coimbra, Portugal) |
| P-476 QUALITY CONTROL OF RED BLOOD CELL BUFFY-COAT REMOVED, OUR EXPERERIENCE |
| V. Durro, A Abazaj, S Spahiu, S Seferi (NBTSA, Tirana, Albania) |
| P-477 QUALITY OF LEUKOCYTE REMOVAL FILTERS USED IN MARMARA UNIVERSITY HOSPITAL BONE MARROW TRANSPLANTATION UNIT |
| S. Erdal, E. Birtas Atesoglu, I. Kaygysuz, S. Aktas, F. Noyan, C. Adiguzel, P. Engin, Z. Gulen, S. Sisman, G. Ataman, G. Yaman, M. Cetiner, T. Firalati Tuglular, M. Bayik (Marmara University, Istanbul, Turkey) |
| P-478 A MODIFIED NAGEOTTE HEMACYTOMETER METHOD FOR COUNTING LEUKOCYTES IN LEUKOREDUCED WHOLE BLOOD, RED CELL AND PLATELET PRODUCTS |
| M. Kline, V. George, J. Webb (American Red Cross, Rockville, United States of America) |
| P-479 A COMPARISON OF LEUCODEPLETION FILTERS (LABORATORY AND BEDSIDE USE) FOR FILTRATION OF RED BLOOD CELLS |
| B. Sawant, S. Jathar, P. Kadam, S. Rajadhyaksha (Tata Memorial Center - ACTREC, Navi Mumbai, India) |
| P-480 PROFILE OF CD14+ CELLS IN PLATELET CONCENTRATE AT DAY-6 STORAGE IN YOGYAKARTA INDONESIA |
| T. Triyono, B. Mulyono, U. S. Intansari (Sardjito Hospital, Yogyakarta, Indonesia) |
| P-481 MONOCYTE COLLECTION WITH MCS+ |
| H. Vrielink, P.F. van der Meer, E. Liu, J.J. Zwaginga, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| Topic 07.2 |
| Topic 07.2. |
| Clinical Transfusion Practice - Massive Transfusion/Resuscitation |
| P-482 ROLE OF BLOOD TRANSFUSION IN CARDIAC SURGERIES AT UNIVERSITY TEACHING HOSPITAL LUSAKA ZAMBIA |
| M. Chama, K. Muyinda, K. Mulenga, T. Sakala, P. Kumwenda (Zambia National Blood Transfusion, Lusaka, Zambia) |
| P-483 MASSIVE TRANSFUSION DURING SPLENECTOMY AND COAGULATION DISORDERS |
| V. Jovanoska, N.M. Nikoloski, D.B. Dimeski, M.T. Momiroska, V. Spirkoska, M.T. Momiroska (JZU General Hoospital, Prilep, Macedonia) |
| P-484 SUCCESSFUL TREATMENT OF A PATIENT WITH AML AND A CLOSTRIDIUM PERFRINGENS SEPSIS WITH MASSIVE HEMOLYSIS |
| F. Knutson, N. Alsadauri, A. Kinch (Clinical Immunology and Transfusion Medi, Uppsala, Sweden) |
| P-485 EFFECTS OF PERIOPERATIVE BLOOD TRANSFUSION ON THE CYTOKINE RESPONSE AND PROGNOSIS IN PATIENTS AFTER TOTAL HIP AND KNEE ARTHROPLASTY |
| I. Korzh, I. Fedotova, V. Nemtsova (Kharkov Medical University, Kharkov, Ukraine) |
| Topic 07.3 |
| Topic 07.3. |
| Clinical Transfusion Practice - Paediatric Transfusion Practice |
| P-486 ANEMIA AND THE USE OF RED BLOOD CELLS IN PREGNANT WOMEN IN CLINIC FOR OBSTETRIC AND GYNECOLOGY IN SKOPJE |
| M. Blagoevska, R. Grubovik, M. Stojovski, M. Grubovik, J. Samonikov, T. Makarovska (National Institute for Transfusion Medicine, Skopje, Macedonia) |
| P-487 GRANULOCYTE TRANSFUSIONS FROM G-CSF-STIMULATED RELATED DONORS FOR THE TREATMENT OF SEVERE INFECTIONS IN NEUTROPENIC PEDIATRIC PATIENTS. |
| J.J. Juscinska, N.E. Nowakowska, M. Zaborowska-Soltys, P.A. Ploszynska, B.A. Balcerska (Regional Center forTransfusion Medicine, Gdansk, Poland) |
| P-488 ACCEPTANCE OF SELF-TREATMENT IN HEMOPHILIC PATIENT: A TRAINING METHOD |
| S.H. Kavari (Darab Azad University, Darab, Iran) |
| P-489 TEN YEARS EXPERIENCE WITH PEDIATRIC APHERESIS |
| A. Kemahli, N. Solaz, N. Karaca, V. Arslan (Ankara University, Ankara, Turkey) |
| P-490 PEDIATRIC BLOOD BANKING PRACTICE AT ANKARA UNIVERSITY FACULTY OF MEDICINE |
| A. Kemahli, N. Solaz, S. Aydogan, N. Karaca (Ankara University, Ankara, Turkey) |
| P-491 DECREASING THE RISKS OF TRANSFUSION THERAPY IN CHILDREN HOSPITAL WITH SIMPLE MEASURES: SUCCESSFUL CHANGES IN USE OF FRESH FROZEN PLASMA AFTER ANALYSIS OF ITS MISUSE WITH CLINICIANS EVERY SIX MONTHS |
| D. Pirc-Tiljak (Croatian Institute of transfusion medicine, Zagreb, Croatia) |
| P-492 FREQUENCY OF TRANSFUSION REACTIONS IN TRANSFUSION DEPENDANT THALASSAEMIA MAJOR PATIENTS |
| H.A. Zaheer, K. Hasan, S. Ahsan, S. Aslam (Pakistan Institute of Medical Sciences, Islamabad, Pakistan) |
| Topic 07.4 |
| Topic 07.4. |
| Clinical Transfusion Practice - Blood Substitutes |
| P-493 CORRELATION BETWEEN ENDOTHELIAL HAEMOSTATIC MARKERS IN PATIENTS REQUIRING URGENT TRANSFUSION WITH A RED CELL SUBSTITUTE |
| O. Korzh, S. Krasnokutskiy, G. Kotchuev (Kharkov Medical Academy, Kharkov, Ukraine) |
| P-496 CLINICAL EFFICIENCY OF GRANULOCYTES IN NEUTROPENIC CHILDREN |
| S. Rummler, F. Heinemann, K. Althaus, Th. Lorenzen, F. Zintl, D. Barz (University Hospital Jena, Jena, Germany) |
| P-497 COMPARISON OF GRANULOCYTE COLLECTION FROM G-CSF TREATED AND UNTREATED DONORS |
| S. Rummler, F. Heinemann, K. Althaus, Th. Lorenzen, D. Barz (University Hospital Jena, Jena, Germany) |
| Topic 07.5 |
| Topic 07.5. |
| Clinical Transfusion Practice - Non-infectious Hazards of Transfusion |
| P-498 VALIDATING THE RADIOTHERAPY LINEAR ACCELERATOR VARIAN 23 EX MACHINE FOR BLOOD IRRADIATION USING BIOLOGICAL INDICES |
| C. Anyaegbu, A. Abdelaal, M. Malaker, H. Weatherburn, M. Anwar, M. Hafiz, M. Kassar, J. Desonza, D. Friend (King Abdul Aziz Medical City-WR, Jeddah, Jeddah, Saudi Arabia) |
| P-499 THREE TRALI CASES ASSOCIATED WITH ONE DONOR WITH HLA II ANTIBODIES: A LOOKBACK STUDY |
| A.M. Beckers, D. van Stein, K. Sintnicolaas, L. Porcelijn, A. Brand, D.J. van Rhenen (Sanquin Blood Bank South West region, Rotterdam, Netherlands) |
| P-500 IRON OVERLOAD IS A MOST IMPORTANT ADVERSE EFFECT OF LONG-TERM TRANSFUSION THERAPY IN MYELODYSPLASTIC SYNDROME |
| J. Cermak, L. Walterova, M. Pisacka (Institute of Hematology and Blood Transfusion, Praha 2, Czech Republic) |
| P-501 THE IMPACT OF USING MALE DONOR PLASMA ON HAEMOVIGILANCE REPORTS OF TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI) IN THE UK |
| C.E. Chapman, L.M. Williamson, H. Cohen, D. Stainsby, H. Jones (National Blood Service, UK, Newcastle Upon Tyne, United Kingdom) |
| P-502 THREE YEARS HAEMOVIGILANCE OF METHYLENE BLUE-TREATED FRESH FROZEN PLASMA : NO INCREASE IN TRANSFUSION REACTION INCIDENCE |
| M.C. Deneys, D. Latinne, C. Guerrieri, P. Baele (Cliniques Universitaires Saint Luc, Brussels, Belgium) |
| P-503 ETHYLENE OXIDE (ETO) AND TRANSFUSION-INDUCED ADVERSE REACTIONS IN A PATIENT ON MAINTENANCE HEMODIALYSIS |
| A. Kokubunji, R. Murata, R. Imaizumi, Y. Otaki, S. Imoto, S. Kai (Hyogo College of Medicine, Nishinomiya, Japan) |
| P-504 ANTI-GRANULOCYTE ANTIBODY DETECTION BY SOLID-PHASE ASSAY USING A MAGNETIC FORCE |
| T. Mazda, H. Kamada, T. Tamai, Y. Watanabe, H. Okazaki, K. Tadokoro (Japanese Red Cross Central Blood Institute, Tokyo, Japan) |
| P-505 INCIDENCE OF TRALI AND RESPIRATORY COMPLICATIONS IN THE QUEBEC HEMOVIGILANCE SYSTEM |
| P. Robillard, K.I. Karl Itaj, A.C. Chapdelaine (Quebec Public Health Institute, Montreal, Canada) |
| P-506 A SIMPLE SENSITIVE ELISA FOR THE DETECTION OF HAPTOGLOBIN DEFICIENCY AND THE CHARACTERISTICS OF THE IDENTIFIED CASES |
| E. Shimada, Y. Watanabe, T. Mazda, H. Okazaki, K. Tadokoro, T. Juji (The Japanese Red Cross, Tokyo, Japan) |
| P-507 TRANSFUSION RELATED LUNG INJURY (TRALI) DUE TO ANTI-HLA CLASS II ANTIBODIES |
| M. Tomicic (Croation Institute of Transfusion Medici, Zagreb, Croatia), M.Culjak-Aleksic (Magdalena Hoospital for Cardiovascular Surgery, Krapinske Toplice, Croatia), N. Todoric (Magdalena Hoospital for Cardiovascular Surgery, Krapinske Toplice, Croatia), V. Balog (Tissue Typing Center, University Department of Uroplgy, Zagreb, Croatia), V. Drazic (Croatian Institute of Transfusion Medicine, Zagreb, Croatia), J. Bingulac-Popovic (Croatian Institute of Transfusion Medicine, Zagreb, Croatia), Z. Hundric-Haspl (Croatian Institute of Transfusion Medicine, Zagreb, Croatia), M. Balija (Croatian Institute of Transfusion Medicine, Zagreb, Croatia), I. Jukic (Croatian Institute of Transfusion Medicine, Zagreb, Croatia). |
| P-508 REDUCED RATE OF ADVERSE REACTIONS TO PLASMA REDUCED POOLED PLATELET UNITS – POSSIBLE ROLE OF MINOR INCOMPATIBLE TRANSFUSIONS |
| F. Wagner, W. Adamo (DRK Blutspendedienst NSTOB, Springe, Germany) |
| P-509 USE OF AN ELECTRONIC BARCODE CHECKER TO IMPROVE THE SAFETY OF BEDSIDE ADMINISTRATION OF BLOOD |
| J.P. Wallis, S. Whitehead (Freeman Hospital, Newcastle Upon Tyne, United Kingdom) |
| P-510 TRALI AT FREEMAN HOSPITAL SINCE THE INTRODUCTION OF MALE DONOR ONLY FRESH FROZEN PLASMA. |
| J.P. Wallis, S. Whitehead, C.E. Chapman (Freeman Hospital, Newcastle Upon Tyne, United Kingdom) |
| P-511 TYPE I HEREDITARY HEMOCHROMATOSIS: ROLE OF BODY MASS INDEX ON THE PHENOTYPIC EXPRESSION OF THE C282Y/C282 AND C282Y/H63D GENOTYPES |
| V. Scotet, G. le Gac, M.C. Mérour, A.Y. Mercier, B. Chanu, C. Ka, C. Mura, J.B. Nousbaum, C. Férec (Inserm U 613, Brest, France) |
| TOPIC 08.1-3 |
| Topic 08.1-3. |
| Auto-Transfusion |
| P-512 PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN TOTAL KNEE ARTHROPLASTY: AN ITALIAN SINGLE-CENTRE EXPERIENCE |
| G. Aprili, M. Franchini, M. de Gironcoli, G. Gandini (Servizio Trasfusionale, Verona, Italy) |
| P-513 COST-EFFECTIVENESS OF AUTOLOGOUS HAEMOTHERAPY METHODS |
| R. Karger, V. Kretschmer (Philipps University Marburg, Marburg, Germany) |
| P-514 EFFECTIVE PRE-OPERATIVE AUTOLOGOUS BLOOD DONATION IN ORTHOPAEDIC SURGERY |
| E.K. Klausa, J.M. Majda, W.W. Wodzislawski, R.K. Kozlowski (Regional Centre of Transfusion Medicine, Wroclaw, Poland) |
| P-515 SEROLOGIC INFECTION TESTING OF AUTOLOGOUS BLOOD DONORS |
| M. Lukic, B. Golubic Cepulic, I. Bojanic, F. Plenkovic, S. Mazic, Z. Ivankovic, B. Tripkovic, M. ·ulentic, K. KorÏinek, D. Orlic (Clinical Hospital Center Zagreb, Zagreb, Croatia) |
| P-516 THE PREDEPOSIT AUTOLOGOUS BLOOD PROGRAM OF THE NATIONAL ORTHOPAEDIC HOSPITAL LAGOS, NIGERIA (1992-2004) |
| O.E. Nnodu, C.O. Maduka (National Orthopaedic Hospital, Lagos, Nigeria) |
| P-517 NEW AUTOMATED APHERESIS SYSTEM FOR SINGLE OR DOUBLE-DOSE RED CELL COLLECTION WITH ADVANTAGES OF REDUCED EXTRACORPOREAL VOLUME FOR AUTOLOGOUS USE |
| W. Nussbaumer (Univ.-Hospital Innsbruck, Innsbruck, Austria) |
| P-518 OUTCOME OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN ELDERLY PATIENTS |
| E. Rodriguez, R.J. Fernández, B. Amerise, A. Skripnik Strelecki (Fundación Hemocentro Buenos Aires, Buenos Aires, Argentina) |
| P-519 RECENT ADVANCES AND PROBLEMS OF THE AUTOLOGOUS BLOOD TRANSFUSION |
| H. Tsuno, A. Kamijo, N. Hori, Y. Kudo, M. Murakami, S. Masuda, A. Mabuchi, S. Sone, M. Matsuhashi, K. Takahashi (The University of Tokyo, Tokyo, Japan) |
| P-520 SUCTION-INDUCED HEMOLYSIS DURING BLOOD SALVAGE |
| E.N. Hansen, J. Kling, G. Roth, M.T. Pawlik (University of Regensburg, Regensburg, Germany) |
| P-521 REASONS AGAINST THE RETRANSFUSION OF UNWASHED WOUND BLOOD |
| E.N. Hansen (University of Regensburg, Regensburg, Germany) |
| P-522 SAFETY AND EFFICACY OF AUTOLOGOUS DRAINAGE BLOOD REINFUSION FOLLOWING TOTAL KNEE ARTHROPLASTY PREPARED WITH HYDROGEN PEROXIDE |
| J.D. Kolt, D. Robin, A. Carr, D. Chew, I.J. Critchley, R. Horton (St. George Hospital, New South Wales, Australia) |
| TOPIC 09.1 |
| Topic 09.1. |
| Stem Cells - Peripheral Blood and Bone Marrow Progenitor Cells |
| P-523 HIGH QUALITY OF PERIPHERAL BLOOD PROGENITOR CELLS COLLECTED BY A CONTINUOUS FLOW BLOOD CELL SEPARATOR AND A DUAL STAGE SEPARATION CHAMBER |
| M. Alberti, D. Graziano, C. Falco, G. Mele, L. Pezzullo, M. Di Somma, M. Macrì (Aorn "Cardarelli", Marano Di Napoli, Italy) |
| P-524 PERIPHERAL BLOOD OPPOSING BONE MARROW TRANSPLANTATION FOR MALIGNANT AND AUTOIMMUNE DISEASES |
| B. Balint, M. Trkuljic (Institute of Transfusiology, Belgrade, Serbia and Montenegro) |
| P-525 TUMOR CELLS, BONE MARROW AND PERIPHERAL BLOOD STEM CELLS ASSESSMENT AFTER LONG TERM CRYOPRESERVATION (LTC) |
| C.D. Dufour, H. Longoni, M.A. Sorrentino, C. Merlo, M. Bascoy, E. Pastorino Aubri, P. Luchetta, A. Robinson, C. Di Risio - Bianchi, P. Franchini (Navy Hospital Buenos Aires, Buenos Aires, Argentina) |
| P-526 OPTIMIZING PERIPHERAL BLOOD STEM CELL (PBSC) COLLECTION IN PAEDIATRIC PATIENTS |
| G. Bezuidenhout (South African National Blood Service (SANBS), Johannesburg, South Africa) |
| P-527 FACTORS PREDICTING MOBILIZATION AND COLLECTION OF PERIPHERAL BLOOD PROGENITOR CELLS IN PATIENTS AFFECTED BY HAEMATOLOGICAL MALIGNANT DISEASES |
| C. Falco, M. Alberti, D. Graziano, S. Palmieri, G. Scalia, P. Morabito, M. Di Somma, M. Macrì (Aorn "Cardarelli", Naples, Italy) |
| P-528 EVALUATION OF AUTOLOGOUS PERIPHERAL CD34+ CELL DOSE USING IDEAL OR ACTUAL BODY WEIGHT |
| C.T.G. Gonzalez, A. Zubair, D. Gastineau, R. Beveridge, J. Winters, H. Adams, J. Slack, J. Maningo-Salinas, C. Befort, B. Nolot, A. Torloni (Fairfax-NoVA Hematology Oncology, Herndon, United States of America) |
| P-529 DURABLE REMISSION OF RECURRENT THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION. A CASE REPORT |
| D. Graziano, C. Falco, L. Pezzullo, M. Alberti, S. Rocco, M. Di Somma, M. Macrì (Aorn "Cardarelli", Naples, Italy) |
| P-530 MONOCYTE ENRICHMENT FROM LEUKAPHERESIS PRODUCTS USING THE ELUTRA CELL SEPARATOR |
| H. Kim, J. Suh, O. Kwon (Yonsei University, Seoul, South-Korea) |
| P-531 BLOOD RHEOLOGY IN PERIPHERAL BLOOD STEM CELL DONORS |
| M. Mariano, M. Ballestri, F. Ferrari, A. Donelli, P. Bresciani, A. Cuoghi, M. Quartieri, F. Narni (Transfusion Medicin Policlinic Hospital, Modena, Italy) |
| P-532 MEDIUM TO LONG TERM SURVIVAL OF PATIENTS RECEIVING CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS |
| S.B. Marrs (South African National Blood Service, Gauteng, South Africa) |
| P-533 IDENTIFICATION OF CD34+/CD61+ MEGAKARYOCYTIC PROGENITORS BY REAL TIME PCR QUANTIFICATION AS PREDICTOR OF LATE PLATELET RECOVERY AFTER AUTOGRAFTING IN NON-HODGKIN LYMPHOMA PATIENTS |
| K.R. René Nielsen, R. Steffensen, J. Baech, H.E. Johnsen (Aalborg Hospital, Aalborg, Denmark) |
| P-534 PROGNOSTIC FACTORS FOR HEMATOPOIETIC STEM CELL MOBILIZATION SUFFICCIENCY FOR TWO TRANSPLANTS USING ONLY G-CSF AND THE DEVELOPMENT OF A PROGNOSIS INDEX |
| C. Pinto Rebello, C. martins Nogueira, R. Schafel (UFRJ- BRASIL, Rio De Janeiro, Brazil) |
| P-535 PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION AND COLLECTION IN 23 PATIENTS WITH SYSTEMIC MULTIPLE SCLEROSIS |
| A. Ribeiro, A.M.K. Sakashita, K.C.A. Alvarez, N. Hamerschlak, J.M. Kutner, A.N. Cipolletta, R.A.A. Pereira (IIEP Hospital Israelita Albert Einstein, Sao Paulo, Brazil) |
| P-536 GENE AND HAPLOTYPE FREQUENCIES FOR THE LOCI HLA-A, HLA-B, HLA-DR BASED ON OVER 20000 CHINESE HEMATOPOIETIC STEM CELL DONORS |
| J.L. Sun, K.M. Du, M. Fu, Y. Sun, Y. Jin, J.H. Xie, Y. Ji, J.H. Yang, Y.H. Ji, Z. Zhang, Z. Mao, D.Z. Liu, K.C. Qian, Z. Zhu (The Transfusion Institute of SBC, Shanghai, China) |
| P-537 MONITORING OF THE HEMATOCRIT DURING APHERESIS FOR PBSC WITH THE AMICUS SYSTEM IN VERY SMALL CHILDREN AND ADOLESCENTS V.W. Witt, E. Beiglböck, G. Fritsch, C. Peters, H. Gadner (St. Anna Kinderspital, Vienna, Austria) |
| TOPIC 09.2 |
| Topic 09.2. |
| Stem Cells - Umbilical Cord Blood Stem Cells |
| P-538 THE STUDY OF EXPANSION AND MULTIPOTENCY OF CORD BLOOD STEM CELLS AFTER TWO TIMES FREEZING AND THAWING |
| A. Atashi, M. Soleimani, M. Hafizi (Tarbiat Modarres University, Tehran, Iran) |
| P-539 LEGAL NEEDS TO REGULATE AND PROMOTE THE CONSERVATION OF CORD BLOOD STEM CELLS FOR ALLOGENIC TRANSPLANTATION IN ARGENTINA |
| R. Di Tullio Budassi, M.A. Spósito, L. Di Tullio Budassi (Ctro. Invest. Der. de la Ancianidad- UNR, Rosario, Argentina) |
| P-540 THERMOGENESIS AXP AUTOXPRESS™ PLATFORM AND BIOARCHIVE™ SYSTEM FOR AUTOMATED CORD BLOOD BANKING |
| L. Dobrila, J. Chapman, D. Marr, V. Kumar, P. Coelho, P. Rubinstein (National Cord Blood Program at New York, New York, United States of America) |
| P-541 DOES CORD BLOOD TRANSPLANTATION (CBT) HAVE A FUTURE IN ARGENTINA AND LATIN AMERICA? |
| C.D. Dufour, M.A. Sorrentin, P. Luchetta, A. Mino, L. Rizzo, P. Franchini, E. Pastorino Aubry, C. Merlo, A. Robinson (Navy Hospital Buenos Aires, Buenos Aires, Argentina) |
| P-542 UMBILICAL CORD BLOOD BANKING: ARGENTINA’S UNRELATED PROGRAM |
| C. Gamba, A. Marcos, S. Casini, E. Ramos, A. Bernasconi, C.Y. Marcos, G. Theiler, L. Casimir, E. Del Pozo (National Public Cord Blood Bank, Ciudad Autonoma De Buenos Aires, Argentina) |
| P-543 CHARACTERIZATION OF MEGAKARYOCYTES PROGENITOR CELLS DIFFERENTIATED FROM UMBILICAL CORD BLOOD CD133+ AND CD133- CELLS |
| M. Kheirandish, M. Aghaeii Pour, A. Firozi, A. Pourfathaollah, A. Tabatabaeian, S. Vaeli, S. Niroomanesh, M. Ebtekar, A. Goodarzi (Iranian Blood Transfsion Research Center, Tehran, Iran) |
| P-544 EX VIVO EXPANSION OF MEGAKARYOCYTES PROGENITOR CELLS FROM UMBILICAL CORD BLOOD CD133+ AND CD133- CELLS |
| M. Kheirandish, A. Firozi, A. Pourfathaollah, A. Tabatabaeian, S. Niroomanesh, A. Goodarzi, S. Vaeli (Iranian Blood Transfsion Research Center, Tehran, Iran) |
| P-545 COMPARATIVE ANALYSIS OF THE PREVALENCE OF ABNORMAL INFECTIOUS DISEASE TESTS IN SCREENING OF WHOLE BLOOD DONORS AND UMBILICAL CORD BLOOD DONORS IN A SINGLE INSTITUTION IN BRAZIL |
| A. Ribeiro, J.M. Kutner, M.B. Polite, A.T. Kondo, C.S. Guerra, S.V.F. Santos, R.M. Miranda (IIEP Hospital Israelita Albert Einstein, São Paulo, Brazil) |
| P-546 UMBILICAL CORD BLOOD: SAFETY OF THE STEM CELL PRODUCT CAN BE IMPLEMENTED BY NAT TRIPLEX ASSAY |
| L. Salvaneschi, P. Bergamaschi, C.G. Perotti, L. Bellotti, C. Parisi, A. Marchesi, V. Galiazzo, R. Poma, C. Del Fante, G.L. Viarengo (IRCCS Policlinico "San Matteo", Pavia, Italy) |
| TOPIC 09.3 |
| Topic 09.3. |
| Stem Cells - Cellular Therapies |
| P-547 APHERESIS EXPERIENCE OF SULEYMAN DEMIREL UNIVERSITY BLOOD BANK APHERESIS UNIT |
| D. Canatan, G. Alanoglu, M. Polat, S. Ogut (Suleyman Demirel University, Isparta, Turkey) |
| P-548 THE STUDY ON THE MECHANISMS OF V?24NKT CELLS FROM HUMAN PERIPHERAL BLOOD CELLS IN ANTI-TUMOR IMMUNITY |
| H. Fan, J. Yang, B. Zheng (Shanghai Blood Center, Shanghai, China) |
| P-549 TIME COURSE ASSAY AFTER TRANSFECTION SHOW DENDRITIC CELLS LOADED WITH K562 RNA CAN EXPRESS P210BCR-ABL PROTEIN |
| L. Gao, H.H. Fan, Y. Ren, X.X. Nie, Y Liu, Y.M. Yang, R.F. Xie, K.C. Qian (Shanghai Blood Center, Shanghai, China) |
| P-550 EVALUATION OF INTRACELLULAR PERFORIN IN CD56+ CELLS IN CORD AND PERIPHERAL BLOOD |
| M. Kheirandish, A. Firozi, M. Ebtekar, M. Aghaeii Pour, A. Tabatabaeian (Iranian Blood Transfsion Research Center, Tehran, Iran) |
| P-551 COMPARISON OF INTRACELLULAR PERFORIN IN CD8+ CELLS IN CORD AND PERIPHERAL BLOOD IN RESTING CONDITION |
| M. Kheirandish, A. Firozi, M. Ebtekar, M. Aghaeii Pour, A. Tabatabaeian, A. Goodarzi (Iranian Blood Transfsion Research Center, Tehran, Iran) |
| P-552 TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD) BY EXTRACORPOREAL PHOTOCHEMOTHERAPY WITH A NEW CE CERTIFIED UV A IRRADIATION MACHINE |
| H. Ullrich, N. Kroeger, J. Schrum, A. Zander, P. Kühnl (University Clinics, Hamburg, Germany) |
| TOPIC 10.1 |
| Topic 10.1. |
| Platelet - Transfusion |
| P-553 PROSPECTIVE AND RANDOMIZED COMPARATIVE STUDY OF PLATELETPHERESIS USING TWO CELL SEPARATORS BASED ON INTERMITTENT AND CONTINUOUS FLOW CENTRIFUGATION |
| R.N. Makroo, V. Raina, P. Kumar, S. Gautam (Apollo Hospitals, Delhi, India) |
| P-554 ROLE OF PLATELET TRANSFUSION IN THE MANAGEMENT OF DENGUE PATIENTS IN A TERTIARY CARE HOSPITAL |
| R.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India) |
| P-555 THE EFFECT OF PRESTORAGE FILTRATION ON PLATELET ACTIVATION IN PLATELET CONCENTRATES |
| A. Solaimany ferizhandy, M. Aghaee Por, P. Pourfatholla (Iranain Blood Transfusion ORG Rresearch, Tehran, Iran) |
| P-556 QUALITY OF APHERESIS PLATELET CONCENTRATES COLLECTED BY COBE SPECTRA OR TRIMA ACCEL AND STORED FOR 7 DAYS |
| N. Tynngard, T. Lindahl, M. Trinks, M. Studer, G. Berlin (Linköping University Hospital, Linköping, Sweden) |
| P-557 SINGLE DOSE PLATELET PREPARATION (OUR EXPERIENCE) |
| K. Milenkov, P. Gerasimova, K. Dukovski, L.J. Samonikova (Institute of Blood Transfusion of-Skopje, Skopje, Macedonia) |
| P-558 STORAGE OF BUFFY-COAT-DERIVED PLATELETS IN ADDITIVE SOLUTIONS: FLOW CYTOMETRY ANALYSIS OF PLATELET QUALITY AT 4 DEGREES C STORAGE |
| P. Sandgren, M. Hansson, H. Gulliksson, A. Shanwell (Karolinska University Hospital, Stockholm, Sweden) |
| P-559 IN VITRO EVALUATION OF THREE ADDITIVE SOLUTIONS FOR THE STORAGE OF PLATELETS |
| L. Larrea, M.J. Belenguer, E. Costa, C. Franco, C. Herreros, C. Leon, M. Gil, I. Saiz, M.D. Garcia, M.A. Soler, R. Roig (Centro Transf de la Comunidad Valenciana, Valencia, Spain) |
| P-560 THE RISK FACTOR ANALYSIS FOR PLATELET ANTIBODY(POSITIVE) PATIENTS REQUIRING PLATELET TRANSFUSION |
| W. Shen, J.L. Wang, D.Z. Liu (Shanghai Blood Center, Shanghai, China) |
| P-561 SURVEY OF EXTENDED SHELF LIFE PLATELETS AT THE WELSH BLOOD SERVICE |
| R. Ahya, G. Rowe, R. Jones (Welsh Blood Service, South Glamorgan, United Kingdom) |
| P-562 MCS+ APHERESIS PLATELETS: 7-DAY STORAGE IS FEASIBLE |
| H. Vrielink, P.F. van der Meer, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-563 EFFECT OF IRRADIATION ON PLATELET CONCENTRATES IN PLATELET ADDITIVE SOLUTION, STORED FOR 8 DAYS |
| P.F. van der Meer, L.A.E. Liefting, R.N.I. Pietersz (Sanquin Blood Bank North West region, Amsterdam, Netherlands) |
| P-564 EFFECTS OF INTERRUPTION OF AGITATION ON IN VITRO PARAMETERS OF PLATELET CONCENTRATES STORED IN COMPOSOL-PS |
| P.F. van der Meer, L.A.E. Liefting, R.N.I. Pietersz (Sanquin Blood Bank North West region, Amsterdam, Netherlands) |
| P-565 NON-INVASIVE MEASUREMENT OF PLATELET CONCENTRATE PH WITH A FIBER OPTIC FLUORESCENCE DETECTOR |
| D. de Korte, R. Vlaar, C.W.N. Gouwerok, I. de Cuyper, E.J. Klip, M.W. Reed, S. Geelhoed, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-566 OPTIMISATION OF COLLECTION STRATEGIES USING THREE APHERESIS PLATFORMS TO MAXIMISE DONOR ELIGIBILITY AND PLATELET SUPPLY |
| S. Lechner, R.G. Gassler, S.A. Sima (Austrian Red Cross, Klagenfurt, Austria) |
| P-567 INVESTIGATION OF COMPOYIELD, A WHOLE BLOOD FILTER THAT DOES NOT REMOVE PLATELETS |
| P.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West region, Amsterdam, Netherlands) |
| P-568 PARAMETERS OF CENTRAL HEMODYNAMICS IN PREGNANT WOMEN BEFORE AND AFTER OPERATION PERIOD IN THE CONDITIONS OF AUTODONATION OF PLASMA |
| B. Bahovadinov, B. Zajdulloev (Republican Sientific Centre of Blood, Dushanbe, Tajikistan) |
| P-569 EVALUATION OF THE NEW C-SDP MCS+ PROTOCOL: APHERESIS PLATELET CONCENTRATES IN ADDITIVE SOLUTION |
| M. Mariano, I. Varinelli, R. Roncaglia, A. Mansi, I. Lonetti, M. de Palma (Transfusion Medicine, Modena, Italy) |
| P-570 INFLUENCE OF THE CITRATE CONCENTRATION IN PLATELET CONCENTRATES FROM TRIMA ACCEL (GAMBRO BCT) |
| K. Althaus, S. Rummler, Th. Lorenzen, S. Straube, G. Nowak, D. Barz (University Hospital Jena, Jena, Germany) |
| P-571 ANTICOAGULATION, ACTIVATION AND THE ADHESION ABILITY OF PLATELETS IN CONCENTRATES |
| K. Althaus, S. Rummler, S. Straube, Th. Lorenzen, G. Nowak, D. Barz (University Hospital Jena, Jena, Germany) |
| P-572 ADDITION OF ACETATE ALLOWS FOR THE MAINTENANCE OF THE QUALITY OF MIRASOL PATHOGEN REDUCTION TREATED PLATELETS IN A LOW PLASMA ENVIRONMENT FOR 7 DAYS |
| K.A. Buytaert-Hoefen, R. Goodrich, N. Hovenga, J. Li (Navigant Biotechnologies, Lakewood, United States of America) |
| P-573 SUCCESFUL PLATELET TRANSFUSION IN PATIENTS WITH A COMBINATION OF HLA- HPA AND PLATELET AUTOANTIBODIES |
| A.G. van den Bos, Y.C.M. van Berkel, L. Porcelijn, T.A.S. Tomson, J.A.H.G. Wollersheim, V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands) |
| P-574 EFFICACY OF FENWAL-AMICUS BLOOD CELL SEPERATOR IN DOUBLE DOSE PLATELET COLLECTION |
| O. Arslan, S. Gurak (Ankara University, Ankara, Turkey) |
| P-575 QUALITY ASSESSMENT OF BAGS FOR SEVEN-DAY STORAGE OF PRESTORAGE FILTERED PLATELET CONCENTRATE POOL |
| M. Strauss Patko, T. Vuk, C. Maglov, M. Balija, I.J. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia) |
| P-576 EFFECTS OF STORAGE INDUCED PLATELET MICROPARTICLES ON THE INITIATION AND PROPAGATION PHASE OF BLOOD COAGULATION |
| J.F.W. Keuren, E.J.P. Magdeleyns, T. Lindhout, J. Curvers (Sanquin Blood Bank Southeast Region, Maastricht, Netherlands) |
| P-577 EFFECT OF MICROPARTICLES FROM PLATELET CONCENTRATES ON HAEMOSTASIS IN A THROMBOCYTOPENIC PERFUSION MODEL |
| J.F.W. Keuren, E.J.P. Magdeleyns, J. Curvers, T. Lindhout (Sanquin Blood Bank Southeast Region, Maastricht, Netherlands) |
| P-578 EVALUATION OF 4 DIFFERENT METHODOLOGIES FOR PLATELET ANTIBODY SCREENNING (PAS) IN TRANSFUSED PATIENTS |
| R. Fontão-Wendel, L.C.N. Silva, C.B.R. Savioli, P. Borelli, S. Wendel (Blood Bank - Hospital Sirio Libanês, São Paulo, Brazil) |
| P-580 NATION-WIDE PROTOCOL FOR THE MEASUREMENT OF CD62P AND ANNEXIN V-BINDING IN PLATELET CONCENTRATES |
| P.F. van der Meer, J. Curvers, A.J. Verhoeven, J. Scharenberg, J. Heeremans, W. Kuipers, M. Eijzenga, D. de Korte, J. de Wildt (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-581 PROTEIN PROFILE CHANGES IN PLATELET CONCENTRATE ACCORING TO STORAGE: USING PROTEOMICS TECHNOLOGY |
| S. Ryu, I. Suh, N. Cho, K. Lee, Y. Cho (Kangwon National University, Chuncheon, Kangwon-do, South-Korea) |
| P-582 PROTEIN PROFILE CHANGES IN PRESTORAGE AND POSTSTORAGE LEUKOFILTERED PLATELET CONCENTRATE: USING PROTEOMICS TECHNOLOGY |
| S. Ryu, I. Suh, N. Cho, K. Lee, C. Lim, M. Whang, S. Kwon, Y. Cho (Kangwon National University, Chuncheon, Kangwon-do, South-Korea) |
| P-583 PROTEIN PROFILE CHANGES IN PRESTORAGE AND POSTSTORAGE IRRADIATED PLATELET CONCENTRATES : USING PROTEOMICS TECHNOLOGY |
| S. Ryu, I. Suh, N. Cho, K. Lee, C. Lim, C. Lee, Y. Kim, Y. Cho, S. Yoon (Kangwon National University, Chuncheon, Kangwon-do, South-Korea) |
| P-584 AUTOMATIZATION OF PLATELET COMPONENTS PREPARATION PROCESS EXPERIENCE OF CRSP SINCE 2003 |
| M.O. Ramoa Rodrigues, M. Pacheco, S. Oliveira, F. Quelhas, S. Maia (Portuguese Blood Institute, Porto, Portugal) |
| TOPIC 10.2 |
| Topic 10.2. |
| Platelet - Immunology |
| P-585 A PROSPECTIVE STUDY OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA – A SINGLE INSTITUTIONAL STUDY IN TAIWAN |
| C.H. Tzeng, P.S. Chen, H.M. Liu, Y.R. Chen, J.Y. Lyou, H.Y. Hu, J.S. Lin (Taipei Veterans General Hospital, Taipei, Taiwan) |
| P-586 RELEASE OF POTENTIAL IMMUNOMODULATORY FACTORS DURING PLATELET STORAGE |
| O. Garraud, F. Cognasse, F. Boussoulade, P. Chavarin, S. Acquart, P. Fabrigli, B. Lamy (French Regional Blood Bank, Saint Etrienne, France) |
| P-587 HUMAN PLATELETS ACTIVATE PERIPHERAL BLOOD B CELLS AND INCREASE THE PRODUCTION OF IMMUNOGLOBULINS |
| O. Garraud, F. Cognasse, H. Hamzeh-Cognasse, P. Chavarin, S. Acquart, Y. Richard (French Regional Blood Bank, Saint Etrienne, France) |
| P-588 DIRECT COMPARISON BETWEEN ELISA AND MAIPA IN THE MEASUREMENT OF ANTI-HPA-1A (IN IU/ML AND AU/ML) IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA |
| H. Bessos, M. Matviyenko, M. Killie, S. Urbaniak (Scottish Blood Transfusion Service, Edinburgh, United Kingdom) |
| P-589 PSEUDOTHROMBOCYTOPENIA, THROMBOCYTOPENIA AND ANTIPLATELETS ANTIBODIES IN BLOOD DONORS |
| M. Palange, A. Agresti, D. Fioravanti, F. Terlizzi, A. Di Lorenzo, P. Iudicone, M. Miceli, C. Amedeo, R. Colaceci, A. Tudisco, S. Berardini, E. Mannella (A.O. "S. Camillo - Forlanini", Roma, Italy) |
| P-590 IN VITRO EVALUATION OF PLATELET EXPRESSING P-SELECTIN AND PLATELET AGGREGATION IN STORED PLATELET CONCENTRATES |
| A. Gharehbaghian, S. Sadri, M. Aghayeepour, S. Vaeli, M. Karbasizadeh, J. Ghaledi, Z. Atarchi, M. Ahmadinejad, T. Shashaani, A. Tabatabaeeyan, F. Kami, F. Babahossein (The Research Center of IBTO, Tehran, Iran) |
| P-591 THE OBJECTIVE INTERPRETATION OF THE RESULTS OF MIXED-PASSIVE HEMAGGLUTINATION (MPHA) METHOD BY THE APAS-2000 SYSTEM |
| M. Matsuhashi, N.H. Tsuno, K. Takahashi (The University of Tokyo, Tokyo, Japan) |
| P-592 FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: ANTENATAL SCREENING |
| G. Fratellanza, A. Fratellanza, A. D'Ambra, S. Misso, B. Feola, L. Paesano, M. D'Onofrio, E. D'Agostino, S. Formisano (University of Naples "Federico II", Naples, Italy) |
| P-593 COST-UTILITY ANALYSIS OF ANTENATAL SCREENING FOR NEONATAL ALLOIMMUNE THROMBOCYTOPENIA |
| M.K. Killie, J. Kjeldsen-Kragh, A. Husebekk, B. Skogen, J.A. Olsen, I.S. Kristiansen (University Hospital of Northern Norway, Tromsø, Norway) |
| P-594 PLATELET ANTIBODIES IN TRANSFUSED THAI PATIENTS |
| A. Romphruk, C. Puapairoj, J. Prasertsang, C. Wanhakit, S. Wiengnon, C. Sirijeerachai, C. Leelayuwat (Khon Kaen University, Khon Kaen, Thailand) |
| P-595 CHARACTERIZATION OF HUMAN PLATELET ANTIGENS IN THE ARGENTINEAN POPULATION |
| D.A. De la vega Elena, S. dr. Oyonarte, N. dr. Nogués, P.D. prof. Blanzaco, E. dr. Theiller, M.A. dr. Raillon, S. dr. Chialina, E. prof. Solis, A. dr. Fernández Montoya, V. prof. Crespo Ferrer, A. prof. Campos Muñoz, E. dr Muñiz-Diaz (Hospital Italiano Garibaldi, Rosario, Argentina) |
| P-596 IMMUNE PLATELET TRANSFUSION REFRACTORINESS (PTR): PLATELET ANTIBODY TESTING AND TRANSFUSION SUPPORT |
| H. Pearson, W. Grimm, J. Moss, N. Watson, S. Gordon, P.M. Dennington, H. Dunckley (Australian Red Cross Blood Service, Sydney, Australia) |
| TOPIC 10.3 |
| Topic 10.3. |
| Platelet - Biology |
| P-597 ASSESSMENT OF IN VITRO PLATELET ACTIVATION AFTER ADP STIMULI USING FLOW CYTOMETRY AND ADVIA 120 |
| Y.A. Lim, S.R. Cho, W.G. Lee, S.M. Lee, S.W. Kim (Ajou University School of Medicine, Suwon, South-Korea) |
| P-598 PLATELET ADDITIVE SOLUTION FOR EXTENDED PLATELET STORAGE |
| A. Castrillo, M. Adelantado, A. Castro, M. Abalo, C. Areal, J. Cid, A. Eiras, J. Flores, J. Cabrera (Centro de Transfusion de Galicia, Santiago De Compostela, Spain) |
| P-599 DYNAMIC OBSERVATIONS FOR YEARS ON PLATELETAPHERESIS CONCENTRATES CRYO-PRESERVED AT MINUS EIGHTY DEGREES CENTIGRADE (I): IN VITRO CHANGES OF ADHESION, AGGREGATION AND FACTOR III ACTIVITY |
| W.G. Zhu, L.K. Kong (Shenzhen Blood Center, Shenzhen, China) |
| P-600 BLOOD SAMPLES EXPOSED TO 4 DEGREES C: EFFECTS ON A PLATELET ADHESION AND AGGREGATION TEST – THE CONE AND PLATELET ANALYSER (CPA) – IMPACT R |
| P. Sandgren, G. Naess, A. Shanwell (Karolinska University Hospital, Stockholm, Sweden) |
| P-601 OSCILLATION OF GPIIB/IIIA SURFACE EXPRESSION IN PLATELETS, A NOVEL MEASURE OF SUBACUTE ACTIVATION |
| G. Wong, J. Ma (Canadian Blood Services, Edmonton, Alberta, Canada) |
| P-602 PLATELET ACTIVATION DURING TRIMA ACCEL SYSTEM SEPARATION |
| J. Antoniewicz-Papis, E. Lachert, A. Goller, J. Kubis, A. Rosiek, D. Piotrowski, M. Letowska (Institute of Hematol. and Blood Transf., Warsaw, Poland) |
| P-603 EFFECT OF EXTRACELLULAR PH ON PLATELET CONCENTRATES |
| D. de Korte, D.W.C. Dekkers, I. de Cuyper, R. Verhaar, P.F. van der Meer, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-604 REGULATION OF PHOSPHATIDYLSERINE EXPOSURE BY THE AMP-DEPENDENT KINASE IN HUMAN PLATELETS |
| D. de Korte, D.W.C. Dekkers, I. de Cuyper, C.W.N. Gouwerok, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-605 COMPARISON OF PH IN PLATELET CONCENTRATES WITH ADDITIVE SOLUTIONS III MODIFIED FOR 9 DAYS |
| N.V. de Valensart, M. Leclercq, A. Rapaille, D. Sondag, M. Lambermont (Service du Sang, Belgian Red Cross, Liège, Belgium) |
| P-606 PLATELET COUNTING USING VARIOUS HEMATOLOGY CELL ANALYZERS |
| M.J. Dijkstra-Tiekstra, W. Kuipers, A. Setroikromo, J. de Wildt-Eggen (Sanquin Blood Bank North East Region, Groningen, Netherlands) |
| P-607 EFFECT OF STORAGE TIME OF WHOLE BLOOD ON PLATELET CONCENTRATES IN VARIOUS PLATELET SYSTEMS |
| M.J. Dijkstra-Tiekstra, W. Kuipers, A. Setroikromo, C.J. van Delden, J. de Wildt-Eggen (Sanquin Blood Bank North East Region, Groningen, Netherlands) |
| P-608 FACTOR XIII ACTIVITY IN PLATELET RICH AND POOR PLASMA. |
| I.B. Suh, S.W. Ryu, C.S. Lim (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea) |
| TOPIC 11.1 |
| Topic 11.1. |
| Quality Management - Regulatory |
| P-609 E-TEACHING IN TRANSFUSION MEDICINE FOR MEDICAL STUDENTS |
| R.M. Moog (University Clinics Essen, Essen, Germany) |
| P-610 QUALITY CONTROLS OF HEMOCOMPONENTS |
| S. Misso, L. Paesano, M. D'Onofrio, B. Feola, G. Fratellanza, E. D'Agostino, M. Nigro, A. Minerva, S. Formisano (Unit Operative Haemapheresis, Caserta, Italy) |
| P-611 THE NEW GUIDELINES FOR TRANSFUSION PRACTICE (TP) AND THE NEW INDICATION CRITERIA OF BLOOD PRODUCTS FOR TRANSFUSION IN JAPAN |
| K. Takahashi (The University of Tokyo, Tokyo, Japan) |
| P-612 BIOLOGIC PRODUCT DEVIATIONS MONITORING: DOES A DECREASE IN NUMBER EQUATE WITH IMPROVED PROCESS CONTROL? |
| C.F.M. Danielson, J. Vian, M. Rasmussen, A. Parker (Wishard Memorial Hospital, Indianapolis, United States of America) |
| P-613 A JOURNEY THROUGH THE EARLY DAYS OF BLOOD TRANSFUSION |
| D.W. Brown, D. Hill (South African National Blood Service, Bloemfontein, South Africa) |
| P-614 SANBS NOW TO ACCREDITATION |
| B. Mr. Watt (South African National Blood Service (SANBS), Roodepoort, South Africa) |
| P-615 FROM THEN TO ACCREDITATION |
| B. Mr. Watt, B. Hlalukana, D. Hill (South African National Blood Service (SANBS), Roodepoort, South Africa) |
| P-616 CHANGE CONTROL: A USEFUL TOOL FOR MANAGING CHANGES IN CITM |
| D. Sarlija, T. Vuk, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-617 FORMULATING A MISSION STATEMENT FOR THE ZAMBIA NATIONAL BLOOD TRANSFUSION SERVICE |
| T Sakala, M Chama, K Muyinda, M Mulenga (Zambia National Blood Transfusion, Lusaka, Zambia) |
| TOPIC 11.2 |
| Topic 11.2. |
| Quality Management - Industry Perspective |
| P-618 USING NEW QUALITY TOOLS FROM LEAN MANUFACTURING TO EVALUATE PRETRANSFUSION TESTING WORK PROCESSES |
| P. Bonomo, S. South, W. Malomgre, C. Criscione (Azienda Ospedaliera Civile MPA Ragusa, Ragusa, Italy) |
| P-619 RESULTS IN APPLYING LEAN QUALITY TOOLS TO PRETRANSFUSION TESTING PROCESSES IN A LARGE METROPOLITAN HOSPITAL IN ITALY |
| A. Bulla, F. Curti, S. South, W. Malomgre (ASO San Giovanni Battista, Torino, Italy) |
| P-620 USING LEAN TOOLS TO ASSESS WORK PROCESSES IN A LARGE TRANSFUSION SERVICE BEFORE IMPLEMENTING AUTOMATION |
| A. Dada, S. South, T. Casina (Clinic of University of Regensburg, Regensburg, Germany) |
| P-621 TAKING LESSONS FROM HENRY FORD AND APPLYING THEM TO PRETRANSFUSION TESTING |
| C. Colavecchia, L. Merkley, A. Coovadia, J. Callum, M. Reis, T. Casina, S. South (Sunnybrook & Womens College HS Centre, Toronto, Canada) |
| P-622 GOING LEAN IN AN AUSTRALIAN TRANSFUSION SERVICE |
| K. Toumpas, S. South, W. Malomgre (Queensland Medical Laboratory, West End, Australia) |
| P-623 PROCESS IMPROVEMENTS IDENTIFIED IN A UK TRANSFUSION SERVICE LABORATORY WITH QUALITY TOOLS FROM LEAN MANUFACTURING |
| F. South, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| P-624 OUR EXPERIENCES IN INTRODUCING THE QUALITY SYSTEM ISO 9001:2000 |
| V. Urlep Salinovic, I. Maracic, B. Majcen Vivod, L. Lokar, B. Bizjak, P. Leber (Maribor Teaching Hospital, Maribor, Slovenia) |
| P-625 PRODUCTION OF STANDARDIZED LABILES BLOOD PRODUCTS FROM A SINGLE WHOLE BLOOD DONATION AT THE EFS–ALSACE BLOOD CENTER |
| H. Isola, F. Bigey, D. Kientz, C. Waller, M. Laforet, M.L. Wiesel, J.P. Cazenave (EFS-ALSACE, Strasbourg, France) |
| P-626 ANALYSIS OF QUALITY CONTROL DATA IN THE ASSESSMENT OF LEUKOREDUCED BLOOD PRODUCTS |
| C. Jenkins, D. Devine, S. Doyle (Canadian Blood Services, Ottawa, Canada) |
| P-627 USING LEAN TOOLS TO IDENTIFY IMPROVEMENT OPPORTUNITIES IN NINE TRANSFUSION SERVICES IN FIVE COUNTRIES |
| F. South, W. Malomgre, T. Casina (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| TOPIC 11.3 |
| Topic 11.3. |
| Quality Management - Automation and Data Processing |
| P-628 THE USE OF ISBT 128, A QUALITY SYSTEM FOR STANDARDIZED BAR CODE LABELLING OF BLOOD PRODUCTS WORLD WIDE. FOUR YEARS OF EXPERIENCE IN NORWAY |
| G.S. Aandahl, T.R. Knutsen, K. Nafstad (Akershus University Hospital, Oslo, Norway) |
| P-629 AUTOMATION OF BLOOD BANK TESTS IMPROVE THE EFFECTIVENESS OF THE LAB |
| K.C. Kwon, C. Ihm (Chungnam National University, Taejeon, South-Korea) |
| P-630 A STRATEGIE FOR FAST, RAPID AND COST- EFFECTIVE DETERMINATION OF CELL VITALITY PARAMETERS DURING STORAGE OF PACKED RBC’S |
| A. Doescher, E.K. Petershofen, C. Vogt, C. Grote, T. Mueller (German Red Cross Blood Transf.Service, Oldenburg, Germany) |
| P-631 BLOOD BAGS WITH INTEGRATED RFID-LABELS TO PROVIDE A COMPLETE TRACEABILITY FROM PRODUCTION TO PATIENT: FIRST ROUTINE EXPERIENCES AND FUTURE PROSPECTS |
| T. Wagner, J. Zimmermann, G. Schwondra, U. Ockenfuss, M. Behague, F. Bidet, W. Kaufmann, G. Lanzer (University Hospital Graz, Graz, Austria) |
| P-632 IMPLEMENTATION OF ISBT 128 BLOOD LABELING IN IRANIAN BLOOD TRANSFUSION ORGANIZATION |
| M. Fallah Tafti, M. Fallah Tafti, M. Mahmoodian Shooshtari, A. Talebian (Research Center Blood Transfusion Org., Tehran, Iran) |
| P-633 VALIDATION OF COMPUTER SYSTEMS - A NEW CHALANGE FOR QA |
| O. Frenkel, G. Roshkin, S. Abramov, R. Goldman-Levy, B. Rubin, V. Yahalom, E. Shinar (National Blood Services, Ramat-gan, Israel) |
| P-634 TECAN TE-POOLSAFE(TM) BALANCE MODULE ALLOWS MONITORING OF THE POOLING PROCESS FOR NAT-TESTING |
| M.K. Hourfar, M. Koller, R. Kehrli, A. Themann, W.K. Roth, E. Seifried, M. Schmidt (German Red Cross, Institute Frankfurt, Frankfurt, Germany) |
| P-635 HIGHLY SENSITIVE AND FULLY AUTOMATED HBV DNA EXTRACTION WITH THE QIAGEN BIOROBOT MDX TO INDENTIFY CHRONIC HBV CARRIERS |
| M.K. Hourfar, A. Themann, V. Brixner, E. Seifried, M. Schmidt (German Red Cross, Institute Frankfurt, Frankfurt, Germany) |
| P-636 TAQMAN NADIS ENABLES FULL MONITORING OF NAT SCREENING AND PRODUCTION OF NAT REAGENTS |
| M.S. Schmidt, A. Themann, V. Brixner, E. Seifried, M.K. Hourfar (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-637 EVALUATION OF THE COLLECTION LEUKOREDUCED DOUBLE RED CELL CONCENTRATES BY HAEMONETICS MCS PLUS |
| G.A.O.B. Barna, R.K.F. Guillaume, C.R. Kamakura, S.R. Matana, A. Mendrone Jr, M.V. Moço, P.C. Sierra, S.M. Winkaler, P.E. Dorlhiac-Llacer, D.A.F. Chamone (Pro-Sangue Sao Paulo Blood Center, Sao Paulo, Brazil) |
| P-638 EVALUATION OF THE UNIVERSAL BLOOD COMPONENT EXTRACTOR PRESSOMAT FOR MORE AUTOMATION IN WHOLE BLOOD SEPARATION |
| C. Stebler, L. Infanti, M. Santoro, T. Rüefli, M. Brändle, A. Fahrni, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-639 BLOOD BANK BILLING: CUSTOMIZING, INTERFACING, OPTIMIZING AND STANDARDIZING |
| K. De Smidt, B. Hendrickse, H. Harneker, E. Erasmus (Western Province Blood Transf. Serv., Pinelands, South Africa) |
| TOPIC 11.4 |
| Topic 11.4 |
| Quality Management - Haemovigilance |
| P-640 TRALI:FRANCE MAKES UP FOR ITS LOST TIME |
| D.R. Rebibo, L.H. Hauser, J.Y.M. Muller, R.D. Dorne, F.D. Ducroz, O.F. Fontaine, K. Lee, M.C.M. Merillon, F.M. Meyer, H.O.M. Odent-Malaure, N. Ounnoughene, C.R. Rieux, A.S. Slimani, M. Tazerout, G.A. Andreu (EFS, Paris, France) |
| P-641 A FIVE YEARS FOLLOW UP OF POSTTRANSFUSION REACTIONS REPORTED TO THE BLOOD TRANSFUSION INSTITUTE IN NOVI SAD |
| B. Pekovic, G. Dimitrijevic (Blood Transfusion Institute, Novi Sad, Serbia and Montenegro) |
| P-642 LEUKOCYTE ANTIBODIES IN BLOOD DONORS AND A LOOKBACK ON RECIPIENTS OF THEIR BLOOD COMPONENTS |
| K. Maslanka, H. Michur, B. Zupanska, R. Mika-Witkowska, E. Sobczak, A. Smolarczyk, J. Rumas-Bec, D. Domanska, B. Wlodarczyk (Institute of Haematol and Blood Transf., Warsaw, Poland) |
| P-643 HEMOVIGILANCE IN THE HRADEC KRALOVE UNIVERSITY HOSPITAL - 3 YEARS SURVEY OF TRANSFUSION INCIDENTS |
| V. Rehacek, J. Podzimkova, H. Jirousova (University Hospital, Hradec Kralove, Czech Republic) |
| P-644 REFERENCE SAMPLE ARCHIVING FOR BLOOD DONORS |
| N. Solaz, A. Kemahli, S. Aydogan, S. Mert (Ankara University, Ankara, Turkey) |
| P-645 A HEMOVIGILANCE STUDY OF THE APPROPRIATENESS OF FRESH FROZEN PLASMA TRANSFUSION IN SINGAPORE |
| M. Alcantara, J. Ng, B.C. Koh, H. Tan (Health Science s Authority, Singapore, Singapore) |
| P-646 AN AUDIT OF BLOOD ORDERING PRACTICE |
| J. Mesaric, M. Herceg, C. Maglov, I. Jukic (Croatian Institute of Transfusion Medicine, Zagreb, Croatia) |
| P-647 LOOK BACK STUDY OF SERCONVERTED DONORS - WHAT'S THE MESSAGE? |
| V.B. Yahalom, O. Frenkel, R. Daniel, V. Gendelman, A. Korbs, E. Shinar (Magen David Adom - NBS, Ramat Gan, Israel) |
| P-648 HAEMOVIGILANCE IN SLOVENIA 2002-2005 |
| M. Potocnik, M. Macek, V. Hra‰ovec, B. Bizjak, S. Maver, I. Bricl (Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia) |
| P-649 MANAGEMENT OF EVENTS IN CITM |
| T. Vuk, D. Sarlija, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-650 THE TRANSFUSION REPORTS OF GRADE 0 : A NATIONAL DESCRIPTIVE ANALYSIS ON TWO YEARS OF FRENCH PRACTICE |
| K. Martinière, K. Martinière, M.P. Vo Mai, J.J. Cabaud, J.F. Legras, P. Zorzi (Afssaps, Saitn-Denis, France) |
| P-651 HAEMOVIGILANCE - A LABORATORY PERSPECTIVE |
| L. Ramsundar, E. Smart (South African National Blood Service,ECR, Durban, South Africa) |
| P-652 THE FIRST TWO YEARS OF NATIONAL HEMOVIGILANCE REPORTING IN THE NETHERLANDS |
| J.C. Wiersum-Osselton, M.R. Schipperus (TRIP Dutch National Hemovigilance Office, The Hague, Netherlands) |
| P-653 LACK OF HBV TRANSMISSION BY RED BLOOD CELL AND PLATELET CONCENTRATES FROM CHRONIC HBV DNA POSITIVE/HBSAG NEGATIVE DONOR WITH ANTI-HBC AND ANTI-HBE ANTIBODIES. |
| E. Brojer, D. Boguszynska, K. Kledzik, M. Dobrowolna, E. Brojer, M. Letowska, G. Liszewski, J. Styczynski (Institute of Haematology and Blood Transfusion, Warsaw, Poland) |
| P-654 TIME-TRENDS OF ACUTE AND DELAYED IMMUNOLOGIC TRANSFUSION REACTIONS IN E-FIT, THE FRENCH HEMOVIGILANCE DATABASE |
| P. Renaudier, M.P. Vo Mai, N. Ounnoughene, P. Breton, S. Cheze, A. Girard, L. Hauser, J.F. Legras, D. Rebibo, S. Schlanger, C. Waller, C. Caldani (Hopital de la Croix Rousse, Lyon, France) |
| P-655 DANISH REGISTRATION OF TRANSFUSION RISK (DART) |
| E. Morling Taaning, J. Jorgensen, K. Riisom (Herlev Hospital, University of Copenhagen, Herlev, Denmark) |
| TOPIC 12.0 |
| Topic 12.0 |
| Blood Inventory Management, including Disaster Management |
| P-656 THE IMPACT OF THE INTERNET FOR RECRUITMENT OF FIRST TIME DONORS IN A UNIVERSITY BLOOD TRANSFUSION SERVICE |
| R.M. Moog, K. Fourné (University Clinics Essen, Essen, Germany) |
| P-657 IMPACT OF HOSPITAL TRANSFUSION COMMITTEE ON FRESH FROZEN PLASMA USAGE |
| Y.Y. Huang, C.C. Yang, W.H. Shih, Y.C. Sung (Cathay General Hostipal, Taipei, Taiwan) |
| P-658 THE ELECTRONIC CROSSMATCH AND VALIDATION OF GUIDELINE COMPLIANCE BY LABORATORY STAFF, PRIOR TO BLOOD ISSUE, IS HIGHLY EFFECTIVE IN BLOOD CONSERVATION ENABLING A 29% REDUCTION IN BLOOD USE IN ONE YEAR |
| J. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom) |
| P-659 APHERESIS DONATIONS, DO THEY IMPLY AN EXCESSIVE COST AND NOT ENOUGH ADVANTAGES? |
| M. Jimenez-Marco, M. Galmes, M. Sedeno, E. Girona, A. Forteza (Fundacio Banc de Sang Balears, Palma De Mallorca, Spain) |
| P-660 PLATELET INVENTORY MANAGEMENT ACROSS THE BLOOD SUPPLY CHAIN |
| J.F. Chapman, R. Hick, M. Jelly (Blood Stocks Management Scheme, London, United Kingdom) |
| P-661 PLATELET AUDIT: ASSESSMENT AND UTILIZATION OF THIS PRECIOUS RESOURCE FROM A TERTIARY CARE HOSPITAL |
| K. Saluja, B. Thakral, R.R. Sharma, N. Marwaha (PGIMER, Chandigarh, India) |
| P-662 WHAT PARAMETERS PREDICT CHANGES IN THE USE OF RED BLOOD CELL CONCENTRATES |
| C.J. van Delden, W.J. Hoekstra (Sanquin, Groningen, Netherlands) |
| P-663 COMPARISON OF DOUBLE DOSES PLATELET COLLECTIONS FROM TWO APHERESIS DEVICES |
| M. Jimenez-Marco, A. Forteza, E. Girona, M. Sedeno, A. Forteza (Fundacio Banc de Sang Balears, Palma De Mallorca, Spain) |
| P-664 METHODS FOR IMPROVING RECOVERED PLASMA YIELDS |
| K Myers, L. Fults, N. Kalmin, K. Riggins (South Texas Blood & Tissue Center, San Antonio, United States of America) |
| P-665 THE ROLE OF THE SURGICAL CLINICS IN CLINICAL USE OF BLOOD |
| N. Borici, E. Berberi, I.Seferi (National Transfusion Centre,Tirana, Albania) |
| P-666 EFFECTIVE BLOOD INVENTORY MANAGEMENT |
| P.B. Prcic-Knezevic (Health Center Subotica, Subotica, Serbia and Montenegro) |
| P-667 PLASMA COMPONENTS AVAILABLE FOR IMMEDIATE TRANSFUSION |
| A.C. Norda, O. Åkerblom, F. Knutson (Uppsala University Hospital, Uppsala, Sweden) |
| P-668 UNDERSTANDING THE DYNAMICS OF THE BLOOD SUPPLY CHAIN: IS PREDICTION POSSIBLE? |
| J.F. Chapman, R. Hick, R.D. Wilding (Blood Stocks Management Scheme, London, United Kingdom) |
| P-669 HEMOLYSIS EVALUATION IN RETURNED RED BLOOD CELLS CONCENTRATES |
| L.A. Amorim, L.M. Amorim, T.M. Ferreira, J.F. Oliveira, M.E. Lopes (Hemorio, Rio De Janeiro, Brazil) |
| TOPIC 13.0 |
| Topic 13.0 |
| Structure and Governance of Blood Transfusion Services |
| P-670 SUPPLIMENT OF SAFE BLOOD TRANSFUSION |
| T.T. Timova, L. Maninska, D. Stambolieva (General hospital-Strumica, Strumica, Macedonia) |
| P-671 ORGANIZATION AND MANAGEMENT OF TRANSFUSION MEDICINE |
| S.B. Balen, N. Vukelic Damijani (Clinical Hospital Center Rijeka, Rijeka, Croatia) |
| P-672 A NATIONAL BLOOD POLICY IS BORN |
| F. Moftah (NBTS, MOH, Giza, Egypt) |
| P-673 NEEDS AND ESSENTIALS FOR NATIONALLY SUPPORTED STRCUTURE AND ORGANISATION OF THE BLOOD SUPPLY: THE SANQUIN MODEL |
| C.Th. Smit Sibinga (Academic Institute IDTM, Groningen, Netherlands) |
| P-674 BLOOD- FROM EXTREMELY RISKY TO SINCERE: THE NEED FOR POSTACADEMIC LEADERSHIP DEVELOPMENT |
| C.Th. Smit Sibinga (Academic Institute IDTM, Groningen, Netherlands) |
| P-675 BILATERAL INVOLVEMENT OF HEALTH AUTHORITIES, THE KEY TO SUCCESSFUL COOPERATION PROGRAMMES |
| C. Hossenlopp, A. Beauplet, P. Herve (Etablissement Francais du Sang, Paris, France) |
| P-676 EVALUATION OF HOSPITAL BLOOD TRANSFUSION COMMITTEES AND RETURN RATE OF UNUSED BLOOD IN IRAN |
| S. Zolfaghari, D. Bashash, S. Amini Kafi Abad, G. Heidari Rad, M. Shariati (Iranian Blood Transfusion organization, Tehran, Iran) |
| P-677 POSITIVE IMPACT OF NATIONAL SOCIETY TO LAST DECADE PROGRESSES IN BLOOD BANKING & TRANSFUSION MEDICINE PRACTICE IN TURKEY |
| N. Solaz, K. BBTST (Ankara University, Ankara, Turkey) |
| P-678 TWENTY-TWO FRENCH SPEAKING COUNTRIES FROM AFRICA TO BUILD UP LONGER TERM BLOOD SAFETY STRATEGIES |
| C. Hossenlopp, M. Chassaigne, K. Kezzal, M. Ardjoun, A. Beauplet (Etablissement Francais du Sang, Paris, France) |
| P-679 THE PROFIT OF CONTROLLING THE COSTS AND MARGINS OF TRANSFUSION MEDICINE: AN EXPERIENCE OF THE ACTIVITY BASED COSTING (ABC) METHOD |
| G. Follea, L. Deslande (EFS, Nantes, France) |
| P-680 THE CONTRIBUTION OF BLOOD TO HOSPITAL REVENUE IN THE UNITED STATES |
| J. Macpherson, C. Brown Mahoney, L. Katz, C. Bianco (America's Blood Centre, Washington, United States of America) |
| P-681 BLOOD TRANSFUSION IN ALGERIA |
| K.I. Souami, S. Senoussaoui, N. Benchehida, N. Kaouadji, N. Bouzid, N. Bouzid, S. Mokrani, K. Kezzal (National Blood Agency (Ministery of heathl, Algiers, Algeria) |
| TOPIC 14.0 |
| Topic 14.0 |
| Transfusion in Resource Limited Countries |
| P-682 SOCIETAL MARKETTING: THE WAY TO ACHIEVE 100% VOLUNTARY NON-REMUNERATED BLOOD DONORS (VNRBD) AND TO ATTAIN 100% COMPONENT PREPARATION IN DEVELOPING COUNTRIES |
| N. Choudhury, J. Shah, B. Buch (Prathama Blood Center, Ahmedabad, India) |
| P-683 AUDIT OF REQUISITION FORMS FOR RED CELLS |
| H. Ranganathan (Global Hospital, Hyderabad, India) |
| P-684 HIGH INCIDENCE OF HAEMOLSINS AMONG SICKLE CELL ANAEMIA (SCA) PATIENTS WITHIN CALABAR METROPOLIS |
| A. Anyanwu, A.O. Emeribe, J. Akpotuzor, I. Ajayi (Ambrose Alli University, Ekpoma, Nigeria) |
| P-685 QUALITY ASSESSMENT OF HOSPITAL BLOOD BANKS IN BOTSWANA |
| M. Gaolekwe, S. Gaolekwe, C. Pule, B. Gibbs, M. Kayembe, J. van Hasselt, K. Ntshambiwa (Safe Blood for Africa, Johannesburg, South Africa) |
| P-686 ETHNIC COMPOSITION OF BLOOD DONORS POOL |
| J. Samonikov Tosevska, T. Uzunovska, S. Stojkoska, M. Bucevska, T. Makarovska-Bojadzieva, B. Blagoevska (City Hospital surgical clynic, Skopje, Macedonia) |
| P-688 ALGORITHM FOR RECALL OF HIV REACTIVE INDIAN BLOOD DONORS BY SEQUENTIAL IMMUNOASSAYS ENABLES SELECTIVE DONOR REFERRAL FOR COUNSELING |
| B. Thakral, K. Saluja, R.R. Sharma, N. Marwaha (PGIMER, Chandigarh, India) |
| P-689 TRANSFUSION MEDICINE TRAINING IN REPUBLIC TAJIKISTAN |
| B. Bahovadinov, L. Murotov (Republican Sientific Centre of Blood, Dushanbe, Tajikistan) |
| P-690 PROBLEMS OF RECRUITING BLOOD DONORS IN THE REPUBLIC OF TAJIKISTAN |
| B. Bahovadinov, S. Edalieva (Republican Sientific Centre of Blood, Dushanbe, Tajikistan) |
| P-691 APPRAISAL OF PLATELET UTILIZATION PRACTICE AT A TEACHING HOSPITAL BLOOD BANK IN INDIA |
| A. Verma, P. Pandey, D. Khetan, R. Chaudhary (Sanjay Gandhi P.G.I., Lucknow, India) |
| P-692 COST-EFFECTIVENESS OF INTERVENTIONS ENSURING BLOOD TRANSFUSION SAFETY IN AFRICA |
| M. van Hulst, N. Dhingra, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital, Groningen, Netherlands) |
| P-693 BLOOD TRANSFUSION DEMAND AND SUPPLY AT EIGHT HOSPITALS IN KENYA |
| J. Mwangi, L.H. Marum, J.A. Nyamongo (Centers for Disease Control and Preventi, Nairobi, Kenya) |
| P-694 EVALUATION OF EFFICACY AND EFFICIENCY OF THE HEMOMINAS FOUNDATION, A PUBLIC, CENTRALIZED TRANSFUSION SERVICE IN BRAZIL |
| A.B.F. Carneiro-Proietti, J.M.G. Cioffi, T.M.G. Menicucci (Hemominas Foundation, Belo Horizonte, Brazil) |
| P-695 KNOWLEDGE OF GUIDELINES, ATTITUDE TOWARDS BLOOD SAFETY AND TRANSFUSION PRACTICE: AN INDIAN EXPERIENCE |
| K. Chaudhary (Dr. Ram Manohar Lohia Hospital, New Delhi, India) |
| P-696 ORGANISATIONAL AND SOCIAL FACTORS AFFECTING TRANSFUSION PRACTICE: NEED FOR CONTEXTUAL ADAPTATION OF INTERNATIONAL GUIDELINES |
| K. Chaudhary (Dr. Ram Manohar Lohia Hospital, New Delhi, India) |
| P-697 BLOOD SAFETY SITUATION IN THE WHO AFRICAN REGION IN 2004 |
| J.B. Tapko, O. Sam, A.J. Diarra-Nama (W.H.O., Brazzaville, Congo) |
| P-698 EVALUATION OF DETECTION TESTS OF HIV (MUREX HIV 1-2-0, MUREX HIV AG/AB COMBINATION) AND OF THE HEPATITIS B (MUREX HBSAG) IN THE NATIONAL CENTER OF BLOOD TRANSFUSION OF CONAKRY |
| A. Loua, F. Sylla, M. Camara, M.A. Bah (Centre National de Transfusion Sanguine, Conakry, Guinea) |
| P-699 IMPACT ON THE ORGANIZATION OF SAFE BLOOD SERVICES TO RESPOND TO THE INCREASE IN DEMAND FOR BLOOD COMPONENTS DURING THE RAINY SEASON IN COTE D’IVOIRE |
| S. Konaté, S. Doukouré, T. Dogbo, N. Abbe-Koffi, A. Sasse, C. Fretz, J. Siquet, D. Sondag-Thull, P. Rao, J.J. Fournel (National Blood Transfusion Center, Abidjan, Ivory Coast) |
| P-700 COSTING OF BLOOD PRODUCTS AND SERVICES IN A HYPERINFLATIONARY ENVIRONMENT |
| Z. Musekiwa, A. Mupuwi, G. Nyashanu, J. Jowa (National Blood Service Zimbabwe, Harare, Zimbabwe) |
| P-701 REJECTED BLOOD COMPONENTS BY QC IN THE PRODUCTION FORCE IMPLEMENTATION OF A QA SYSTEM |
| O. Todorovska, K. Dimitrovski, V. Stefanovska, D.N. Dimovska (Institute of Transfusion Medicine, Skopje, Macedonia) |
| P-702 IS SERBIA A RESOURCE LIMITED COUNTRY-CONCERNING TRANSFUSION |
| G. Dimitrijevic, B. Pekovic, L. Sikimic, C. Gavrancic, G. Bogdanovic (Blood transfusion Institute, Novi Sad, Serbia and Montenegro) |
| P-703 ESTABLISHMENT OF A NATIONAL BLOOD SERVICE IN NIGERIA |
| F. Ayo (Federal Ministry of Health Nigeria, Abuja, Nigeria) |
| P-704 A RAPID SCALE UP OF THE BLOOD SAFETY PROGRAMME IN ZAMBIA |
| K. Muyinda, K. Mulenga, N. Chikwese (Zambia National Blood Transfusion Servic, Lusaka, Zambia) |
| TOPIC 15.0 |
| Topic 15.0 |
| Emerging Technologies |
| P-705 INVITRO EVALUATION OF CYTARABIN INDUCED APOPTOSIS ON LEUKEMIC BLASTS ( AML & ALL ) |
| M. Zandieh, M. Safari Fard, M. Nikogoftar. (Iranian Blood Transfusion Company, Tehran, Iran) |
| P-706 A COMPARISON OF SERPREVALENCE OF BLOODBRON INFECITONS AMONG REGULAR, SPORADIC AND FIRST TIME BLOOD DONORS IN ISFAHAN: AUGUST 2002 MARCH 2003 |
| Z. Massaeli, M.R. Jaberi, M. Maghsodlu (Iranian Blood Transfusion Organisation, Isfahan, Iran) |
| P-707 EFFICIENCY OF PLASMAPHERESIS FOR PREVENTION AND EARLY THERAPY OF MULTIPLE ORGAN DYSFUNCTION SYNDROM |
| A. Ragimov, S. Poreshina, I. Solovyeva, M. Babaev, E. Salimov, L. Alekseeva, I. Bayramalibeyli (National Research Center of Surgery, Moscow, Russian Federation) |
| P-708 BLOOD COMPONENT FRACTIONATION: IMPACT OF EMERGING TECHNOLOGIES |
| J. Cid, M. Claparols, J.M. Hernández, A. Pinacho, P. Ortiz, L. Puig, R.P. Pla (Banc de Sang i Teixits, Barcelona, Spain) |
| P-709 ERYTHROCYTAPHERESIS IN THE TREATMENT OF EMOCHROMATOSIS |
| M. D'Onofrio, L. Paesano, S. Misso, B. Feola, E. D'Agostino, G. Fratellanza, A. D'Ambra, A. Minerva (AOU "Federico II", Napoli, Italy) |
| P-710 CONCEPTION OF BLOOD FREEZING PROGRAM IN CZECH REPUBLIC |
| M. Bohonek (Central Military Hospital, Prague, Czech Republic) |
| P-711 USERS’ EVALUATION OF AN AUTOMATIC SYSTEM FOR WHOLE BLOOD PROCESSING: ATREUS (VERSION BETA 2.1 AND 2.5) |
| L. Larrea, C. Herreros, M.D. Garcia, M. Gil, E. Costa, I. Saiz, M.A. Soler, R. Roig (Centro Transf de la Comunidad Valenciana, Valencia, Spain) |
| P-712 PURITY OF PLASMA OBTAINED IN ROUTINE BY THE ATREUS 2C+ SYSTEM |
| A.M. Sward-Nilsson, S. Andersson, A. Johansson, P. de Smet (Lund University Hospital, Lund, Sweden) |
| P-713 N VITRO QUALITY OF RED BLOOD CELLS OBTAINED AFTER AUTOMATED SEPERATION OF WHOLE BLOOD BY THE ATREUS 2C+ SYSTEM AND STORED FOR 42 DAYS |
| A.M. Sward-Nilsson, M. Jeansson, E. Gintse, M. Callaert (Lund University Hospital, Lund, Sweden) |
| P-714 QUALITY OF THE PLATELET CONCENTRATES DERIVED FROM ATREUS BUFFY COATS |
| A.M. Sward-Nilsson, M. Jeansson, E. Gintse, M. Callaert (Lund University Hospital, Lund, Sweden) |
| P-715 DEVELOPMENT OF AN IN-LINE PORTABLE NON-ELECTRICALLY POWERED BLOOD AND INTRAVENOUS FLUID WARMER |
| D. Roxby, M. McEwen, J. Robson, R. Woolford (Flinders Medical Centre, Adelaide, Australia) |
| P-716 NEUTROPHIL FUNCTION IS PRESERVED IN A POOLED GRANULOCYTE COMPONENT PREPARED FROM WHOLE BLOOD DONATIONS |
| S. Bashir, E. Massey, S. Stanworth, R. Cardigan (National Blood Service, Essex, United Kingdom) |
| P-717 EIGHT YEARS EXPERIENCE OF THE ELECTRONIC CROSSMATCH DEMONSTRATES IMPROVED EFFICIENCY AND A HIGHLY EFFECTIVE BLOOD CONSERVATION STRATEGY RESULTING IN A 29% REDUCTION IN BLOOD USE IN ONE YEAR |
| J. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom) |
| P-718 COMPARISON OF MANUAL BIOVUE ANTIBODY IDENTIFICATION WITH AUTOMATED IDENTIFICATION USING AUTOVUE INNOVA AND RESOLVIGEN 3 SOFTWARE |
| D. Roxby, M. Phillips, M. Kraft (Flinders Medical Centre, Adelaide, Australia) |
| P-719 SUPPRESSIVE EFFECT OF CASPASE 3 GENE EXPRESSION IN CELLS TRANSFECTED WITH SHRNA EXPRESSION VECTOR |
| L. Gao, H.H. Fan, J. Yang, X.X. Nie, R.F. Xie, Y Liu, Y.M. Yang, K.C. Qian (Shanghai Blood Center, Shanghai, China) |
| P-720 A NEW TELECONSULTATION SYSTEM FOR PRETRANSFUSION TESTING |
| P. Rozman, P. Rozman, I. Bricl, M. Urbajs, M. Macek, M. Breskvar, M. Meza, J. Tasic (Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia) |
| P-721 FLOW CYTOMETRY TESTING OF GRANULOCYTE-ASSOCIATED ANTIBODIES (GA-ABS) IN ADULT PATIENTS: FACTORS AFFECTING OUTCOMES |
| I.Z. Ivankovic, B. Golubic Cepulic (Clinical Hospital Center Zagreb, Zagreb, Croatia) |
| P-722 WHOLE BLOOD COLLECTION WITH PROPORTIONAL CONTINUOUS ANTICOAGULATION USING THE ABC AUTOMATE (MACOPHARMA) |
| F. Bigey, H. Isola, M.L. Wiesel, J.P. Cazenave (EFS - ALSACE, Strasbourg, France) |
| P-723 MACOTRACE® SYSTEM : TRACEABILITY FROM COLLECTION TO BLOOD ISSUING USING RFID TECHNOLOGY WITHIN MACOPHARMA BLOOD PACKS AND EQUIPMENT |
| L. Larrea, M. Ortiz de Salazar, A. Chaves, A. Blanquer, M.A. Soler, I. Ample, P. Dussert (Centro Transf de la Comunidad Valenciana, Valencia, Spain) |
| P-724 AUTOMATED PROCESSING OF PLATELET CONCENTRATES USING ORBISAC SYSTEM |
| M. Santos, A.R. Ferreira, G. Sousa (Instituto Português do Sangue, Lisbon, Portugal) |
| TOPIC 16.0 |
| Topic 16.0 |
| Evidence Based Transfusion Medicine |
| P-725 HIGH-DOSE PLATELET TRANSFUSION INCREASES THE TRANSFUSION INTERVAL: RESULTS OF A META-ANALYSIS |
| J. Cid, M. Lozano, L. Puig (Banc de Sang i Teixits, Barcelona, Spain) |
| P-726 THE TNF-ALPHA 308 POLYMORPHISM IS ASSOCIATED WITH PERSISTENT MICROCHIMERISM IN TRANSFUSED SEVERE TRAUMA PATIENTS |
| T.H. Lee, R. Gill, M.P. Busch (Blood Systems Research Institute, San Francisco, United States of America) |
| P-727 IMMUNOSUPPRESSIVE EFFECT OF AUTOLOGOUS OR ALLOGENEIC BLOOD TRANSFUSION IN ORTHOPEDIC SURGICAL PATIENTS |
| S. Misso, B. Feola, M. D'Onofrio, L. Paesano, G. Fratellanza, E. D'Agostino, A. D'Ambra, P. Amato, A. Minerva, S. Formisano (Unit Operative Haemapheresis, Caserta, Italy) |
| P-728 ERYTHROCYTAPHERESIS IN HEREDITARY HEMOCHROMATOSIS PATIENTS – A STUDY OF IRON ELIMINATION |
| V. Rehacek (University Hospital, Hradec Kralove, Czech Republic) |
| P-729 SANITARY PERSONNEL EXPOSURE TO HBV, HCV AND HIV VIRUSES TRANSMITTED THROUGH BLOOD: THE PROBLEM AND ITS PREVENTION |
| C. Veneti (General Hospital Saint Olga, Athens, Greece) |
| P-730 VERIFICATION THAT REQUESTS FOR BLOOD ARE GUIDELINE COMPLIANT PRIOR TO ISSUE OF BLOOD FROM THE LABORATORY ENABLES THE IMPLEMENTATION OF EVIDENCE BASED TRANSFUSION PRACTICE |
| J. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom) |
| P-731 SUCCESSFUL MANAGEMENT OF A SEVERE STEROID-RESISTANT WARM AUTOIMMUNE HEMOLYTIC ANEMIA WITH PLASMA EXCHANGE |
| A. Verma, S. Sinha, R. Chaudhary, V.L. Ray (Sanjay Gandhi P.G.I., Lucknow, India) |
| P-732 TRANSFUSION REQUIREMENTS FOR PATIENTS UNDERGOING MULTI-VISCERAL AND INTESTINE-ONLY TRANSPLANTATION |
| C.F.M. Danielson, J. Vian, M. Rasmussen, M. Skipworth, W. Jackson, C. McCormick, S. Rothenberger, A. Miguel, E. Vianna, J. Tector III, A. Fridell, P. Mishler, A. Waxman, S. Smith, C. Goggins (Wishard Memorial Hospital, Indianapolis, United States of America) |
| P-733 THE CONTRIBUTION OF THE HOSPITAL TRANSFUSION MEDICINE COMMITTEE IN THE RATIONAL USE OF BLOOD AND BLOOD PRODUCTS IN ORTHOPEDIC SURGERY |
| L. Sikimic, G. Dimitrijevic, G. Bogdanovic (Institute of Orthopedic surgery and trau, Beograd, Serbia and Montenegro) |
| P-734 SHORT-TERM AND LONG-TERM SURVIVAL OF TRANSFUSED RBCS: A COMPARISON BETWEEN STORED RCC OF SHORT AND LONG SHELF LIFE |
| M. Luten, B. Roerdinkholder-Stoelwinder, N.P.M. Schaap, J. Curvers, H.J. Bos, W.J. de Grip, G.J.C.G.M Bosman, V.M.J. Novotny (Sanquin Blood Bank South East Region, Nijmegen, Netherlands) |
| P-735 EARLY DIAGNOSIS AND MANAGEMENT OF POSTPARTUM THROMBOTIC MICROANGIOPATHY WITH PLASMA EXCHANGE USING SINGLE DONOR PLASMA AS REPLACEMENT |
| M.S. Shrivastava, S. Naved, A.J. Jain, G.M. Modi (Bhopal Memorial Hospital ( BMHRC), Bhopal, India) |
| P-736 BLOOD-VOLUME; A DECISION TOOL TOWARDS MORE EVIDENCE BASED COLLECTION AND/OR TRANSFUSION OF BLOOD AT THE LEVEL OF THE INDIVIDUAL DONOR OR PATIENT. |
| P.A.H. van Noord, P. VanNoord, I. Veldhuizen, C. Puylaert, E. Rombout, W. de Kort (Julius Center UMCU, Utrecht, Netherlands) |
| P-737 TEN YEARS OF BLOOD TRANSUFSIONS: USE, DISEASE AND SURVIVAL |
| M.P. Janssen, C.L. van der Poel, W.P. Schaasberg, G.J. Bonsel, B.A. van Hout (UMC Utrecht, Utrecht, Netherlands) |
| TOPIC 17.0 |
| Topic 17.0 |
| Other - History of Blood Transfusion |
| P-738 AN EFFICIENT METHOD FOR IMMORTALIZATION OF GENETICS DISORDERS PATIENTS’ LYMPHOCYTES BY EPSTEIN-BARR VIRUS (EBV) |
| Z. Sharifi, M. Parsania, A. Talebian (Research Center of IBTO, Tehran, Iran) |
| P-739 HOW MANY TIMES CAN A PERSON BE TRANSFUSED IN JAPAN? |
| S. Inaba, N. Kinukawa (Kanagawa Red Cross Blood Center, Yokohama, Japan) |
| P-740 A DONOR AND A GENTLEMAN - MR. AHMET ANDICEN; PORTRAIT OF A RECORD OWNER BLOOD DONOR OF TURKEY |
| N. Solaz (Ankara University, Ankara, Turkey) |
| P-741 DEVELOPMENT OF BLOOD TRANSFUSION IN THE REPUBLIC OF MACEDONIA |
| V.S. Stefanovska (Institute of Blood Transfusion, Skopje, Macedonia) |
| P-742 AN HISTORICAL OVERVIEW OF THE USE OF APHERESIS TECHNOLOGY IN SOUTHERN AFRICA (A GRANDMOTHER LOOKS BACK) |
| A.M. Anderson (Haemotec (Pty) Ltd, Edenvale, South Africa) |